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ABSTRACT 
Muscular dystrophies are a group of diseases that are often caused by loss-of-
function mutations affecting the dystrophin glycoprotein complex (DGC). The corn mon 
feature of the diseases is muscle degeneration, which is often associated with mental 
retardation and various retinal defects, including ones of synaptic transmission. 
However, the mechanisms of the disease remain largely unknown, especially those in the 
central nervous system. 1 have focused on dystroglycan (DG), the transmembrane protein 
in the DGC that links the cytoskeleton to the extracellular matrix and is essential for 
muscle survival and brain development. 1 have used proteomics and Drosophila genetics 
to study DG function in the brain and retina. 
Using proteomics 1 found that ~-DG is directly associated with the GTPase 
dynamin 1 in the retina and in the brain together with a-DG and Grb2, and 
immunohistochemically ~-DG was colocalized with dynamin 1 in the outer plexiform 
layer where photoreceptorterminals are localized. Moreover, loss of DG in differentiated 
DG-null embryonic stem cells significantly increases dynamin-mediated transferrin-
uptake and re-expression of DG in null cells by infection with an adenovirus containing 
DG reduced transferrin uptake to levels seen in wild-type cells. This result implies that 
one of mechanisms in muscular dystrophy might be the altered synaptic vesicle 
endocytosis, especially in the retina where synaptic transmission defect has been known 
for decades. 
Muscular dystrophies show not only impaired retinal synaptic transmission and 
several DG-related congenital muscular dystrophies also display retinal structural defects. 
To further understand the roles of DG in the retina, 1 used Drosophila eye as a model and 
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demonstrated for the first time that DG is required cell-autonomously for photoreceptor 
morphogenesis in the developing visual system. Deficiency of DG in the eye causes 
severe disruption of retinal structure, aberrant lens formation and abolition of 
electroretinogram in the adult f1y eye. These adult defects appear derived from 
autonomous photoreceptor cell (PRe) defects in the early pupa including size arrest, loss 
of polarity and progressive degeneration. AlI defects in the eye, however, can be reversed 
by re-expression of wild type DG in DG-deficient PRes, suggesting DG functions cell-
autonomously in PRes and non-autonomously for lens. In the 3rd instar larvae DG is 
present in the apical tips and the basal membranes of PRes, two polarized locations 
opposing the extracellular matrix. At the pupal stage it continues to mainly distribute at 
the apical rhabdomere and basal membrane of PRes. Over-expression of DG leads to 
larger ommatidia but the PRe number remains unchanged, suggesting that DG is both 
necessary for and sufficient to promote PRe expansion. By rescue experiments, 1 
demonstrated that the extracellular DG alone could not rescue DG-deficient eye defects, 
whereas the intracellular DG can substantially ameliorate PRe degeneration and 
structural defects while sorne PRes remain disorganized, a sign of disrupted PRe planar 
polarity in absence of the extracellular DG. Therefore, our data suggest that the 
degeneration and planar polarity disruption in DG-deficient PRes are two independent 
processes that appear to require the respective function of intracellular and extracellular 
DG. In summary, our experiments demonstrated several novel findings and provided the 
basis for future investigations on DG function and the molecular mechanisms of nervous 
system defects in muscular dystrophies. 
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RESUME 
Les dystrophies musculaires sont un groupe de maladies qui sont souvent causées 
par des mutations résultant en une perte de fonction du complexe associé à la dystrophine 
(DGC). Une caractéristique commune de ces maladies est la dégénérescence musculaire, 
qui est souvent accompagnée d'un retard mental et de défauts rétiniens, incluant ceux 
affectant la transmission synaptique. Les mécanismes pathologiques de ces maladies sont 
principalement inconnus, surtout ceux affectant le système nerveux central. J'ai étudié le 
dystroglycane (DG), une protéine transmembranaire du DGC qui lie le cytosquelette 
d'actine à la matrice extracellulaire et qui est essentielle à la survie musculaire et au 
développement du cerveau. J'ai utilisé la protéomique et la génétique de la mouche du 
vinaigre Drosophila pour étudier la fonction de DG dans le cerveau et dans la rétine. 
En utilisant la protéomique, j'ai découvert que ~-DG est directement associé à la 
GTPase dynamine 1 dans la rétine et dans le cerveau ainsi qu'à a-DG et Grb2; par 
immunocytochimie, ~-DG co-localise avec dynamine 1 dans la couche plexiforme 
externe de la rétine là où se trouvent les terminaux des cellules photoréceptrices. La perte 
d'expression de DG dans des cellules souches embryonnaires différentiées et dépourvues 
de DG cause l'augmentation du recaptage de la transferrine contrôlée par la dynamine; la 
ré-expression de DG dans ces même cellules par infection avec un adénovirus exprimant 
DG réduit le recaptage de la transferrine à un niveau similaire aux cellules de type 
sauvage (DG +/+). Ce résultat suggère qu'un des mécanismes pathologiques des 
dystrophies musculaires est d'altérer l'endocytose des vésicules synaptiques, surtout dans 
la rétine où la transmission synaptique défectueuse a déja été décrite. 
Les dystophies musculaires démontrent des défectuosités de la transmission 
synaptique rétinienne, et de plus, plusieurs dystrophies musculaires congénitales reliées 
au DG démontrent des défauts dans la structure de la rétine. Afin de mieux comprendre le 
rôle de DG dans la rétine, j'ai utilisé l'oeil de la mouche du vinaigre Drosophila comme 
modèle et j'ai démontré pour la première fois que DG est nécessaire par autonomie 
cellulaire à la morphogénèse des cellules photoréceptrices (PRC) lors du développement 
du système visuel. La déficience de DG dans l'oeil de mouche cause de sévères défauts 
dans la structure rétinienne et dans la formation du cristallin, ainsi que l'abolition de 
l'électrorétinogramme dans l'oeil adulte. Ces défauts chez l'adulte semblent provenir de 
défauts d'autonomie des PRC dans la pupe incluant un arrêt de croissance, une perte de 
polarité et une dégénérescence progressive. Tous les défauts de l'oeil peuvent être 
corrigés par la ré-expression du gène normal de DG dans les PRC dépourvues de DG, ce 
qui suggère que DG fonctionne par autonomie cellulaire dans les PRC et par non-
autonomie cellulaire dans la formation du cristallin. Dans la larve de 3ième instar, DG est 
présent dans les terminaises apicales et la membrane basale des PRC qui sont deux 
structures polarisées adjacentes à la matrice extracellulaire. A l'étape de la pupe, DG est 
distribué dans le rhabdome apical et la membrane basale des PRC. La sur-expression de 
DG mènent à de plus grosses ommatidies, mais le nombre de PRC reste constant, ce qui 
suggère que DG est à la fois nécessaire et suffisant à l'expansion des PRC. 
Par des expériences de restoration, j'ai démontré que la portion extracellulaire de 
DG ne peut pas corriger les défauts oculaires causés par la déficience de DG, alors que la 
portion intracellulaire de DG peut améliorer considerablement la dégénérescence et les 
défectuosités de structure des PRC malgré que quelques PRC restent désorganisés, ce qui 
indique un défaut dans la polarité des PRe. Par conséquent, nos données suggèrent que la 
dégénérescence et les défauts de la polarité planaire dans les PRe dépourvues de DG 
représentent deux processus indépendants qui semblent requérir des fonctions respectives 
aux portions intracellulaire et extracellulaire de DG. En résumé, nos expériences 
apportent plusieurs nouvelles découvertes et établissent les fondations pour de futurs 
travaux sur la fonction de DG et sur les mécanismes moléculaires des défauts 
pathologiques du système nerveux dans les dystrophies musculaires. 
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Chapter 1 
General Introduction 
1 
RATIONAL AND OBJECTIVES 
Muscular dystrophy is a group of diseases that are often caused by loss-of-
function mutations affecting the dystrophin glycoprotein complex (DGC). The common 
pathological features of the disease involve muscle degeneration, mental retardation 
and various retinal defects. However, mechanisms of the disease are largely unknown, 
especially for those in the nervous system. 
The DGC is a protein complex spanning the sarcolemma in muscle (Fig. 1-1). 
The core members of DGC are comprised of dystrophin, syntrophin, dystrobrevin, 
nNOs in the cytoplasm, protein sarcoglycans (a-, f3-, y- and ô-sarcoglycans) and 
sarcospan in the sarcolemma, and the transmembrane protein dystroglycan (DG) 
(Ervasti and Campbell, 1991; Ervasti and Campbell, 1993b; Ervasti et al., 1991; 
Ibraghimov-Beskrovnaya et al., 1992). DG is comprised of a transmembrane f3-DG and 
an extracellular a-DG (Ervasti and Campbell, 1991; Ibraghimov-Beskrovnaya et al., 
1992). Through the carbohydrate chains of a-DG, the DGC is linked to laminin, agrin 
or perlecan in the extracellular matrix (Bowe et al., 1994; Gee et al., 1993; Gee et al., 
1994; Ibraghimov-Beskrovnaya et al., 1992; Jacobson et al., 2001; Peng et al., 1998; 
Smalheiser and Schwartz, 1987), and to neurexin or the transmembrane agrin in other 
cells (Burgess et al., 2002; Burgess et al., 2000; Sugita et al., 2001). The composition of 
the DGC differs in tissues. For example, at neuromuscular junctions (NMJs), utrophin 
replaces dystrophin to bind to f3-DG (Ohlendieck et al., 1991a); in the central nervous 
system (CNS), no sarcoglycans and sarcospan exist in the complex (Blake and Kroger, 
2000; Imamura et al., 2000) and a-DG connects to neurexin (Sugita et al., 2001). 
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Therefore, it would be very interesting to identify novel proteines) in the CNS of this 
complex. 
Several congenital muscular dystrophies such as Fukuyama congenital muscular 
dystrophy (FCMD), Muscle-eye-brain (MEB) disease and Walker-Warburg Syndrome 
(WWS) are caused by mutations in putative glycosyltransferase genes and result in a 
defective glycosylation of a-DG (Yoshida et al., 2001; Michele et al., 2002; Michele 
and Campbell, 2003; Moore et al., 2002; Muntoni et al., 2002; Jimenez-Mallebrera et 
al., 2003) and display severe mental retardation, disrupted brain architecture, ab normal 
neuronal migration in brain (Michele et al., 2002; Moore et al., 2002) and retinal 
defects in human. The retina defects include severe structural abnormalities, retinal 
degeneration and blindness (Fahnehjelm et al., 2001; Hino et al., 2001; Vervoort et al., 
2004; Zervos et al., 2002). For example, patients with FCMD have misfolded retina and 
impaired retinal structure (Hino et al., 2001). Sorne patients with MEB show retinal 
degeneration and early blindness (Fahnehjelm et al., 2001; Zervos et al., 2002). Mice 
models of FCMD show an abolished electroretinogram (ERG) and severely impaired 
retinal structure (Takeda et al., 2003). Mutations in LARGE gene, encoding a protein 
LARGE that is required for O-linked glycosylation of a-DG (Barresi et al., 2004; 
Kanagawa et al., 2004), lead to muscular dystrophy in humans (congenital muscular 
dystrophy ID) (Longman et al., 2003) and in mice (Grewal et al., 2001; Holzfeind et 
al., 2002). These mi ce have neuronal migration defects in brain and defective synaptic 
transmission, and disrupted ERGs. However, eyes show no signs of neuronal migration 
defects and are largely functional (Grewal et al., 2001; Holzfeind et al., 2002) with only 
mild structural abnormalities in the outer plexiform layer (Lee et al., 2005). Although 
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these retinal phenotypes appear variable, they suggest that function of DG, especially 
the glycosylation of a-DG, is required for the normal retinal development. 
It is known that DG and dystrophin isoforms are expressed in multiple Iayers of 
vertebrate retina, including photoreceptor terminaIs (Blake and Kroger, 2000; Blank et 
al., 2002; Jastrow et al., 2006; Kouien et al., 1998), and synaptic transmission defects in 
muscular dystrophy such as the DuchennelBecker muscular dystrophy (Lenk et al., 
1996; Piliers et al., 1993) caused by mutations in dystrophin gene (Hoffman and 
Kunkel, 1989; Koenig et al., 1988; Monaco et al., 1993) occur between photoreceptors 
and their postsynaptic target celis (Blake and Kroger, 2000). However, we do not know 
the mechanisms leading to the defective synaptic transmission; neither do we know 
those similar synaptic defects in congenital muscular dystrophies. One step toward 
answering the question is to look for novel DG-associated proteins in the CNS. Chapter 
2 of this thesis describes experiments that show DG is associated with the GTPase 
dynamin 1 in brain and in the outer plexiform layer of retina and regulates dynamin-
dependent endocytosis. 
Furthermore, although the function of DG in the brain has been nicely studied in 
brain-specific DG-null mice that show similar defects as in FCMB, MEB, WWS and 
congenital muscular dystrophy ID (Michele et al., 2002; Moore et al., 2002), sorne 
questions remain to be answered. First, we do not know the celi type that causes a 
specific phenotype in brain because DG is expressed in both neuron and glia and the 
gene deletion affects DG in both of them. It is critical to understand in what celi type 
and how the neuronal migration defects unfold and what causes the misfoiding of 
cortex. Furthermore, as suggested from retina in the human congenital muscular 
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dystrophies and in LARGE mutant mice, the phenotypes in retina appear quite variable. 
Therefore, the precise roi es of DG in the eye remain to be revealed in animal models. 
Chapter 3 of this thesis describes experiments using Drosophila eye as a model to study 
DG function in the nervous system. Drosophila allows the unbiased and easily 
manipulable genetics, and its simple anatomy can provide c1ear information about the 
requirement of DG in different developmental stages. Moreover, the highly conserved 
DG structural domains (discussed below in general Iiterature review) suggest a highly 
conserved function in non-vertebrate and vertebrate. My genetic studies reveal that 
deficiency of DG in the eye causes loss of retina, a severe phenotype that is derived 
from autonomous photoreceptor cell (PRC) defect during early pupal development. 
Furthermore, with rescue experiments 1 demonstrate that degeneration and planar 
polarity disruption in DG-deficient PRCs are two independent processes, which appear 
to be functions of intracellular and extracellular DG respectively. 
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GENERAL LITERA TURE REVIEW 
Part 1: Dystroglycan and muscular dystrophy 
1: Muscular dystrophy and the dystrophin glycoprotein complex 
Muscular dystrophies are a group of muscle disorders that primarily affect 
skeletal muscles and are marked by progressive muscle wasting and weakness. Among 
aIl the muscular dystrophies, Duchenne and Becker muscular dystrophies are the most 
common ones, affecting one in 3300 (Duchenne) or 30,000 (Becker) and often leading 
to death in late teens and early twenties (Brown, 1997; Dalkilic and Kunkel, 2003). 
Both diseases are the consequence of mutations in a gene called the Duchenne 
muscular dystrophy (DMD) gene located on the X chromosome and encoding a protein 
called dystrophin (Hoffman and Kunkel, 1989; Koenig et al., 1988; Monaco et al., 
1986). Dystrophin is very large cytoskeletal protein that is underneath the muscle 
sarcolemma, and is completely absent in Duchenne muscular dystrophy (DMD) 
patients but parti aIl y expressed in mil der patients with Becker muscular dystrophy 
(BMD) (Campbell, 1995). Biochemical purification of dystrophin from skeletal muscle 
led to identification of the dystrophin glycoprotein complex (DGC) (Campbell and 
Kahl, 1989; Yoshida and Ozawa, 1990; Ervasti and Campbell, 1991; Ervasti et al., 
1991; Ohlendieck et al., 1991b). The identified complex contains the extracellular 
protein laminin, the transmembrane protein ~-dystroglycan (DG) and its firmly 
attached extracellular protein a-DG, the intracellular proteins syntrophin, dystrobrevin 
as weIl as membrane proteins sarcoglycans and sarcospan (Chan et al., 1998; Ervasti 
and Campbell, 1993b). As illustrated in Figure 1-1, the DGC spans the muscle 
sarcolemma and links the intracellular cytoskeleton to the extracellular matrix through 
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multiple protein-protein interactions (Ibraghimov-Beskrovnaya et al., 1992). 
Intracellularly, actin binds to the N-terminus of dystrophin, whereas DG, syntrophin 
and dystrobrevin bind to its C-terminus. These proteins form cytoplasmic complex and 
are linked to the extracellular matrix through the transmembrane protein DG as its 
extracellular portion binds to matrix protein laminin. Within the sarcolemma four 
sarcoglycans including alpha, beta, gamma and delta, epsilon and zeta-sarcoglycan and 
one sarcospan are associated with DG (Chan et al., 1998). 
It is generally believed that one important function of the DGC is to protect 
muscle sarcolemmal integrity against shear stresses imposed by constant muscle 
contraction. As is known by genetic studies, mutations in genes encoding DGC 
members are responsible for many muscular dystrophies (Table 1) (Campbell, 1995; 
Dalkilic and Kunkel, 2003; Straub and Campbell, 1997). As noted above, mutations in 
dystrophin gene leading to absence or reduced levels of dystrophin protein are 
responsible for DMD and BMD. In addition, mutations in four sarcoglycans are 
responsible for four variants of type 2 Limb-girdle muscular dystrophies (Bonnemann 
et al., 1996; Nigro et al., 1996a; Noguchi et al., 1995; Vainzof et al., 1996). Mutation in 
a2 laminin (merosin) is responsible for at least one form of congenital muscular 
dystrophy as its murine model called dlj mou se (Xu et al., 1994a; Xu et al., 1994b). 
There have no reported human mutations in genes encoding DG, syntrophin or 
dystrobrevin to cause diseases. However, recent studies have found that hypo-
glycosylation of DG on its extracellular a-subunit is associated with several congenital 
muscular dystrophies (discuss below). 
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II: DG and congenital muscular dystrophies 
DG was first found in the brain as a laminin receptor (Smalheiser and Schwartz, 
1987; Douville et al., 1988) and biochemical studies purified it from muscle and 
showed that it is the core member of the DGC by binding to laminin via its 
carbohydrate chains and to dystrophin via its intracellular last 20 amino acids 
(Campbell and Kahl, 1989; Ervasti and Campbell, 1991; Ervasti and Campbell, 1993a; 
Ervasti et al., 1991; Gee et al., 1993; Ibraghimov-Beskrovnaya et al., 1992; Jung et al., 
1995; Ohlendieck et al., 1991b). Deficiency of DG in mice leads to embryonic lethality 
at day 6.5 due to failure in Reichert's membrane formation (Williamson et al., 1997). 
Studies from Drosophila, which has highly conserved DG ortholog, revealed that DG is 
required for apical-basal polarity formation in epithelial cells (Deng et al., 2003). In 
mice, deletion of DG in skeletal muscles causes muscular dystrophy, similar but more 
severe th an dystrophin-null mice (Cohn et al., 2002; Cote et al., 1999). 
DG is encoded as a single polypeptide by a gene located in human chromosome 
2. The polypeptide is post-translationally cleaved into a and ~-subunits, and modified 
by glycosylation (HoIt et al., 2000). ~-DG is inserted into the plasma membrane as a 
single-pass transmembrane protein and a-DG is non-covalently, but stably, associated 
with the N-terminus of ~-DG. Full-Iength DG contains 895 amino acids. The 
extracellular region of a-DG consists of amino acids 1-653, while the transmembrane 
protein ~-DG consists of ami no acids 654-895. There are proline-rich domains that 
contain PxxP or PPxY consensus sequences in the intracellular portion of ~-DG, 
through which DG can bind to the W-W domain of dystrophin, SH3 domain of Grb2 
and other proteins (discussed in part II). a-DG contains a mucin-like region from 
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amino acid 315 to amino acid 485 with high homology (30% identity) to intestinal 
human mucin-2 and other mucin-like proteins (Brancaccio et al., 1995; Ibraghimov-
Beskrovnaya et al., 1992; Smalheiser and Kim, 1995). Fort y percent of the amino acids 
in this region are proline and threonine residues, and about 50 serine and threonine 
residues are potential sites for O-linked glycosylation, but the particular serine and 
threonine that are glycosylated are unknown (Martin, 2003). Outside the mucin region 
are three potential N-glycosylation sites (lbraghimov-Beskrovnaya et al., 1992) with 
consensus Asn-X-Ser/Thr (where X is any amino acid except proline) (Fig. 1-2). Indeed 
~, especially a-DG is highly glycosylated. The amino acid sequence of ~-DG predicts a 
molecular weight of 26 kilodalton (KD), but by gel electrophoresis it is 43 KD in 
almost aIl tissues. a-DG is predicted as having a molecular weight of 57 KD, but it is 
156 KD in skeletal muscle, 140 KD in cardiac muscle and 120 KD in brain and 
peripheral nerve (Henry and Campbell, 1996; Winder et al., 2001). When purified a-
DG from vertebrate skeletal muscle is treated with trifluoromethanesulfonic acid 
(TFMS), a chemical that removes N- and O-linked oligosaccharides, as weIl as 
glycosaminoglycan chains from proteoglycans (Soroka and Farquhar, 1991), a 57 KD 
core protein is shown on SDS-PAGE (Ervasti and Campbell, 1993b). Chemically 
deglycosylated protein is not recognized by IIH6, a monoclonal antibody raised to 
specific carbohydrate moieties of a-DG, nor does it bind to its ligands laminin (Ervasti 
and Campbell, 1993b) and agrin (Bowe et al., 1994). Removal of the N-linked glycans 
by treatment with N-glycosidase F, which cleaves Asn-linked high mannose and hybrid 
and complex oligosaccharides, alters its molecular weight by about 4 kDa but does not 
affect its binding to extracellular ligands (Ervasti and Campbell, 1991). Treatment with 
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neuraminidase, an enzyme which removes sialic acids, results in 10 KD decrease in 
size but does not affect laminin binding ability (Ervasti and Campbell, 1993). The 
lectin jacalin and peanut agglutinin bind to GaIPl-3GaINAc disaccharides of a-DG, 
while the binding of the se lectins to a-DG is increased by neuraminidase treatment that 
removes the terminal sialic acid (Smalheiser and Kim, 1995), it does not affect the 
laminin binding to a-DG (McDearmon et al., 2003). Together, these data demonstrated 
that a-DG is heavily glycosylated, and the glycan chains appear critical for laminin 
binding. 
Recent genetic and biochemical experiments have made tremendous advances 
in our understanding of the pathogenesis of congenital muscular dystrophies and the 
importance of carbohydrate moieties in these diseases. Hypo-glycosylation of a-DG 
secondary to mutations in enzymes required for glycosylation has been demonstrated to 
be responsible for Fukuyama congenital muscular dystrophy (FCMD), Muscle-eye-
brain (MEB) disease, and Walker-Warburg Syndrome. In addition, muscular dystrophy 
patients also have severe mental retardation and neuronal migration abnormalities. 
FCMD is one of the most common muscular diseases in Japan (Kobayashi and Toda, 
2004). The FCMD gene was defined because of a retro-transposon inserted into the 3" 
untranslated region, resulting in unstable transcript (Kobayashi et al., 1998). The gene 
encodes a protein called fukutin which is a putative fringe-like glycosyltransferase 
resident in the Golgi apparatus (Kobayashi et al., 1998; Manya et al., 2003). The 
mutant gene leads to diminished glycosylation of a-DG and inability to binds to 
extracellular ligands (Hayashi et al., 2001; Michele et al., 2002). A gene encoding a 
fukutin-related protein has also been identified to be a putative glycosyltransferase that, 
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when mutated, is responsible for congenital muscular dystrophy type 1C (Brockington 
et al., 200la; Brockington et al., 2001b). Muscle-eye-brain (MEB) disease has similar 
symptoms as FCMD, which is caused by mutations in the gene that encodes 0-
mannose ~-1,2-N-acetylglucosaminyl-transferase (POMGnT!) that is known to 
parti ci pate in O-mannosyl glycan synthesis (Yoshida et al., 2001). Walker-Warburg 
Syndrome (WWS) is another form of congenital muscular dystrophy associated with 
cobblestone lissencephaly (Kanoff et al., 1998). The mutant gene in this disease 
encodes O-mannosyltransferase 1 (POMT1) located in the endoplasmic reticulum and 
might involve in initial O-linked protein glycosylation (Jurado et al., 1999; Willer et al., 
2003). A common feature of these muscular dystrophies appears to involve in defective 
glycosyltransferases, thus resulting in loss of the carbohydrate side chains of a-DG, 
and loss of ligand binding of a-DG to the extracellular matrix (Michele et al., 2002). 
Various mouse models in which these genes have been deleted by homologous 
recombination mimic the human diseases (Takeda et al., 2003; Willer et al., 2004; 
Grewal et al., 2001). Deletion of fukutin gene results in early embryonic lethality at 
embryonic day 6.5-7.5 prior to muscle development, and chimeric mice consisting of 
the mixture of fukutin-deficient and wild-type cells develop severe muscuJar dystrophy 
with Joss of a-DG glycosyJation and Jaminin-binding activity (Takeda et al., 2003). In 
addition, there are central nervous system (CNS) phenotypes resulting from abnormal 
neuronal migration and retinal disruption including loss of the retinal laminar structure 
and retinal detachment as weIl as the non-neural structural anomal y of the Jens 
(Michele et al., 2002; Takeda et al., 2003). Targeted deletion of POMT1 gene resulted 
in embryonic developmental arrest at day 7.5 and death between day 7.5 and 9.5, which 
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appear due to failure of Reichert's membrane formation, a possible consequence of loss 
of a-DG glycosylation (Willer et al., 2004). In myd mice, a spontaneous loss-of-
function mutation in the LARGE gene leads to deficiency in a-DG glycosylation, loss 
of laminin binding, muscular dystrophy, brain malformation and retinal phenotypes but 
mice survive to the adulthood (Grewal et al., 2001; Holzfeind et al., 2002). LARGE 
appears to bind to a sequence N-terminal to mucin-like domain and essential for 
initiating the glycosylation of a-DG (Kanagawa et al., 2004). Over-expression of. 
LARGE in cells isolated from MEB, FYMD and WWS patients restores functional 
carbohydrates that can bind to laminin and circumvent the a-DG defect (Barresi et al., 
2004). Mutations in the LARGE gene have also been identified in a single family with 
congenital muscular dystrophy ID (MDCID), which shows congenital onset of muscle 
weakness, profound mental retardation and brain malformation (Longman et al., 2003). 
Although no mutations in DG gene are associated with human congenital muscular 
dystrophies, targeted-deletion of DG in muscle and brain results in similar phenotypes 
of congenital muscular dystrophies (Cohn et al., 2002; Cote et al., 1999; Moore et al., 
2002). These data suggested that carbohydrates of a-DG are essential for the function 
of DG. This is supported by recent data that viral introduction of intracellular portion of 
DG in DG-deficient muscles is sufficient for assembly and targeting of the DGC 
complex to the muscle surface, but to prevent muscular dystrophy in DG-deficient 
muscles, a-DG and its carbohydrates are required (Kanagawa et al., 2004). 
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Part II: DG and its associated proteins in muscle 
Serving as the core member of the DGC and the transmembrane linker between 
the cytoskeleton and basement membrane, DG plays its biological roles through 
interactions with many extracellular and intracellular proteins. 
Laminin and Basement membrane 
In skeletal muscle, a layer of extracellular matrix called basement membrane 
(BM) coats muscle fibers providing structural and regulatory roi es and involved in 
biological processes such as cell growth, differentiation, and migration, tissue 
development and repair (Erickson and Couchman, 2000; Timpl, 1996; Y urchenco et al., 
2004). The BM contains glycosylated proteins but no lipid or nucleic acid (Sanes, 
2003). BM proteins are classified as collagenous glycoproteins, non-collagenous 
glycoproteins and proteoglycans (Hall and Sanes, 1993). Collagen (collagen IV) is the 
major component of the BM and can self-assemble into a network. The major heparan 
sulfate proteoglycans (HSPG) are perlecan and agrin. The major non-collagenous 
proteins of BM are entactin and laminin (Carbonetto and Lindenbaum, 1995; Hall and 
Sanes, 1993; Jenniskens et al., 2005). The BM has two networks, the collagen type IV 
network and the laminin network interconnected via entactin-l (Battaglia et al., 1992; 
Brown et al., 1997; Fox et al., 1991). Recent data suggest that the laminin network is 
prerequisite for the basement formation, which may bring the collagen, nidogen, 
perlecan and other components to form big BM network (Yurchenco et al., 2004). 
Laminin is a glycoprotein heterotrimer consisting of a a, ~ and y chains. The 
individual polypeptide chains are joined together to produce a molecule with one long 
arm and three separate short arms (Fig. 1-3) (Beck et al., 1990; Miner and Yurchenco, 
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2004), but laminin isoform laminin 6-9 lacks the a-chain short arm. The a-chain 
extends beyond the coiled-coil of the long arm and forms five ~-sandwich LG modules 
called G-domains (Fig.1-3) (Timpl et al., 2000). Five laminin a, four ~ and three y 
chains have been identified in mammals which can join to form 15 distinct laminin 
heterotrimers (Laminins 1-15) (Jenniskens et al., 2005; Timpl et al., 2000). Four out of 
15 have been found in skeletal muscle. Laminin 2 (a2~lyl) is located in the extra 
synaptic BM, whereas laminin 4 (a2~2y1), laminin 9 (a4~2y1) and laminin Il 
(a5~2y1) are located in the synaptic BM although laminin 4 is also non-synaptic 
(Miner et al., 1997; Miner and Yurchenco, 2004; Patton et al., 1998; Patton et al., 1997; 
Sanes,2003). 
Laminin binds to entactin through its y chain at its short arms (Timpl et al., 
2000) and collagen IV through the globular domains on its short arms (Charonis et al., 
1985). In addition, N-terminal globular (LN) domains of short arms can interact 
homophilically to form laminin pol ymer network in the presence of calcium 
(Yurchenco and Cheng, 1993). Thus, laminin, entactin and collagen form an 
interconnected BM scaffolding (Yurchenco et al., 2004). 
The five LG domains on the COOH-terminal of a chains beyond the coiled-coil 
region mediate interactions with the cell surface receptors (Yurchenco et al., 2004). DG 
and integrin are the two cell surface receptors known to interact with the G-domains of 
laminin. Integrins are heterodimers composed of non-covalently associated a and ~ 
subunits, acting as a mechanical linker and a signaling transducer to regulate cell 
proliferation, differentiation, adhesion, migration and survival (Hynes, 1992). The 
major forms of integrin in skeletal muscle which bind laminin are a7~1, a6~1 and 
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a3~1 (Fig. 1-3) (Collo et al., 1993; Kaufman et al., 1985; Mayer, 2003; Velling et al., 
1996), aIl of which interact with LG domain 1-3 of laminin. al and a2 chains and 
a1~2 and a2~1 integrins also bind to LN domain of laminin a-chain (Miner and 
Yurchenco, 2004). The LG 4 of laminin a-chain interacts with carbohydrates of a-DG 
(ldo et al., 2004; Li et al., 2002; Talts et al., 2000; Yu and Talts, 2003) in a calcium-
dependent manner (Gee et al., 1993; Ibraghimov-Beskrovnaya et al., 1992; Smalheiser 
and Kim, 1995). Kanagawa et al. (Kanagawa et al., 2004) have demonstrated that 
carbohydrates attached on the first half (amino acid 316-418) of the mucin-like domain 
of a-DG interact with laminin, which appears to require interaction of LARGE with the 
NH2-terminal (amino acid 29-316) of a-DG. 
Laminin interacts with its receptors DG and integrin and plays roles in muscle 
maintenance, muscle survival, signaling and myogenesis. It is weil known that laminin 
plays a structural role as the linker between cytoskeleton and BM to maintain the 
muscle integrity. Laminin couid aiso send signaIs from extracellular matrix to the cell 
inside through DG and integrin to promote cell survival. For example, absence of the 
a2 chain induces high level of apoptosis (Sanes, 2003; Vachon et al., 1996) and loss of 
LG domain 4-5, the DG-binding domains, of Iaminin 1, results in early death at 
embryonic day 6.5 (Scheele et al., 2005), indicating active signaIs may come from 
laminin a2 and G-domain of a 1 chain. Furthermore, Montanaro et al. (Montanaro et 
al., 1999) have found that cultured myoblasts with significantly decreased DG 
expression showed significant apoptosis in the myotubes. Similarly apoptosis was also 
found in the DG-knock-out embryoid bodies in culture (Li et al., 2002). Another 
interesting report cornes from studies of BM and alveolar epithelial cells in the lung 
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(Jones et al., 2005), which shows that mechanical stretch of the lung induces activation 
of mitogen-activated-protein kinase (MAPK) in epithelial cells. This activation is 
significantly reduced when function-perturbing antibodies against a3 laminin and a-
DG were used or when DG is knocked down with RNAi. No reduction in MAPK 
activity was observed when the tissue was treated with function-perturbing antibodies 
against ~1 or a3 integrins, or with the RGD peptide that inhibits binding of integrin to 
another BM component fibronectin. Moreover, a recent report from Yurchenco and 
colleagues also showed that galactosyl-sulfatide (a laminin binding glcolipid)-induced 
laminin polymerization can activate Src kinase phosphorylation and association of c-
Src with DG in culture Schwann celIs, a biochemical process that requires laminin 
interaction with DG but not integrin (Li et al., 2005). These experiments strongly 
suggest that active signaIs could come from BM and laminin transduced through DG 
into the cells. Laminin is also involved in myogenesis. Myogenesis is a process 
including myoblast proliferation, myoblast fusion and myotube formation. Laminin has 
been shown to promote myoblast proliferation and myotube formation (Kroll et al., 
1994; Kuhl et al., 1982; Ocalan et al., 1988; von der Mark and Ocalan, 1989), and, in 
the absence of laminin, formation of myotubes by myoblast fusion decreased, but is 
still present (Foster et al., 1987; Sanes, 2003). However, both in vitro and in vivo data 
suggest that the laminin receptor DG is not required for myoblast proliferation and 
fusion (Cohn et al., 2002; Cote et al., 1999; Montanaro et al., 1999). But, remarkably, 
in skeletal muscles DG appears to be required for satellite cell-mediated muscle 
regeneration (Cohn et al., 2002; Cote et al., 1999). When homozygous DG-null alleles 
were used to generate DG-deficiency in the chimeric mice, skeletal muscles showed 
16 
severe muscle degeneration with increasing age, remarkable tissue fibrosis and 
macrophage infiltration (Cote et al., 1999). However, in conditional knock-out mice 
when DG-deficiency is induced by muscle creatine kinase (MCK) promoter that does 
not target the satellite cells, skeletal muscle showed very mild muscle degeneration 
because DG-positive satellite cells make new muscle fibers (Cohn et al., 2002). The 
difference in muscle phenotypes in two kinds of experimental mice strongly suggests 
that DG is necessary for muscle satellite cell-induced regeneration. 
That laminins are required for BM assembly has been weil documented 
(Yurchenco et al., 2004; Yurchenco and Wadsworth, 2004). For example, failure to 
form the laminin heterotrimer leads to lack of BM assembly in y1 and a2 chain 
knockout mice (Smyth et al., 1999; Xu et al., 1994a). However, whether the receptors 
of laminin, DG and integrin, are required for BM assembly is not conclusive. In skin 
131 integrin knock-out results in disrupted epidermal basement membrane (DiPersio et 
al., 1997; Raghavan et al., 2000), but 131 integrin in muscle, Schwann cell, brain and 
cultured embryoid bodies appears not required for BM formation (Feltri et al., 2002; 
Schwander et al., 2003). In muscle and developing embryos, evidence does not support 
DG is required for BM assembly either. First, deficiency of DG does not prevent 
basement membrane assembly in muscle and peripheral nerve (Cohn et al., 2002; Cote 
et al., 1999; Moore et al., 2002; Saito et al., 2003). Secondly, genetic deletion of the 
DG-binding domain LG 4-5 of a chain of laminin 1 (a1j31y1), the major BM protein in 
the early embryogenesis, results in lethality at embryonic day 6.5, but the BM is intact 
(Scheele et al., 2005). Thirdly, DG-null embryoid bodies spontaneously form basement 
membrane in-vitro (Li et al., 2002). These experiments suggest that for muscle and 
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embryoid body DG-deficiency does not result in BM disruption. Therefore, DG-
deficiency-induced muscle degeneration and embryonic lethality are probably not due 
to disruption of BM. On the other hand, several observations appear to support that DG 
is required for BM assembly in sorne instances. First, DG-nuU embryos at day 6.5 
appeared to result in failure in Reichert's membrane formation (Williamson et al., 
1997). Second, in brain DG is required for integrity of the glial limitans that separates 
the marginal zone from the subarachnoid space, which is disrupted in DG-null mice 
(Moore et al., 2002). Third, in the neuromuscular junctions, DG appears to regulate BM 
molecules such as laminin, achetylcholinesterase, perlecan to the synaptic sites 
(Jacobson et al., 2001). Therefore, laminin and its receptor DG are required for normal 
cell function, but BM assembly doesn't appear to require the laminin receptor in sorne 
tissues, at least in muscle and developing embryos. 
Different isoforms of laminins are also found in Drosophila basement 
membranes with similar trimeric subunit composition as that in the vertebrate (FessIer 
et al., 1987). a3,5; (31; yI was first identified in almost aIl organs (FessIer et al., 1987; 
MonteIl and Goodman, 1988; MonteIl and Goodman, 1989). Null mutations in a3,5, 
also called Laminin A (LamA), lead to embryonic lethality with visible defects in 
mesoderm-derived tissues such as heart with cell migration defect, and muscle with 
distorted myotube shape during its extension and failure to attach to epidermis (Prokop 
et al., 1998; Yarnitzky and Volk, 1995). Pathfinding defects are also observed in oceUar 
neurons (Garcia-Alonso et al., 1996). At the neuromuscular junctions, the functional 
synapses form properly without a3,5, but the extent of contact between neuronal and 
muscle surface is reduced significantly (Prokop et al., 1998), and in contrast embryos 
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lacking PS integrin have increased nerve-muscle contact surface (Prokop et al., 1998). 
Hypomorphic mutants of LamA also give rise to rough eyes with fused photoreceptor 
ce Il s, disorganized cell clusters and sometimes few photoreceptor cells in pupa and 
adult retina (Henchcliffe et al., 1993). Another Drosophila laminin isoform called wing 
blister was also found to cause similar phenotypes as LamA (Martin et al., 1999). Wing 
blister encodes the Drosophila counterpart of vertebrate a2 chain and homozygous 
wing blister clones show disorganized photoreceptor cells in the retina (Martin et al., 
1999). 
Perlecan and Biglycan 
ln addition to laminin in the BM as the ligand for DG, perlecan and biglycan are 
also ligands of DG. Perlecan was first identified from murine tumor cell line as a 
heparan sulfate proteoglycan in BMs (Hassell et al., 1980). Subsequent biochemical 
studies showed it contains a ~395 kDa single polypeptide core with three 
glycosaminoglycan si de chains on its N-terminus and one chondroitin sulfate chain at 
the C-terminus (Ledbetter et al., 1985). The ami no acid sequence of perlecan contains 
five distinct domains (Noonan et al., 1991). Domain 1 is the N-terminus containing 
sites for heparan sulfate attachment; domain II is similar to cholesterol binding region 
of the low density lipoprotein; domains III is the EGF-like repeats; domain IV contains 
21 Ig-like repeats. At the C-terminus is domain V characterized by three laminin-like 
globular G-domains. A homologue of perlecan has also been found in C. elegans 
(Rogalski et al., 1993) and Drosophila (Friedrich et al., 2000). Perlecan binds to BM 
proteins including laminin, collagen IV, entactin and fibronectin through domain IV 
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(Hopf et al., 1999). Fibroblast growth factor (FGF) binds to the core proteins and 
glycosaminoglycan side chains of perlecan (Aviezer et al., 1994; Mongiat et al., 2001), 
thus perlecan modulates growth factor signaling for cell proliferation and 
differentiation (Aviezer et al., 1994; Iozzo et al., 1994). Through the G-domains in its 
C-terminus, perlecan binds to DG and integrin (Brown et al., 1997; Talts et al., 1999). 
At the neuromuscular junctions (NMJ), perlecan interacts with acetylcholinesterase and 
clusters it within the synaptic BM through interaction with DG (Peng et al., 1999). 
Perlecan-null mi ce have no acetylcholinesterase clusters at the NMJ (Arikawa-
Hirasawa et al., 2002) and DG-null mice have disrupted localization of 
acetylcholinesterase at the NMJ (Jacobson et al., 2001). In general, periecan-null mice 
often die at embryonic day 10.5 with defective cephalic and cardiac development, and 
sorne survive until birth but have skeletal dysplasia characterized by shortened long 
bones and craniofacial abnormalities (Arikawa-Hirasawa et al., 1999; Costell et al., 
1999) indicating perlecan is essential for cartilage development and BM integrity. 
Biglycan belongs to a small leucine-rich proteoglycans (SLRP) family that is 
abundantly expressed in tissue such as bone and skin (Ameye and Young, 2002; Young 
et al., 2002). Biglycan has two chondroitin sulfate glycosaminoglycan chains attached 
to the N-terminus, and is an extracellular matrix protein. Biglycan binds to collagen 
and biglycan knockout mice develop various phenotypes which are primarily resulted 
from abnormal collagen fibrillogenesis (Ameye and Young, 2002). The 125 kDa 
biglycan was first identified to interact with DG in Torpedo electric organs by a ligand 
blot overlay assay (Bowe et al., 2000). Biglycan binds with its chondroitin sulfate side 
chains to the core protein of the a-DG at the muscle membrane and the NMJs (Bowe et 
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al., 2000). Moreover, in mdx mice biglycan expression is increased in response to 
changes in the DGC. 
Dystrophin and Utrophin 
In addition to above extracellular proteins that bind to a-DG, several other 
intracellular proteins are known to bind ~-DG to form the core members of the DGC. 
Positional cloning of the gene altered in Duchenne or Becker muscular dystrophy led to 
identification of dystrophin (Monaco et al., 1986). Biochemical characterization 
identified dystrophin as part of a protein complex, the DGC, at the plasma membrane of 
aIl muscle fibers. The dystrophin gene consists of 79 exons spanning 2.4 million base 
pairs of the human short arm of the X chromosome (Koenig et al., 1988). Full-Iength 
dystrophin is translated from a 14 Kb transcript and has 3685 amino acids with a 
molecular weight of 427 kDa. Alternative splicing generates several C-terminal 
dystrophin isoforms that include Dp260, Dp140, Dp116 and Dp70. These dystrophin 
isoforms are expressed tissue-specifically. Full-Iength dystrophin is expressed in 
skeletal muscle, epithelial cells and in brain (Blake and Kroger, 2000; Mehler, 2000; 
Nguyen et al., 1991). In brain, it is expressed in retina and in the postsynaptic density of 
excitatory synapses (Blake and Kroger, 2000; Lidov et al., 1990). Dp71 is expressed in 
a variety of tissues including brain, retina and muscle (Austin et al., 1995). Dp140 is 
brain specifie (Lidov et al., 1995) and Dp116 is expressed in the Schwann cells (Byers 
et al., 1993; Imamura et al., 2000). Dp260 is expressed specifically in the outer 
plexiform layer of the retina (D'Souza et al., 1995). The different expression pattern 
suggests different DGC complexes and distinct functions. Full-Iength dystrophin 
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contains multiple domains with overall similarity to the cytoskeletal proteins ~-spectrin 
and a-actinin (Koenig et al., 1988). The N-terminus from amino acid 1-260 of 
dystrophin is the actin-binding domain similar to the actin-binding region of actinin and 
has been shown to bind to actin (Corrado et al., 1994; Levine et al., 1990; Root, 1997). 
Next to the actin-binding region is 24 spectrin-like repeats called the rod region that 
spans from amino acids 300-3000 (Koenig et al., 1988). C-terminal to the rod region 
lies the cysteine-rich region that includes a WW region, two EF-hand-like regions and 
one ZZ domain. The WW domain is a ",30 amino acid region containing two conserved 
tryptophans (henee WW). The EF-hand like region is usually a motif involved in 
calcium binding, but the consensus sites for calcium-binding in this region are not 
conserved (Koenig et al., 1988). Instead, calcium-calmodulin has been shown to bind to 
the ZZ domain (Anderson et al., 1996), a putative zinc finger motif found in many 
proteins. The most important domains of dystrophin are its WW domain and the coi led-
coil domain, C-terminal to the cysteine-rich domain. Through the WW domain 
dystrophin binds to the PPXY motif on the last 15 amino acids of DG (Jung et al., 
1995; Yoshida and Ozawa, 1990), which can be blocked by tyrosine phosphorylation 
on PPXY motif (Sotgia et al., 2001). Through the coiled-coil domain, dystrophin binds 
to syntrophin and dystrobrevin (Ahn et al., 1996; Peters et al., 1997b; Piluso et al., 
2000; Suzuki et al., 1995). Mutations in dystrophin gene that leads to truncated 
proteins containing no N-terminal actin-binding domain, no cysteine-rich domain, or no 
C-terminal coiled-coil domain result in severe Duchenne muscular dystrophy in human 
(Campbell, 1995). 
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Utrophin is a 395 kDa dystrophin-related protein encoded by an autosomal 
gene. Utrophin is quite similar to dystrophin in its amine acid sequence and contains aIl 
the secondary domain structures of dystrophin (Blake et al., 1996b). Unlike dystrophin 
that is expressed uniformly in the muscle sub-sarcolemma and concentrated at 
neuromuscular junctions (NMJs), utrophin is only expressed at the NMJs, where it 
replaces dystrophin to associate with other DGC members (Matsumura et al., 1992; 
Nguyen et al., 1991). In the regenerating muscle fibers of mdx mice, a line of mice 
which lacks dystrophin (Sicinski et al., 1989), utrophin is expressed in the extra-
synaptic membranes to compensate for dystrophin (Khurana et al., 1991; Nguyen et al., 
1991; Ohlendieck et al., 1991a; Pons et al., 1991), thus, no obvious muscle phenotypes 
are found in these mutant mice (Carnwath and Shotton, 1987; Coulton et al., 1988; 
Torres and Duchen, 1987). Unlike single mutants, mice deficient in both dystrophin 
and utrophin develop severe phenotypes resembling those of DMD (Deconinck et al., 
1997; Grady et al., 1997). However, these double mice survive to adulthood, which are 
different from DG-null mutant mice that die at embryonic day 6.5. This difference 
between DG-null and dystrophin and utrophin-double null mice demonstrates that DG 
plays much broader biological roi es and may have other molecule(s) associated. In 
addition to utrophin, there is another dystrophin-related protein called dystrophin 
related protein 2 (DRP2), which is expressed in brain and enriched in postsynaptic 
density (Dixon et al., 1997; Roberts and Sheng, 2000). DRP2 is also expressed in 
Schwann cells of periphery nerve and is associated with L-periaxin, suggesting a role in 
regulating myelination (Sherman et al., 2001). 
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Syntrophin and dystrobrevin 
Syntrophin and dystrobrevin are two intracellular core members of the DGC, 
which interact with DG indirectly through dystrophin. Syntrophin was originally 
identified as a 59 kDa protein in the Torpedo electroplaques and skeletal muscles 
(Froehner et al., 1987). When dystrophin was purified from the skeletal muscle by 
lectin chromatography, a 59 kDa protein was co-purified with other DGC members, 
which is now named as syntrophin (Butler et al., 1992; Ervasti and Campbell, 1991; 
Ervasti et al., 1991). Studies have identified five syntrophins encoded by five different 
genes, and subsequently named as al, 131, 132, yI and y2 (Adams et al., 1993; Ahn et 
al., 1996; Piluso et al., 2000; Yamamoto et al., 1993). AlI syntrophins can bind to the 
coiled-coil region of dystrophin or DRPs (Piluso et al., 2000; Suzuki et al., 1995). al-
syntrophin, like the full length dystrophin, is expressed primarily in skeletal muscle 
sarcolemma and enriched in the neuromuscular junctions but also in cardiac muscle and 
brain (Adams et al., 1993; Peters et al., 1997a). f31-syntrophin has a similar distribution 
pattern to a l-syntrophin in brai n, skeletal muscle and the neuromuscular junctions, but 
is highly expressed in liver (Ahn et al., 1996). f32-syntrophin, however, is expressed 
only in the neuromuscular junctions of skeletal muscles, but not the extra-synaptic 
membrane (Adams et al., 1993; Peters et al., 1997a). yI and y2-syntrophin are 
exclusively expressed in the brain and associated with Dp71 and Dp140 (Piluso et al., 
2000). Syntrophin is believed to serve as an adapter protein to recruit signaling 
molecules to the DGC. AlI syntrophins contain several distinct domains: a pleckstrin 
homology (PH) domain, a PDZ domain (so named to indicate its presence in 
postsynaptic density protein 95 (PSD-95), Drosophila disc large, and the zonula 
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occludens-l (ZO-l) (Sealock and Froehner, 1994), and a highly conserved-carboxyl 
syntrophin-unique (SU) domain (Adams et al., 1995) through which it binds to 
dystrophin and DRPs (Adams et al., 1995; Piluso et al., 2000). The PDZ domain is a 
protein motif involved in protein-protein interaction. PDZ domains can interact 
homophillically or bind to the S/T XV (where X stands for any amino acid) motif at the 
C-terminus of other proteins (Brenman et al., 1996; Kornau et al., 1995). The PDZ 
domain of al-syntrophin has been known to bind to PDZ protein neuronal nitric oxide 
synthase (nNOs) in brain and in muscle (Brenman et al., 1996; Hashida-Okumura et al., 
1999). nNOs is a required enzyme for production of nitric oxide that regulates 
myogenesis (Lee et al., 1994), metabolism (Roberts et al., 1997), contraction (Kobzik et 
al., 1994) and blood flow (Sander et al., 2000; Thomas et al., 1998) in skeletal muscle. 
f32-syntrophin binds to a family of PDZ domain-containing proteins called microtubule-
associated serine/threonine kinase 205 kDa (MAST205) and syntrophin associated 
serine/threonine kinase (SAST) at the neuromuscular junctions (Lumeng et al., 1999). 
Syntrophin also interacts with sodium channels whose C-terminus contains the PDZ-
binding motif S/TXV in the skeletal muscles (Gee et al., 1998). At the endfeet of 
astrocytes which attach to blood vessels in the brai n, syntrophin interacts with the 
aquaporin-4 water channel through the consensus motif Ser-Ser-Val (Adams et al., 
2001). In al-syntrophin-deficient mice astrocytic endfeet membrane and skeletal 
muscle show significant loss of localization of aquaporin-4 (Neely et al., 2001), 
indicating a role of DGC in stabilizing the water channel. Consistent with this, a recent 
study demonstrated that laminin could induce aquaporin-4 aggregation via the DGC in 
the cultured astrocytes (Guadagno and Moukhles, 2004). Brain yl-syntrophin interacts 
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with diacylglycerol kinase-z (DGK-z), an enzyme containing PDZ binding-consensus 
sequence and could functionally con vert diacylglycerol into phosphatidic acid (Hogan 
et al., 2001). DGK-z, syntrophin and GTPase Rac appear to regulate the neurite 
outgrowth in the cultured cells (Yakubchyk et al., 2005). In muscle, localization of 
DGK-z to the plasma membrane and enrichment at the neuromuscular junction require 
the interaction with syntrophin (Abramovici et al., 2003). 
When a 1-syntrophin gene is deleted, mice have no muscular dystrophy, but loss 
of nNOs and utrophin in the sarcolemma and disrupted neuromuscular junctions. As 
weIl there is loss of aquaporin-4 in the sarcolemma and astrocyte (Adams et al., 2000; 
Kameya et al., 1999; Neely et al., 2001). Loss of nNOs may contribute to the 
pathogenesis of muscular dystrophy by an aberrant regulation of adrenergic 
vasoconstriction and the resulting defective control of muscle blood flow in lack of 
nNOs (Crosbie et al., 2001). An interesting study showed that, in the perivascular 
membranes of astrocyte endfeet (a part of blood-brain-barrier), removal of a1-
syntrophin which causes loss of aquaporin-4 results in a delayed buildup of brain 
edema (Amiry-Moghaddam et al., 2004) in experimental model of acute hyponatremia. 
This data indicates a therapeutic potential that could benefit from interfering with the 
binding of syntrophin to aquaporin-4 in acute brain edema. A recent study showed that 
PDZ-domain of a1-syntrophin binds to potassium channel Kiv4.1 in brain, and a1-
syntrophin null mice show disrupted submembrane localization of Kiv4.1 (Connors et 
al., 2004). An interesting report shows that patients with mesial temporal lobe epilepsy 
(MT LE) and hippocampal sclerosis lose perivascular dystrophin (Dp71) in the 
hippocampus, and have disrupted subcellular localization of aquaporin 4 in astrocytes 
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and ab normal accumulation of extracellular K+ (Eid et al., 2005). Despite their highly 
conserved sequences and PDZ domain, ~1 and ~2-syntrophin have function distinct 
from al-syntrophin. For example, neither ~1 nor ~2-sytrophin binds to nNOs in 
skeletal muscle (Adams et al., 2000). ~2-syntrophin nul! mice show no overal! 
phenotypes or muscular dystrophy, and form morphological!y normal sarcolemma and 
neuromuscular junctions (Adams et al., 2004). Mice nul! for both al and ~2-
syntrophin show normal muscle histology but more severe disrupted neuromuscular 
junctions than those of al-syntrophin nul! mice (Adams et al., 2004), indicating a and 
~2-syntrophin play distinct roles and each can compensate for the loss of the other. 
Dystrobrevin was identified from co-purifications of DGC in skeletal muscle 
(Ervasti et al., 1991) and was initial!y named Ao (Yoshida and Ozawa, 1990), or an 87 
kDa postsynaptic protein (Butler et al., 1992; Wagner et al., 1993). The amino acid 
sequence of dystrobrevin reveals three major domains: the cysteine-rich and coiled-coil 
domain, which is homologous to dystrophin, and aC-terminal dystrobrevin-unique 
domain (Wagner et al., 1993). Dystrobrevin binds directly to syntrophin through amino 
acids 427-480, upstream of the coiled-coil domain (Ahn and Kunkel, 1995; Sadoulet-
Puccio et al., 1997a; Sadoulet-Puccio et al., 1997b). It also interacts directly with 
dystrophin through its C-terminal coiled-coil region (Sadoulet-Puccio et al., 1997b). 
Two dystrobrevin genes, a and ~, are broadly expressed in mice, and give rise to at 
least 5 splicing variants (Blake et al., 1998; Blake et al., 1996a). a-dystrobrevin, the 
first identified 87 kDa protein in Torpedo electric organ, has two major isoforms in 
muscle, which are ful!-Iength a-dystrobrevin-l and the C-terminal truncated a-
dystrobrevin-2 (Blake et al., 1996a). a-dystrobrevin-l is highly restricted to the NMJs, 
27 
whereas a-dystrobrevin-2 is expressed both on the sarcolemma and at the NMJs (Peters 
et al., 1998). f3-dystrobrevin is not expressed in muscle, but in brain, kidney, and other 
organs where it is directly associated with Dp71 and Dp140 (Blake et al., 1998; Peters 
et al., 1997b). When the a-dystrobrevin gene is deleted in mice, neither a-dystrobrevin-
1 nor a-dystrobrevin-2 is expressed but normal muscle integrity and localization of 
other DGC members are observed (Grady et al., 1999). Muscles of these mice appear 
histologically normal during the first two weeks after birth but dystrophic phenotypes 
such as degenerating and regenerating muscle fibers, necrosis and centralized nuclei 
appear by one-month of age (Grady et al., 1999). These mice also show significant loss 
of nNOs in the sarcolemma and fail to produce the second messenger cyclic GMP with 
electrical stimulation (Grady et al., 1999), consistent with previous findings that nitric 
oxide appears to stimulate cGMP production in contracting muscle (Lau et al., 1998). 
At the neuromuscular junctions of a-dystrobrevin deficient mice, clusters of 
acetylcholine receptors are distributed more diffusely and sometimes fragmented 
(Grady et al., 2000). These experiments indicate the importance of dystrobrevin in cell 
signaling, structure and maintenance and neuromuscular junction formation. 
Furthermore, a new coiled-coil protein dysbindin has been identified that interacts with 
a-dystrobrevin in muscle and with f3-dystrobrevin in brain (Benson et al., 2001). 
Mutations in dysbindin have been shown to be associated with schizophrenia (Schwab 
et al., 2003; Straub et al., 2002; Van Den Bogaert et al., 2003) and with an abnormal 
vesicle trafficking disease called Hermansky-Pudlak syndrome (Li et al., 2003). In mdx 
mouse brai n, dysbindin expression was increased, but disrupted in synaptic regions 
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(Sillitoe et al., 2003). However, direct biochemical or molecular evidence regarding 
schizophrenia and dysbindin/dystrobrevin or other DGC members remains unclear. 
Sarcoglycan and Sarcospan 
Sarcoglycan and sarcospan are a group of single pass transmembrane proteins 
that are part of the DGC. Several sarcoglycans, a, ~, y, D, E and ~-sarcoglycans have 
been cloned. Among them, a-, ~-, y- and D-sarcoglycans were first characterized as a 
heterotetramer complex that is tightly associated with sarcospan and ~-DG. Like most 
other DGC members, a-sarcoglycan/adhalin (50 kDa), ~-sarcoglycan (43 kDa) and y-
sarcoglycan (35 kDa) were co-purified from muscle sarcolemma with dystrophin by 
lectin affinity purification (Campbell and Kahl, 1989; Ervasti et al., 1991; Ohlendieck 
and Campbell, 1991; Yoshida and Ozawa, 1990). They could be biochemically 
separated from the rest of the DGC by the detergent n-octyl ~-D-glucoside (Yoshida et 
al., 1994). The sarcoglycan genes were cloned following genetic studies in which 
mutations in these loci have been linked to limb-girdle muscular dystrophies (LGMD) 
(Table 1). The a-sarcoglycan gene was the first found, and is located on chromosome 
17 and associated with mutations leading to LGMD 2D (Roberds et al., 1994). 
Subsequent discoveries showed a total of 39 mutations in a-sarcoglycan in unrelated 
families and sporadic cases with LGMD 2D (Carrie et al., 1997; Piccolo et al., 1995). 
Homozygous missense mutations in ~-sarcoglycan gene were found in a large Amish 
family with LGMD 2E (Bonnemann et al., 1995; Lim et al., 1995). The disease gene of 
severe childhood autosomal recessive muscular dystrophy (now LGMD 2C) was 
identified as y-sarcoglycan and is located on chromosome 13 (Noguchi et al., 1995). ô-
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sarcoglycan (35 kDa) was identified and characterized as the mutant gene on 
chromosome 5 with a single nucleotide deletion affecting the reading frame, from two 
Brazilian families with LGMD 2F (Jung et al., 1996; Nigro et al., 1996a; Nigro et al., 
1996b). c-sarcoglycan, a homologue of a-sarcoglycan, was discovered to replace a-
sarcoglycan in smooth muscle to form a new type of sarcoglycan complex (Ettinger et 
al., 1997; Straub et al., 1999), and mutations in c-sarcoglycan have been implicated in 
myoclonus dystonia (Muller et al., 2002; Zimprich et al., 2001), an autosomal dominant 
disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly 
the arms and axial muscles (Zimprich et al., 2001). ~-sarcoglycan has not found to 
associate with any diseases. The ami no acids of ~-sarcoglycan show a high homology 
to y-and ô-sarcoglycan (Wheeler et al., 2002), and ~-sarcoglycan forms a stable 
complex with a-, ~-, y- and ô-sarcoglycans in the skeletal muscle and is reduced in Ô 
and y-sarcoglycan deficient muscle and in mdx mice (Wheeler et al., 2002). How~­
sarcoglycan binds to the sarcoglycan complex is unknown, but, on the sarcolemma ~, y 
and ô-sarcoglycan associate with one another very tightly by forming intramolecular 
disulfide bonds whereas a-sarcoglycan binds less tightly (Chan et al., 1998). Moreover, 
they tightly connect to ~-DG through Ô-sarcoglycan (Chan et al., 1998). Sarcospan is a 
25 kDa core member of the DGC and forms a complex with sarcoglycans and its 
localization on the muscle sarcolemma is dependant on sarcoglycans (Crosbie et al., 
1997; Crosbie et al., 1999). It is known that sarcoglycans, DG and sarcospan form a 
large complex in the Golgi network (Noguchi et al., 2000). In fact, loss of any one of 
sarcoglycans (a-, ~-, y-, Ô-) in LGMD patients leads to failure of the sarcoglycan 
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complex to assemble (Ozawa et al., 2005; Vainzof et al., 1996), which results in a 
damaged integrity of muscle sarcolemma. 
Animal models have been established to further investigate the mechanisms of 
type 2 LGMD caused by mutations in a, p, y, ô-sarcoglycan (Araishi et al., 1999; 
Coral-Vazquez et al., 1999; Duclos et al., 1998b; Durbeej et al., 2000; Hack et al., 
1998; Okazaki et al., 1996). For each type, skeletal muscles begin to degenerate around 
2 weeks after birth. Cell infiltration, fibrosis and other typical muscular dystrophic 
phenotypes such as sarcolemmal injury and creatine kinase efflux are observed (Ozawa 
et al., 2005). In y-sarcoglycan deficient mice, the other three sarcoglycans and 
sarcospan are present on the sarcolemma in trace amount and high level of programmed 
cell death in the muscle fi bers was observed (Hack et al., 1998). In a-, p- or 
Ô-sarcoglycan defici ent mice, the remaining sarcoglycans and sarcospan are not 
present (Crosbie et al., 1999). This indicates loss of y-sarcoglycan alone may be 
sufficient to cause the disease and activate apoptotic signaling pathways. Moreover, 
loss of sarcoglycan complex causes reduction of a-DG and an unstable DGC in the 
sarcolemma (Duclos et al., 1998a; Duclos et al., 1998b; Iwata et al., 1993; Roberds et 
al., 1993; Straub et al., 1998), although p-DG and dystrophin are present in the 
sarcolemma in sarcoglycan-null muscles (Araishi et al., 1999; Coral-Vazquez et al., 
1999; Duclos et al., 1998b; Durbeej et al., 2000; Hack et al., 1998; Okazaki et al., 
1996). Therefore, one role of sarcoglycan complex appears to preserve the whole DGC 
and the linkage between extracellular matrix and cytoskeleton. On the other hand, when 
DG is absent from the skeletal muscle, a, p, y and Ô-sarcoglycan as weil as sarcospan 
are alilost from the sarcolemma (Cote et al., 1999; Cohn et al., 2002). Re-introduction 
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of ~-DG in DG-deficient skeletal muscle restores the sarcoglycans and sarcospan 
complex in the sarcolemma (Kanagawa et al., 2004). Reduction of sarcoglycans is also 
found in mdx:utrophin-/- mice (Grady et al., 1997). These data establish mutual 
functional connections between DG and sarcoglycan-sarcospan complex as weIl as 
between dystrophin-utrophin and sarcoglycan-sarcospan. However, we may not assume 
that DG-deficiency-induced phenotypes come from loss of sarcoglycans. Several 
known results support this. 1), DG-deficiency causes lethality but sarcoglycans-
deficiency doesn't. 2), In the skeletal muscle, restoration of sarcoglycan-sarcospan 
complex on the sarcolemma by introduction of ~-DG in DG-null muscles does not 
prevent the muscular dystrophy (Kanagawa et al., 2004). This strongly suggests that 
sarcoglycan and sarcospan doesn't contribute significantly to DG-deficiency-induced 
phenotypes. To understand if loss of sarcoglycans contributes to the muscle dystrophic 
phenotype in DMD/BMD, similar rescue experiment with re-introduction of 
sarcoglycan in mdx:utrophin-/- mice would provide interesting information. 
Like the skeletal muscle, the cardiac muscle contains same sarcoglycans (a-, ~-, 
y- and ô-sarcoglycan) and sarcospan. Interestingly, a cardiomyopathy including a 
dilated ventricle, areas of necrosis and fibrosis was reported from ~, y and ô-
sarcoglycan knock-out mice, but not from a-sarcoglycan knock-out mice (Coral-
Vazquez et al., 1999; Okazaki et al., 1996). Just as in skeletal muscle, ~-DG is not 
altered in cardiac muscle even in the loss of sarcoglycan-sarcospan complex (Coral-
Vazquez et al., 1999). In the smooth muscle of coronary arteries, 10, ~, ô-sarcoglycan 
and sarcospan form a complex (Straub et al., 1999), and mice deficient in Ô-sarcoglycan 
develop an irregular coronary artery that was shown to underlie the pathogenesis of 
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cardiomyopathy in sarcoglycan knock-out mice (Coral-Vazquez et al., 1999). Unlike 
the skeletal and smooth muscles, Schwann cells of the peripheral nerve contain only ô, 
()- and E-sarcoglycan with no sarcospan (Imamura et al., 2000). In neurons, however, 
neither sarcoglycan nor sarcospan is expressed (Blake and Kroger, 2000; Imamura et 
al.,2000). 
Grb2 
In addition to core members of the DGC, there are several other proteins 
considered to be members of the DGC. Grb2 (growth factor receptor-bound protein 2) 
is a small SH2/SH3 (Src homology 2/Src homology 3) domain-containing signaling 
molecule that binds to the C-terminus of ()-DG through its SH3 domains (Yang et al., 
1995). Grb2 is weIl known as an adapter protein that participates in receptor-tyrosine 
kinase, PB kinase (phosphoinositide 3-kinase) and MAPK (mitogen-activated protein 
kinase) signaling cascades. Grb2 is comprised of a central SH2 domain and an SH3 
domain at its NH2- and COOH-terminus. Through its SH2 domain, Grb2 typically 
binds to the tyrosine-phosphorylated receptor after ligands activate the receptor and 
induce tyrosine residue autophosphorylation (Mayer et al., 1988; Olivier et al., 1993; 
Schlessinger, 2000). The SH3 domains of Grb2 bind to proline-rich proteins such as 
Sos (Son of sevenless) (Schlessinger, 1994), and brings Sos in close proximity to the 
plasma membrane protein Ras (Mayer et al., 1988; Olivier et al., 1993; Schlessinger, 
2000). Many experiments have demonstrated that Sos then transforms inactive GDP-
Ras to active GTP-Ras, which can then activate several effector proteins such as Raf 
and PB kinase (McCormick, 1993; Schlessinger, 1994; Schlessinger, 2000). Activated 
33 
Raf stimulates MAP-kinase-kinase (MAPKK), and the activated MAPKK 
phosphorylates MAP-kinase (MAPK), which in tum phosphorylates many cytoplasmic 
and membrane-linked substrates as weIl as sorne transcription factors after translocation 
into nucleus (McCormick, 1993; Schlessinger, 1994; Schlessinger, 2000). Thus, Grb2 
couples receptor tyrosine kinase activation to a variety of cellular processes. 
DG contains the consensus motif PXXP (P, proline; X, any amino acid) for SH3 
domain binding on its C-terminus. DG binds to both SH3 domains of Grb2 in muscle 
and in brain, but with higher affinity for the N-terminal SH3 domain (Russo et al., 
2000; Yang et al., 1995). Therefore, Grb2 may link DG to the receptor tyrosine kinase 
signaling by affecting Ras activation and MAPK signaling pathway. There have no 
direct evidence for this, however, individual experiments showed that tyrosine residue 
(Y892) of ~-DG can be phosphorylated by Src kinase and recruit SH2-domain 
containing proteins in co-transfected cells (Sotgia et al., 2003; Sotgia et al., 2001), and 
extracellular stress in alveolar epithelial cells induces MAPK activation which is 
dependent on DG (Jones et al., 2005). More interestingly, perturbation of DG-Iaminin 
binding in muscle cells appears to cause decreased phosphorylation of AKT and 
glycogen synthase kinase (GSK)-3~ and an increased apoptosis resulting from 
disrupted the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway 
(Langenbach and Rando, 2002). These experiments suggest that DG play roles in 
intracellular signaling pathways suck as MAPK and PI3K pathways. 
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Part III: DG in the nervous systems 
1 Agrin, MuSK and rapsyn in formation of the Neuromuscular Junctions (NMJs) 
NMJs are the sites where motor nerves make contact with postsynaptic muscle 
fibers to establish chemical synapses, in which nicotinic acetylcholine receptors 
(AChRs) in muscle receive signaIs from the nerve. In the newly formed myotubes, 
AChRs are inserted into the plasma membrane and reach a density of "-' 1000/!lm2 prior 
to the nerve innervation (Sanes and Litchtman, 2001; Burden, 2002). In adult muscles, 
however, AChRs are considerably concentrated and reach a density of > 1O,000/!lm2 at 
the muscle membrane opposing the nerve terminal, whereas other muscle membrane 
has very little (,,-,1O/!lm2) AChRs (Sanes and Lichtman, 2001). The clustering of AChRs 
at the synaptic site is a hall mark of synaptogenesis. The mechanisms of AChR 
clustering have been intensively studied. Agrin, MuSK and rapsyn have been 
demonstrated as the key molecules required in this process (Sanes and Lichtman, 2001; 
Burden, 2002; Kummer et al., 2006). 
Agrin 
In the late seventies, scientists found that plaques of basal lamina heparan 
sulfate proteoglycan are associated with aggregates of acetylcholine receptors in the 
neuromuscular junction (Anderson and Fambrough, 1983; Burden et al., 1979; Godfrey 
et al., 1984; Nitkin et al., 1983; Sanes et al., 1978). In the 1980s, McMahan and 
colleagues isolated agrin as the bioactive component of the basal lamina that organizes 
post-synaptic proteins in muscle membranes (McMahan, 1990; Nitkin et al., 1987). 
Agrin is a large (400-600 kDa) heparan sulfate proteoglycan with a 200 kDa core 
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(Gesemann et al., 1995; Tsen et al., 1995), secreted, most notably, by neurons (Smith et 
al., 1987) and muscle (Lieth et al., 1992) and deposited in the BM of the NMJs by 
binding to yI chain of laminin (Denzer et al., 1998; Kammerer et al., 1999). Alternative 
splicing generates a non-BM associated transmembrane agrin containing a short N-
terminus and specifically expressed in neurons (Burgess et al., 2002; Burgess et al., 
2000). Like laminin, agrin contains three LG domains at it C-terminus: the first G-
domain (G 1), the second G-domain (G2) which contains 0 or 4 amino acid insert due to 
alternative splicing; and the third G-domain (G3) which contains a 0, 8, Il or 19 ami no 
acid insert (Carbonetto and Lindenbaum, 1995; Ferns et al., 1992). The biological 
activity of agrin to promote AChR clustering is located in its G-domains. Isoforms with 
4 ami no acid insert in G2 and 8, Il or 19 (8+ Il) amino acid insert in G3 at a site called 
Z site in mammals, which is secreted by motor neurons but not by myotubes, are the 
most active forms of agrin to aggregate the receptors in cultured myotubes (Ferns et al., 
1992; Ferns et al., 1993; Hoch et al., 1993; Ruegg et al., 1992). The G-domains of agrin 
bind directly to carbohydrate chains of a-DG and the binding could be blocked by 
heparin and monoclonal antibody IIH6 (Bowe et al., 1994; Campanelli et al., 1994; Gee 
et al., 1994). Both nerve and muscle-derived agrins bind a-DG with high affinity, but 
nerve-derived agrin is much more active in promoting AChR clustering (Ferns et al., 
1992; Ferns et al., 1993; Gesemann et al., 1995; Sugiyama et al., 1994) and is 
indispensable for the NMJ synaptogenesis whereas muscle-derived agrin appears not 
required in synaptogenesis (Burgess et al., 1999). When the agrin gene was deleted, the 
size, number and density of AChR clusters were dramatically reduced at the NMJs of 
diaphragm and muscles from agrin-deficient mice fail to make mature NMJ s, which 
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results in death at birth due to failure of synaptic transmission (Gautam et al., 1996). 
This experiment firmly established an essential role of agrin in the NMJ formation. 
MuSK 
Similar to failure in formation of mature synapses in agrin-deficient mice, when 
the MuSK gene is deleted the NMJs completely lack AChR clusters and lack synaptic 
differentiation and animaIs die at birth because they have difficulty breathing 
(DeChiara et al., 1996; Sanes and Lichtman, 2001). Early experiments have suggested 
MuSK is the agrin receptor. Agrin induces rapid tyrosine phosphorylation in the juxta-
membrane domain of MuSK which appears to be required for agrin-induced AChR 
clustering (Glass et al., 1997; Glass et al., 1996; Herbst and Burden, 2000; Meier et al., 
1996; Zhou et al., 1999). Since agrin does not bind directly to MuSK, a hypothetical 
co-receptor is required to activate MuSK (Glass et al., 1997; Glass et al., 1996). 
Interestingly, the ectodomain of MuSK was shown to be essential to cluster AChRs 
(Apel et al., 1997) in which the first immunoglobulin (lg)-like domain is required for 
agrin response whereas the fourth Ig-like domain for interaction with rapsyn, the 
effector of AChRs (Zhou et al., 1999). Thus, a hypothetical protein is proposed to link 
the fourth Ig-domain and rapsyn (Apel et al., 1997; Zhou et al., 1999). Moreover, the 
juxtamembrane and kinase domains of MuSK interact with dishevelled, a downstream 
molecule in Wnt/Frizzled signaling pathway (Luo et al., 2002). This interaction appears 
to mediate agrin-induced activation of a small GTPase, p21-activated kinase (PAK) that 
is required for AChR clustering by regulating the cytoskeleton (Luo et al., 2002). In 
cultured myotubes agrin induces phosphorylation of ~- and ô-subunits of AChRs that 
precedes the receptor clustering events and MuSK is required for this phosphorylation 
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process (Ferns et al., 1996; Glass et al., 1997; Qu and Huganir, 1994; Wallace, 1994). 
Phosphorylation of AChR stabilizes its association with the cytoskeleton (Borges and 
Ferns, 2001). 
However, recent genetic studies suggest that agrin is not required for initiating 
AChR clusters and for MuSK activation, even more, these data challenge the central 
role of nerve innervation in the postsynaptic differentiation (Ferns and Carbonetto, 
2001). On embryonic day 14, AChR clusters do form in the central band of muscle in 
the agrin-deficient mice, but do not form in MuSK-deficient muscle (Lin et al., 2001). 
In addition, overexpression of mutant MuSK without its ectodomain is sufficient to 
induce AChR clustering without ligand activation (Sander et al., 2001). Furthermore, 
Burden and colleagues (2001) have demonstrated that the embryonic patterning of 
AChR clustering does form in the absence of nerve innervation, but not in the absence 
of MuSK (Yang et al., 2001), thus, they propose that nerve-derived signaIs such as 
agrin refine the endogenous patterning (Yang et al., 2001). It has been shown later by 
an independent group that muscle intrinsic factors but not nerve released-factors or 
agrin assemble the AChR clusters (Pun et al., 2002). Time-Iapse imagining has 
revealed the sequential events for synaptogenesis at the zebrafish NMJs in which 
postsynaptic AChRs clusters form in advance of growing axons, even before the axons 
leave the spinal cord, and these pre-innervation clusters later incorporate into the 
synapse (Flanagan-Street et al., 2005). More recent experiments showed that nerve-
released acetyIcholine in fact serves as a negative factor to disperse the pre-existing 
AChR clusters, whereas neural agrin counters the effect of transmitter to refine the 
clusters of AChRs at the late stage of differentiation (Lin et al., 2001; Lin et al., 2005; 
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Misgeld et al., 2002; Misgeld et al., 2005). These experiments suggested that it is 
muscle-intrinsic factors including MuSK is required for initiating AChR clustering and 
MuSK can be activated independently of agrin. Moreover, they suggest that nerve 
innervation and nerve-released agrin are required to refine the clusters in the late 
developmental stage, a process that is also essential for normal synaptogenesis because 
agrin-null mice have severe NMJ defects (Gautman et al., 1996). 
In addition, agrin also works with other molecules to promote AChR clustering. 
For example, with DG and the DGC (discuss below), and Rho family of the small 
GTPase such as Rac1 and Cdc42 (Weston et al., 2003; Weston et al., 2000). Rac1 and 
Cdc42 can be activated by agrin and the activation appears required for agrin-refined 
AChR clustering (Weston et al., 2003; Weston et al., 2000). 
Rapsyn 
Rapsyn, a 43 kDa cytoplasmic protein, has long been known to tightly associate 
with AChRs in the Torpedo electric organ and mammalian postsynaptic muscle. 
Rapsyn co-distributes perfectly with AChRs from the earliest stage of synaptogenesis 
and is present at 1: 1 stoichiometry with AChRs (Burden et al., 1983; Froehner et al., 
1990; Noakes et al., 1993; Phillips et al., 1993; Sobel et al., 1977). Rapsyn-deficient 
mice die at birth because animaIs fail to move and breathe due to defective NMJs 
(Gautam et al., 1995), a similar phenotype as agrin or MuSK-deficient mice. 
Histological studies in the se mice revealed Joss of AChR clusters and Joss of utrophin 
and DG in the postsynaptic muscle membrane, but normal synaptic localization of 
MuSK, acety1cholinesterase and laminin (Apel et al., 1997; Gautam et al., 1995), 
demonstrating that synaptic Jocalization of MuSK is independent of rapsyn. Co-
39 
expression of AChRs and rapsyn in heterologous cells leads to formation of AChR-
rapsyn clusters whereas AChR is diffusely distributed when expressed on their own 
(Froehner et al., 1990; Phillips et al., 1991). Interestingly, treatment of agrin does not 
promote AChR clustering in rapsyn-deficient muscle (Fuhrer et al., 1999) and forced 
expression of rapsyn in heterologous cells clusters MuSK and recruits AChRs and other 
synaptic components to the MuSK-containing scaffold (A pel et al., 1997; Gillespie et 
al., 1996). These and man y other experiments have firmly established that rapsyn is the 
downstream effector of agrin or MuSK (Sanes and Lichtman, 2001). Rapsyn contains 
several domains: a myristoylated amino terminus (Frai 1 et al., 1988), eight 
tetratricopeptide repeats (TPRs) involved in self-association and a coiled-coil domain 
that binds to the AChR ~-subunit and is necessary for AChR clustering (Burden et al., 
1983; Ramarao et al., 2001; Ramarao and Cohen, 1998). In addition there is a RING-
H2 domain that is involved in interacting with the intracellular juxtamembrane portion 
(from ami no acid 784 to 819) of ~-DG (Bartoli et al., 2001; Cartaud et al., 1998; 
Ponting and Phillips, 1996). Over-expression and deletion of this DG region disrupted 
agrin-induced AChR clustering in cultured myotubes (Kahl and Campanelli, 2003). 
AChRs, utrophin and DG form membrane-associated clusters in the non-muscle cells 
only when they were co-transfected with rapsyn (Apel et al., 1995). Therefore, rapsyn 
serves as the link between AChRs and the DGC. 
II Roles of DG in the NMJ s 
In addition to MuSK, agrin and rapsyn, many other proteins are also involved in 
the NMJ formation, which include the extracellular protein laminin (Vogel et al., 1983), 
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acetylcholinesterase and the DGC. The DGC members are concentrated at the NMJ s 
and match with AChRs in addition to its peripheral sarcolemma expression (Matsumura 
et al., 1992; Ohlendieck et al., 1991b). DG colocalizes with AChRs at very early stages 
before and after nerves make contact with muscles (Cohen et al., 1995). At the muscle 
membrane of the NMJ, DG serves as the receptor of agrin and laminin (Gee et al., 
1993; Gee et al., 1994; Campanelli et al., 1994; Bowe et al., 1994; Montanaro et al., 
1998) and man y experiments have demonstrated DG is involved in the NMJ formation. 
When the DG gene is deleted, the NMJs and AChR clusters are formed, but the clusters 
are dispersed and fragmented both in vivo and in vitro (Cote et al., 1999; Grady et al., 
2000; Jacobson et al., 2001), which is similar to phenotypes observed in a-
dystrobrevin- and utrophin/dystrophin-deficient NMJs (Grady et al., 2000; Kong and 
Anderson, 1999). The synaptic localization of acetylcholinesterase is also disrupted in 
DG-deficient myotubes because the DG-perlecan complex anchors acetylcholinesterase 
(Jacobson et al., 2001; Peng et al., 1999). In addition, other BM proteins such as 
laminin and perlecan are no longer concentrated at the AChR aggregates but agrin and 
rapsyn are not affected (Jacobson et al., 2001). These genetic and cell biology data 
demonstrated DG is required for the stabilization and condensation of AChR clusters 
and formation of synaptic BM. There are several possible mechanisms to explain the 
involvement of DG in the formation of AChR clusters. First: laminin 1 was 
demonstrated to induce AChR clustering twenty years ago (Vogel et al., 1983), 
independent and additive to the effect of agrin (Sugiyama et al., 1997). The laminin-
induced effect was shown to function through DG (Montanaro et al., 1998; Sugiyama et 
al., 1997), and experiments have demonstrated that antibody inhibition of a-DG blocks 
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its ability to induce AChR clustering (Gee et al., 1994) and in DG-deficient cells 
laminin is no longer able to induce AChR aggregates (Jacobson et al., 2001; Montanaro 
et al., 1998). Recent data have suggested that the sialylated core 1 oligosaccharides of 
a-DG that differ from the laminin-binding oligosaccharides mediate laminin-induced 
AChR clustering (McDearmon et al., 2003). Intracellularly DG binds to rapsyn (Bartoli 
et al., 2001; Cartaud et al., 1998) and rapsyn is also essential for laminin-induced 
AChR clustering (Marangi et al., 2002). Therefore, a pathway through laminin-DG-
rapsyn-AChRs effectively participates in postsynaptic differentiation. Second, DG also 
interacts with agrin and functional blocking of DG and agrin interaction has negative 
effect on AChR clustering (Bowe et al., 1994; Campanelli et al., 1994; Gee et al., 
1994). A recent study indicated that over-expression of the intracellular ~-DG can serve 
as a dominant negative molecule and inhibited agrin-induced AChR clustering because 
the intracellular ~-DG sequesters its binding partners (Kahl and Campanelli, 2003). 
Especially noteworthy for agrin's effect on AChR clustering, over-expression of a 
construct containing the rapsyn-binding juxtamembrane domain of DG is sufficient to 
inhibit agrin-induced AChRs clustering (Kahl and Campanelli, 2003). Very 
interestingly, a recent experiment suggested that non-neural muscle agrin can induce 
AChR clustering in cooperation with phosphorylations of MuSK and AChR ~-subunit, 
a process that is laminin-dependent and requires laminin polymerization (Smirnov et 
al., 2005). This provides a likely mechanism for pre-existing AChR clusters in the 
aneral muscles, and future experiments would be to determine the role of DG in this 
laminin-dependent and non-neural (muscle) agrin-induced AChR clustering. 
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III DG in the Schwann cells 
DG is located at the outermost wrappmg of myelin in peripheral nerves 
opposing the basal lamina (Masaki et al., 2000; Saito et al., 1999; Yamada et al., 1994). 
There, it interacts with agrin and laminin 2 (Occhi et al., 2005; Yamada et al., 1996), 
and is complexed intracellularly with Dp116, Ô, 13- and E-sarcoglycan (lmamura et al., 
2000). In addition, DG is also complexed with DRP2 and L-periaxin (Sherman et al., 
2001). Mutations of L-periaxin cause demyelination of peripheral nerves in mi ce and 
human (Boerkoel et al., 2001; Gillespie et al., 2000). a- and j3-DG, Dp116, utrophin are 
also enriched at the microvilli of Schwann cells at nodes of Ranvier and extracellularly 
connect to a2 chain of laminin, whereas DRP2 and periaxin are not present at the nodes 
of ranvier (Occhi et al., 2005; Saito et al., 2003). Mutation in a2 laminin causes 
muscular dystrophy and non-myelinated nerves (Shorer et al., 1995). In DG-deficient 
Schwann cells, other members of the DG complex are also lost or dramatically reduced, 
and mice display extensively folded and long myelin sheaths, reduced sodium channel 
density in nodes of Ranvier and disorganized Schwann cell microvilli, which leads to 
reduced conduction velocity and reduced sensitivity to pain in aged animaIs (Saito et 
al., 2003). 
Interestingly DG is also the Schwann cell receptor for Mycobacterium leprae, a 
pathogen that causes leprosy (Rambukkana, 2001; Rambukkana, 2004). By binding to 
carbohydrate chains of a-DG in the presence of LG-domains of a2-1aminin 
(Rambukkana et al., 1997; Rambukkana et al., 1998), Mycobacterium leprae enters the 
Schwann cell and cause demyelination in vivo and in vitro (Rambukkana et al., 2002). 
In dy/dy dystrophic mice that do not express a2 chain of laminin 2, Mycobacterium 
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leprae fails to attach to the Schwann cell basal lamina (Rambukkana et al., 1997) and 
fail to infect the Schwann cells (Rambukkana et al., 1998). 
IV DG in the brain 
As opposed to muscle, the extracellular space among neurons in the CNS has no 
basement membranes but the extracellular matrix is abundant and contains hyaluronan, 
the main structural component of brain extracellular matrix, and proteolgycans such as 
agrin, perlecan, syndecan, aggrecan, versican, neurocan and more (Holt and Dickson, 
2005; Rauch, 2004; Rutka et al., 1988) with little laminin and collagen (Jucker et al., 
1996; Ruoslahti, 1996). However, DG, dystrophin and other DGC members are 
abundantly expressed in neurons and glia of many brain regions (Blake and Kroger, 
2000; Ibraghimov-Beskrovnaya et al., 1993; Kim et al., 1992; Lidov et al., 1990; 
Moukhles and Carbonetto, 2001; Tian et al., 1996). Unlike in muscle where the 
function and composition of the DGC is better understood, the composition of the DGC 
and its subcellular localization are just beginning to be studied in brain. However, it has 
been known for decades that one third of DMD and BMD patients have cognitive 
defects and mental retardation (Emery, 1998), and recent rndx mice display retention-
related behavioral abnormalities (Vaillend et al., 1995). 
Dystrophin isoforms including Dp427, Dp140 and Dp71 are expressed in 
cerebral cortex, hippocampus, cerebellum, striatum and thalamus (Blake and Kroger, 
2000; Goreeki and Barnard, 1995; Lidov et al., 1995). Full length Dp427 is neuronal 
specifie and localized at central synapses and enriched at the postsynaptic densities of 
excitatory synapses (Blake et al., 1999; Kim et al., 1992; Lidov et al., 1990), where it 
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forms a complex with syntrophin and f3-dystrobrevin (Blake et al., 1999). In 
differentiated astrocytes, Dp71 replaces Dp427 and utrophin to associate with 
syntrophin and a-dystrobrevin (Blake et al., 1999; Imamura and Ozawa, 1998). 
Together with DG and the aquaporin4 water channel, they form a complex at astrocyte 
endfeet surrounding the basement membrane of blood vesicles and regulate brain fluid 
volume (Moukhles and Carbonetto, 2001; Neely et al., 2001; Tian et al., 1996; Zaccaria 
et al., 2001). Like Dp427, DG is also expressed in the neurons and glia of similar brain 
regions (Moukhles and Carbonetto, 2001; Tian et al., 1996; Zaccaria et al., 2001). 
However, unlike Dp427 DG is not enriched biochemicaIly in the postsynaptic density 
of excitatory synapses (Moukhles and Carbonetto, 2001; Mummery et al., 1996). 
Instead, in cultured hippocampal neurons, DG was found at the postsynaptic sites of 
inhibitory GABAergic synapses together with syntrophin and Dp427 (Brunig et al., 
2002; Levi et al., 2002). But it appears that formation of postsynaptic GABA receptors 
and GABAergic synaptogenesis is independent of the complex of DG, dystrophin and 
syntrophin (Brunig et al., 2002; Levi et al., 2002). Therefore, these data suggest 
different complexes exist in the excitatory, inhibitatory synapses and in astrocyte 
endfeet with unrevealed functions. Future experiments should address whether DG is 
localized at the presynaptic terminais of excitatory synapses and whether it is localized 
at the CNS cholinergic synapses. 
Recently, neuronal specific ceIl surface protein neurexins are shown to form a 
physical complex with a-DG (Sugita et al., 2001). Neurexins are encoded by three 
genes and several promoters, which generates longer a-neurexins and shorter f3-
neurexins (Missler and Sudhof, 1998). Both types of neurexins are transmembrane 
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proteins and contain laminin-like G-domains within their extracellular domain 
structures (Rudenko et al., 1999). ~-neurexin interacts with the post-synaptic protein 
neuroligin to initiate the excitatory synapses (Graf et al., 2004; Ichtchenko et al., 1995; 
Song et al., 1999). The neurexin-neuroligin complex is linked to intracellular 
scaffolding protein postsynaptic density 95 (PSD95) via neuroligin (lrie et al., 1997), 
and to the presynaptic scaffolding protein CASK at the neurexin si de (Butz et al., 
1998). The synaptic proteins, neurexin and neuroligin, have been shown to be able to 
induce both pre- and post-synaptic differentiation (Graf et al., 2004; Scheiffele et al., 
2000). Similar to laminin, single G-domains of a- and ~-neurexin bind to carbohydrate 
chains of a-DG, which is tissue-specific and dependent on presence of calcium (Sugita 
et al., 2001). However, at inhibitatory synapses, neurexin seems unable to cIuster DG 
together with other postsynaptic proteins in cuItured hippocampal neurons (Graf et al., 
2004), which certainly raises the question about the role of neurexin-DG complex in 
brain. 
A decisive illustration of DG functions in central nervous system came from the 
brain-specifie DG-null mi ce (Moore et al., 2002). These DG-null mice have fusion of 
cerebral interhemisphere and cerebellar folia, disorganized cerebral layers, aberrant 
migration of granule cells, and discontinuous glia limitans that normally separates the 
marginal zone of the cortex from the subarachnoid space (Moore et al., 2002). These 
mutant mice also show severely blunted long-term potentiation (LTP), suggesting that 
DG may have a role in learning and memory (Moore et al., 2002). 1 mportantly , these 
mutant mice provided suggestions for brain pathogenesis of several congenital 
muscular dystrophies in human. Walker-warburg syndrome, muscIe-eye-brain disease 
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and Fukuyama congenital muscular dystrophy display 'cobblestone lissencephaly' in 
their brains, in which overmigrated neurons result in a brain with a bumpy, cobblestone 
appearance and loss of normal brain folding pattern (Muntoni et al., 2004; Ross, 2002; 
Montanaro and Carbonetto, 2003). These diseases are caused by putative or confirmed 
glycosyltransferase mutant genes (described in the page 10-12), which leads to a 
greatly reduced glycosylation of a-DG and loss of laminin binding in the extracellular 
matrix (Michele et al., 2002). As suggested from the DG-null mice that DG-deficiency 
causes disrupted glia limitans and aberrant neuronal migration (Michele et al., 2002; 
Moore et al., 2002), thus 'Cobblestone lissencephaly' in human may form due to 
neuron over-migration into the subarachnoid space (Ross, 2002). DG mutant brain 
phenotypes were further demonstrated in myd mice which bear a mutant LARGE 
protein. LARGE has been confirmed to participate directly in the glycosylation of a-DG 
(Kanagawa et al., 2004; Barresi et al., 2004) and myd mice show loss of glycosylation 
of a-DG and display similar brain phenotypes including neuronal migration defects in 
cerebral cortex, hippocampus, and cerebellum and discontinued glia limitans (Grewal et 
al., 2001; Holzfeind et al., 2002; Michele et al., 2002). Therefore, a-DG subunit 
appears essential for the function of DG protein in brain and loss of glycosylation of a-
DG, similar as loss of DG, causes abnormal brain structure and organization. Moreover, 
it suggests that glycosylation defect of a-DG might be the common pathway leading to 
those congenital muscular dystrophies, although this remains to be precisely 
determined. 
However, these CNS data do not prove that carbohydrates of a-DG are the only 
functional units required in the CNS development. Very simply, loss of ligand-binding 
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could affect the intracellular DG function, such as its associated proteins or signaling 
molecules or the structure of f3-DG. For example, DG-null muscles lose the f3-DG 
binding partners including dystrophin, sarcoglycans and sarcospan from the muscle 
sarcolemma (Cote et al., 1999; Cohn et al., 2002), thus, loss of f3-DG alone could 
disrupt the muscle membrane integrity because the sarcolemma loses sorne of its 
internaI proteins which are indeed known to cause the muscle dystrophy. Nevertheless, 
open questions remain for clarifying roles of DG in the CNS. For example, since DG is 
expressed in both neuron and glia, we don't know in which cell type loss of DG gives 
rise to the respective brain phenotype, and how they happen? Moreover, we don't know 
if any intracellular signalings that are associated with f3-DG contribute to the brain 
phenotype. 
Similar to the phenotypes in DG-null brain, deletions of extracellular matrix 
components such as aS, yI laminin or their receptors such as a6, 131 integrin in brain 
often result in cortical disorganization, abnormal laminination and disrupted glia 
limitans (Georges-Labouesse et al., 1998; Graus-Porta et al., 2001; Miner et al., 1998; 
De Arcangelis et al., 1999). Interestingly, loss of the intracellular focal adhesion kinase 
(fak), an effector of integrin activation, and integrin-linked kinase in non-neuronal cells 
lead to 'cobblestone li ssencephaly , , aberrant neuronal migration and defective cortical 
lamination similar to the congenital muscular dystrophies (Beggs et al., 2003; 
Niewmierzycka et al., 2005). These data suggest that disruption of the intracellular 
signaling components is sufficient to cause similar phenotypes as disrupted binding 
between the receptor and extracellular ligands 
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V DG in the retina 
In addition to muscle and brain, DG together with dystrophin and its other 
associated proteins functions in the retina. The first evidence for retinal involvement 
came from the electroretinogram (ERG) defects in sorne of the DMDIBMD patients 
and the mdx!cv mice which lacks aIl dystrophin isoforms and results in disrupted DG 
location in the retina (Blank et al., 1999; Dalloz et al., 2001; Moukhles and Carbonetto, 
2001). The ERGs in these patients and mice are reduced and delayed in the amplitude 
of the b-wave under dark-adapted (scotopic) condition, but the ultrastructure of the 
retina is weIl preserved (PilIers et al., 1990; PilIers et al., 1993);(Cibis et al., 1993; 
Pillers et al., 1995). The ERG is a summed electrical signal evoked by a flash of light 
(Weleber and Eisner, 1988). The b-wave of the ERG is a positive summed potential 
which is thought to originate from the depolarization of ON-bipolar cells that receive 
and are activated by synaptic transmitter glutamate released from photoreceptor cells 
(Schmitz and Drenckhahn, 1997a; Stockton and Slaughter, 1989). Cone photoreceptor 
cells make synapses on both ON- and Off-bipolar celIs, whereas rod photoreceptor cells 
are only connected to ON-bipolar cells (Schiller, 1982; Wassle et al., 1991). Sorne 
experiments have demonstrated that b-wave defects in DMDIBMD patients result from 
depolarizing ON-bipolar cells that receive transmission from both cone and rod 
photoreceptor cells (Cibis et al., 1993; Fitzgerald et al., 1994; Pillers et al., 1993; 
Schmitz and Drenckhahn, 1997a). In addition, Muller cells appear also involved in the 
generation and modification of the b-wave in which the synaptic current (K+) flows into 
Muller cells to contribute to b-wave (Wen and Oakley, 1990). However, more evidence 
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suggests that b-wave defects in DMDIBMD are originated from impaired synaptic 
transmission from rods and cones to postsynaptic cells (Blake and Kroger, 2000). 
In the vertebrate retina, full length Dp427 and isoform Dp260 are expressed 
exc1usively in the photoreceptor celI membrane of the outer plexiform layer (D'Souza 
et al., 1995; Claudepierre et al., 1999), where photoreceptor cells form the invaginating 
ribbon synapses with bipolar and horizontal cells (Muntoni et al., 2003). The ribbon is a 
structurally and functionally specialized presynaptic organelle that constitutes an 
electron-dense band extending from the site of transmitter release into the cytoplasm 
(Sterling and Matthews, 2005). An invagination is created because the presynaptic 
photoreceptor cell membrane forms a cavity that contains the postsynaptic dendrites of 
bipolar and horizontal celIs. AlI bipolar cells that have dendrites within the invagination 
belong to ON-pathway and respond to illumination with depolarization whereas bipolar 
cells that do not have dendrites within the invagination belong to OFF-pathway and 
hyperpolarize in response to light (Schmitz and Drenckhahn, 1997a). The altered b-
wave of the ERG in DMDIBMD patients appears to be produced by the ON-pathway 
mediated by the bipolar cells within the invagination (Gurevich and Slaughter, 1993). 
DG is also expressed in the outer plexiform layer (Drenckhahn et al., 1996; Montanaro 
et al., 1995). Electron microscopy studies together with genetic and biochemical studies 
have revealed that DG and dystrophin immunoreactivities are found in the 
photoreceptor membranes that form the invagination and retrieve vesic1es, but little is 
found at the site where the ribbon attaches and vesic1es are released (Dalloz et al., 
2001; Claudepierre et al., 1999; Koulen et al., 1998; Schmitz and Drenckhahn, 1997b; 
Sterling and Matthews, 2005; Ueda et al., 1997; Ueda et al., 1995). Therefore, DG and 
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Dp427/Dp260 form a presynaptic membrane complex in the outer plexiform layer, 
together with ~-dystrobrevin, syntrophin and extracellular matrix protein agrin (Jastrow 
et al., 2006; Blank et al., 2002; Kroger and Mann, 1996) at the sites of endocytosis 
(Sterling and Matthews, 2005). mdx mice that lack Dp427 do not show b-wave 
abnormalities (Cibis et al., 1993), but deletion of Dp260 results in reduced level of DG 
at the outer plexiform layer and an ab normal scotopic b-wave in both mice and human 
(D'Souza et al., 1995; Kameya et al., 1997; Piliers, 1999; PilIers et al., 1999), which is 
quite similar to what is observed in mdxcv mice, which lack aIl dystrophin isforms, and 
DMD/BMD patients. Therefore it is reasonable to assume that Dp260 contribute to 
normal ERG production at the presynaptic membranes of photoreceptor cells. Indeed, 
other dystrophin isoforms such as Dp427 and Dp71 are not sufficient to replace the 
function of Dp260 (Fitzgerald et al., 1999). Isoform Dp71 and DG are also expressed 
and form a complex with utrophin, Ô-sarcoglycan, a-dystrobrevin and a l-syntrophin in 
the endfeet of Muller glial cells, which make contact with agrin in the inner limiting 
membranes, as weIl as in the perivascular astrocyte endfeet (Claudepierre et al., 2000; 
Dalloz et al., 2003; Kroger and Mann, 1996; Mann and Kroger, 1996). Deficiency of 
Dp71 in this two places leads to reduced level of DG, impaired clustering of the 
rectifying potassium channel Kir4.1 and aquaporin 4, but does not lead to abnormal b-
wave (Dalloz et al., 2003). Because loss of Dp71 and reduced level of DG in Muller 
cells and astrocyte endfeet lead to no disrupted b-wave, it suggests that defective 
synaptic transmission in DMDIBMD patients mainly result from the disrupted complex 
of Dp260 and DG located at the presynaptic membranes of the photoreceptor cells. 
However, how this disrupted complex in the presynaptic photoreceptor cells leads to b-
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wave defects remains unknown. Although the DGC could play a structural role by 
linking the presynaptic photoreceptor cells to the postsynaptic cells, the normal 
ultrastructure in the mdx3cv mice and DMDIBMD patients (Cibis et al., 1993; Pillers et 
al., 1995), which show b-wave defects, suggests that the synaptic defects in the retina 
are unlikely due to structural defects. 
DG has an altered expression and localization at the photoreceptor membranes 
in Dp260-deficient animaIs, in md2cv mice as well as in DMD/BMD patients (Blake 
and Kroger, 2000; Blank et al., 1999; D'Souza et al., 1995; Kameya et al., 1997). 
Mutations in the DG gene are not found so far in human and mouse models with eye-
specific DG gene deletion are not available for studying the function of DG in retina. 
However, recent findings from the several human mutations in genes that alter 
glycosylation of DG have indicated important functions of DG in the retina. In 
particular with mutation in LARGE, that has resultant hypo-glycosylation of a-DG, the 
amplitude of the b-wave is significantly reduced and profound mental retardation is 
displayed in human (Longman et al., 2003) but vision is largely normal. Reduced 
amplitude and delay in the b-wave are also observed in myd mice bearing LARGE 
mutations, but retinal layering appears normal and no sign of neuronal migration 
defects (Holzfeind et al., 2002). In fukutin-deficient chimeric mice with 
hypoglycosylation of a-DG, there is extinction of the b-wave, anomalous formation of 
eye ball and lens, loss of laminar structure of the retina and retinal detachment (Takeda 
et al., 2003). Similar to mice, humans suffering from FCMD also have eye 
abnormalities including extensive detachrnent and rnis-folding and fusion of the retina 
(Hino et al., 2001). Furthermore, sorne reported MEB patients have severely impaired 
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ocular system including retinal degeneration, bilateral glaucoma, corneal clouding and 
are blind at an early age (Fahnehjelm et al., 2001; Vervoort et al., 2004; Zervos et al., 
2002). Because the severity and histological abnormalities in the retina of individual 
mutant genes seem not to phenocopy one another, this raises sorne doubts whether 
hypo-glycosylation of a-DG is the cause of the se retinal defects, rather it might be the 
consequence or only partially contribute to the pathologies observed in the eye. A 
decisive dissection of DG function in the ocular system will need an animal model with 
eye-specific deletion of DG, or an animal model with a mutated DG having defective 
glycosylation of a-DG, or a rescue experiment with a-DG re-introducing into the DG-
null eye. These experiments not only can clarify the function of DG in the ocular 
system, they can also help understand the mechanisms of retinal impairments in several 
congenital muscular dystrophies including MEB, FCMD, WWS and congenital 
muscular dystrophy type ID .. 
In chapter 3, 1 will describe experiments using Drosophila melanogaster as a 
model to answer sorne of the questions mentioned above, especially the roles of DG in 
the visual system and distinct function of DG domains in the Drosophila visual system. 
Below, 1 would like introduce sorne background in the Drosophila and its visual 
system, especially focusing on those relevant to DG. 
Part IV: DG in Drosophila melanogaster 
1 Drosophila DGC 
Drosophila melanogaster is a powerful model organism being used to 
understand a particular gene function by "reverse" genetics and to look for genes 
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involved in a biological process by "forward" genetic screen, because of its completed 
genomic sequence, sophisticated genetics and evolutionary conservation of most 
cellular events. DG and man y of its associated proteins in vertebrates are also found in 
Drosophila (Dekkers et al., 2004; Greener and Roberts, 2000; Roberts and Bobrow, 
1998). The Drosophila ortholog of dystrophin gene encodes at least four isoforms, 
three of which are expressed during embryogenesis (Neuman et al., 2001). The mRNAs 
of longer dystrophin isoforms dmDLP1 and dmDLP2 are mainly located in the 
mesoderm and gut, whereas mRNA of small isoform dmDLP186 is predominantly 
located in the ventral nerve cord and brain (Dekkers et al., 2004). The Drosophila 
dystrobrevin ortholog is expressed in the ventral nerve cord, the brain and the muscle 
during late embryonic stage (Dekkers et al., 2004). The Drosophila syntrophin 1 is 
mainly expressed in the ventral nerve cord and brain, but syntrophin 2 is expressed in 
the visceral mesoderm, the dorsal pharyngeal muscle as weIl as midgut (Dekkers et al., 
2004). a, j3 and ô-sarcoglycan Drosophila orthologs are expressed in the ventral nerve 
cord and midgut as weIl as muscle (Dekkers et al., 2004). These data indicate that like 
in vertebrate Drosophila dystrophin, syntrophin, dystrobrevin and sarcoglycan are 
predominantly expressed in the muscle and sorne of them are also in the central nervous 
system. 
Drosophila DG 
Drosophila DG is encoded by a single gene located on the second chromosome 
and alternative splicing generates three isoforms, and several bands appear in the SDS-
PAGE ranging from 75 kDa to 200 kDa (Deng et al., 2003), probably due to different 
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glycosylation. The Drosophila DG ortholog is highly conserved comparing with its 
human counterpart. The entire amino acid sequence is about 27% identical, while the 
intracellular portion is about 31 % identical and the last 20 amino acids in the C-
terminus is 51 % identical. In vertebrates, residues from 653-657 (GSIVV) of the DG 
polypeptide are conserved among several vertebrate species and a S654A point 
mutation at the cleavage site can prevent the cleavage of DG polypeptide into a- and 13-
subunits and leads to muscular dystrophy in vivo, but normal localization of DG on the 
cell surface (Esapa et al., 2003; Jayasinha et al., 2003). In the Drosophila DG, although 
the attachment site of two subunits are conserved from ami no acid 934-969 (Sciandra et 
al., 2001), the cleveage site appears mutated. In the N-terminus, the two longer 
isoforms of Drosophila DG (type A and C) (CG1825-PA and CG1825-PC) (Deng et 
al., 2003) contain the mucin-like domain that is enriched with serine and threonine. In 
the mammals, the mucin region of a-DG contains 19 consensus sequences {S(T)P or 
PXXS(T)} for O-linked glycosylation (Martin and Freeze, 2003). By sequence 
comparison, the mucin-like region of Drosophila DG type Chas 30% identity in amino 
acid sequence to human mucin-l and 21 % identity to human mucin 2 and contains 15 
consensus sites for O-linked glycosylation (Fig. 1-2). Drosophila DG (type A) has 
17.3% identity to human mucin-l and 20% identity to mucin-2 and contains 5 putative 
O-linked glycosylation sites whereas the shortest DG (type B) has 6 putative sites (Fig. 1-2). 
However, so far no reported data show that the Drosophila ortholog, like the vertebrate 
one, is glycosylated. Interestingly, the Drosophila orthologs of human protein 0-
mannosyltransferase-l (hPOMTl) known to participate in glycosylation of a-DG and 
lead to WWS, when mutated, have been identified as dPOMTl and dPOMT2, which 
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seem to function together in transferring a mannose to the vertebrate a-DG (lchimiya et 
al., 2004). RNAi of dPOMT2 knock-down causes a "twisted abdomen" phenotype 
(Ichimiya et al., 2004) similar to rotated abdomen (rt) as seen in mutant dPOMT1 flies 
(Bridges and Morgan, 1923). Both dPOMT1 mutant and dPOMT2 RNAi knock-down 
flies have reduced viability and escapers show a "rotated abdomen" phenotype due to 
defects in muscle development (Martin-Blanco and Garcia-Bellido, 1996; Ichimiya et 
al., 2003). However, as in vertebrates, homozygous DG-null alleles are embryonic 
lethal in Drosophila (Deng et al., 2003), no escaper can live to adulthood. This viability 
difference simply suggests a functional difference between dPOMT and Drosophila 
DG. 
During the embryogenesis DG mRNA is located in many places including the 
brain, visceral mesoderm, the ventral nerve cord and midgut (Dekkers et al., 2004). 
Indeed, in the follicle cell epithelium, DG-null cells lose their apical-basal polarity. In 
the DG-null epithelial cells, apical proteins such as crumbs (crb) , ~-Heavy-Spectrin, 
discs lost (dit) are mislocalized to both basolateral and basal sides, whereas expression 
of basal protein such as Disc large (Dlg) is reduced (Deng et al., 2003). In oocytes, DG 
is also required for the anteroposterior polarity in that the microtubule organization 
center (MTOC) fails to localize to the anterior part of the oocytes in DG-deficiency 
(Deng et al., 2003). These data suggest that in the early embryonic development DG 
serves as a cell polarity determinant. 
Drosophila Eye Development 
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Drosophila has a typical insect compound eye. Each eye is composed of about 
800 functional units, the light-sensitive ommatidia. Each ommatidium is a ",20-cell 
assembly containing eight photoreceptor neurons (RI-R8), and 12 accessory cells 
including four non-neuronal cone cells, three classes of pigment cells and a bristle 
complex (Longley and Ready, 1995; Ready et al., 1976). In adult ommatidia each 
photoreceptor cell (PRC) extends a photosensitive organelle, called rhabdomere, 
toward the center of the ommatidium that is separated by a space called 
interrhabdomeral space. The rhabdomeres of R7 lie in the center position surrounded 
by RI-R6 whereas rhabdomere of R8 lie underneath the rhabdomeres of R7. The 
rhabdomere is a dense stack of microvilli of photoreceptor apical membranes, whereas 
the basal membranes of the photoreceptor cells are connected to the surrounding 
pigment cells mainly by cell adhesion molecules (Cagan and Ready, 1989; Longley and 
Ready, 1995). 
The eye develops from a sheet of epithelial tissue called the eye imaginaI disc. 
Beginning at the 3rd instar larval stage, an indentation called morphogenetic furrow 
(MF) in the disc, caused by the apical shift of a monolayer epithelial cells, initiates the 
cell differentiation at the posterior tip and move anteriorly in a wave across the disc 
(Hsiung and Moses, 2002). This process appears dependent on specific signaIs 
mediated by Hedgehog, Decapentaplegic (Dpp), the epidermal growth factor (EGF) 
receptor homolog (Egfr) and Notch (Borod and Heberlein, 1998; Curtiss and Mlodzik, 
2000; Dominguez and Hafen, 1997; Kumar and Moses, 200Ib). Photoreceptors are the 
first cells to differentiate followed by non-neuronal lens-secreting cone cells and 
primary pigment cells (Nagaraj and Banerjee, 2004; Tomlinson and Ready, 1987). 
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Among all photoreceptor celIs, R8 is the first to be specified followed by R5 and R2, 
then R4 and R3 to form five cell clusters (Fig. 1-4), posterior to morphogenetic furrow. 
Around this five cell stage, PRCs begin to rotate as a group. In dorsal part of disc these 
PRCs rotate clockwise whereas in the ventral part they rotate counterclockwise (Zheng 
et al., 1995; Strutt and Strutt, 2003)(Fig. 1-4). The boundary that separates the two parts 
is called "equator" (Fig. 1-4). Following the five cell stage, R7, RI and R6 are finally 
recruited to form an eight cell trapezoid (Hsiung and Moses, 2002; Nagaraj and 
Banerjee, 2004). These processes generate mirror-symmetrically patterned PRC 
clusters so that they have a uniform pattern at one side of equator and another part has 
an opposite pattern (Fig. 1-4). This polarity is formed within a plane perpendicular to 
the apical-basal direction and is referred as planar cell polarity of PRe. 
CeIl-ceIl communications play a major role in PRC differentiation and fate 
determination. Best known is the notch-delta signaling pathway. Activation of the 
notch ligand, delta requires high level of EGFR signaling, and delta in PRC activates 
notch in the undifferentiated neighboring cells and initiate the signaling (Baker and 
Rubin, 1989; Baker and Rubin, 1992; Nagaraj and Banerjee, 2004; Tsuda et al., 2002). 
This process is required specification of aIl cells in the eye (Freeman, 1996). In 
addition, bride of sevenless (Boss), a seven-pass transmembrane protein in R8, binds to 
and activates sevenless, a receptor tyrosine kinase expressed in R7, R3/R4 and Rl/R6 
(Banerjee et al., 1987; Reinke and Zipursky, 1988). This binding results in activation of 
Ras by Grb2/Sos complex, which in turn activates the MAPK signaling cascades 
(Biggs et al., 1994; Biggs and Zipursky, 1992; Bonfini et al., 1992; Rogge et al., 1991; 
Simon et al., 1991; Simon et al., 1993). Through combination of complex signaling 
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pathways, the specification of PRCs, cone cells and pigment cells are completed when 
the pupation begins. 
Starting with the pupal stage, following the 90° rotation the apical surfaces of 
PRC become toward the center of ommatidia and apical-basal axis is perpendicular to 
entering light (Longley and Ready, 1995), and cells within the ommatidia begin their 
final differentiation, a process involving in massive cell shape change, cell movement, 
and controlled cell death. After approximately 33% of pupal development the 
differentiation and patterning of the retina is nearly complete, showing already the 
same number of ommatidia and the highly regular hexagonal array observed in the 
adult (Ready et al., 1976; Tomlinson, 1988). Between 37 and 55% of pupallife, PRCs 
dramatically expand their cell volume, and its apical membranes elongate to form long, 
densely-packed arrays of light-sensitive microvilli called rhabdomeres. And, 
rhabdomeres reach and anchor to the retina floor that is formed by meeting of four cone 
cell feet (Longley and Ready, 1995; Pichaud and Desplan, 2002). Cone cells are 
recruited apically into the PRCs cluster in the 3rd instar larvae and lie entirely to the 
sides of the PRCs until 14% pupa life and form the cone cell plate at 37% pupa life 
(Longley and Ready, 1995) and begin to secrete lens at 45% pupal development (Cagan 
and Ready, 1989). The primary pigment cells begin to enwrap the cone cell at 20% of 
pupal development and form a membrane above the retinal floor called fenestrated 
membrane at ",67% of pupal development (Cagan and Ready, 1989). The celI-celI 
contacts mediated mainly by adherens junctions between PRCs and between PRCs and 
cone cells are maintained and extended during this morphogenesis of the eye (Longley 
and Ready, 1995). The adherens junctions between PRCs are localized sub-apically and 
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are connected to the rhabdomeres by the stalk membranes (Longley and Ready, 1995; 
Pellikka et al., 2002). When the adherens junctions are disrupted in the pupal stage by 
mutant polarity determinants such as bazooka and crumbs, the final differentiation of 
PRC is impaired (Hong et al., 2003; Izaddoost et al., 2002; Pellikka et al., 2002). The 
mutant PRC rhabdomeres fail to reach the retinal floor and are mis-positioned in the 
ommatidia, but the PRes are normally polarized and there is no degeneration in pupal 
PRes (Hong et al., 2003; Izaddoost et al., 2002; Pellikka et al., 2002). Many more 
genes involved in polarity formation, transcription regulation, cytoskeleton 
modification, protein trafficking and cell adhesion have been shown to be required for 
eye morphogenesis. 
To understand if DG is required for eye morphogenesis, chapter 3 of this thesis 
de scribes evidence that DG plays essential roles for autonomous PRe differentiation 
and for eye morphogenesis by loss-of-function, gain-of function and other methods. 
Moreover it shows distinct roles of intracellular and extracellular DG in PRe 
development in Drosophila eye. In addition, chapter 2 of the thesis describes 
identification of a new DG interacting protein, the GTPase dynamin 1, in the brain and 
in the outer plexiform layer of vertebrate retina and its functional implication in 
endocytosis is reported. Together, by experiments describing in Drosophila visual 
system (chapter 3) and in vertebrate (chapter 2), 1 show several novel functions of DG 
in the nervous system and its implications will be discussed. 
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Table 1. Muscular dystrophies and their gene products 
Disease Disease subtype Inheritance pattern 
DMD/BMD XR 
LGMD IC AR 
2B AR 
2C AR 
2D AR 
2E AR 
2F AR 
MDC lA AR 
IC * AR 
ID * AR 
Fukuyama CMD * AR 
MEB * AR 
WWS* AR 
Gene product 
Dystrophin 
Caveolin3 
Dysferlin 
y-sarcoglycan 
a-sarcoglycan 
~-sarcoglycan 
ô-sarcogl ycan 
Laminin a2 chain 
Fukutin related protein 
LARGE 
Fukutin 
O-mannose~-l ,2-N-acetyl-
glucosaminyl transferase 
O-mannoslytransferase 1 
This table lists mainly the muscular dystrophies and their gene products that are related to the dystrophin 
glycoprotein complex (DGC). For a complete list, please see Dalkilic and Kunkel (2003). DMD, 
Duchenne muscular dystrophy; BMD, Becker muscular dystrophy; LGMD, limb-girdle muscular 
dystrophy; MDC, congenital muscular dystrophy; CMD, congenital muscular dystrophy; MEB, muscle 
eye brain disease; WWS, Walker-Warburg Syndrome; XR, X-linked recessive; AR, autosomal recessive. 
*, disease having a defective glycosylation of a-DG. 
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Dystroglycan and its associated proteins 
Basement membrane 
1 Out 1 
EJ 
laminin 
... Congenital muscular dystrophy lA 
a -dystroglycan .. :::::::::::::::::::::::::::::::::::: ............................................. . 
[O-linW carboh;h;te chaiffiJ 
/3-dystroglycan 
Fukuyama muscular dystrophy 
Muscle-eye-brain disease 
Walker-Warburg Syndrom 
... Limb-girdle muscular dystrophy type 2C-F 
syntrophin 
Duchenne/Becker muscular dystrophy 
Figure 1-1: Structure of the dystrophin glycoprotein complex (DGC) in muscle. The 
DGC links the cell from intracellular actin to the extracellular laminin, agrin or 
perlecan in the basement membrane. The DGC can be divided into three 
subcomplexes: the cytoplasmic complex containing dystrophin/utrophin, syntrophin, 
dystrobrevin and syntrophin-binding protein nNOs; the sarcoglycan and sarcospan 
complex containing transmembrane protein sarcoglycan (a, ~,y, Ô) and sarcospan (SS); 
the dystroglycan complex containing ~ and a-dystroglycan and its extracellular ligands 
laminin and agrin. Disruption of the DGC causes various muscular dystrophies: 
Mutations in dystrophin causes DuchennelBecker muscular dystrophy; Mutations in 
sarcoglycans causes limb girdle muscular dystrophy type 2C-F; Mutations that affect 
glycosylation of a-DG are found in Fukuyama muscular dystrophy, Muscle-Eye-Brain 
disease and Warker-Warberg Syndrome. Mutations in a2 chain of laminin cause 
congenital muscular dystrophy type lA. No mutations in human have been found in 
agrin and perlecan genes. 
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a-DG (72 kD) B-DG (26 kD) 
mucin region transmembrane 
Human DG 
1 À 315 À 484 751 774 861 895 
3 sites of N-glyco 19 sites of O-glyco 655 
mucin region transmembrane 
Drosophila DG type C 
1 413 À 553 1048 1075 1147 1179 
15 sites for O-glyco 
mucin region transmembrane 
Drosophila DG type B 
-
1 283 À 289 783 810 882 914 
6 sites for O-glyco 
mucin region transmembrane 
Drosophila DG type A 
-1 276 À 364 864 893 865 997 
5 sites for O-glyco 
Figure 1-2: Illustration of human and Drosophila dystroglycan (DG) proteins. The 
human DG is comprised of a and ~-DG with a cleavage site at serine 655. a-DG 
contains 653 amino acids within which a mucin region starting from amino acid 315 to 
484 has 19 consensus sites for O-linked glycosylation (Martin, 2003). Outside the 
mucin region, there are three putative N-linked glycosylation sites. Glycosylation 
changes the molecule weight of a-DG protein (72 kDa) to 100-200 kDa that is found in 
tissues. Glycosylation of the transmembrane ~-DG increases its molecular weight from 
26 to 43 kDa. Alternative splicing generates three isoforms of DG in Drosophila (Deng 
et al., 2003). The longest one is type C DG which contains a highly conserved mucin 
region in its extracellular domain (from ami no acid 413 to 553) and aC-terminal region 
(from amino acid 1147 to 1179). By sequence comparison, fifteen serines or threonines 
are putative O-linked glycosylation sites in the mucin region of the Drosophila DG 
type C. In the type B and A the consensus sites for O-linked glycosylation are six and 
five respectively. The cleavage site is not conserved and it is not unkown if Drosophila 
DG is cleaved into a and ~-subunits or not. So it is not marked. Nor do we know the 
precise molecule weights following the glycosylation. The transmembrane domains are 
marked in Drosophila DG and the conserved C-terminal domains in type A and B are 
labeled too. 
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Figure 1-3 
Laminin al chain 
NH2-@II:9 1 1 1 1 1 0 1 1 coiled-coil 
LG domains 
~-COOH 
Laminin ~l chain NH2- @JI9wl_]wL..__c_o_ie_d_-co_i_---II-cooH 
Laminin yl chain NH2- ~wO-wIL..--c-o-i,e-d--c-oil----II-cooH 
integrin 
Po~ymer 
0!1>~1 ----{l 
02131 
coilded-coil 
a6~1 ~ 
i nteg ri n (0::6134 ~ L 
{a7J31) 
al 
entactin/nidogen 
/ 
Polymer 
(Bottom: modified from Figure 1 in Yurchenco and Wadsworth, 2004) 
Figure 1-3: Structure of laminin 1 comprised of al, ~l and yI chains. The three chains 
of laminin are shown individually (top) and as a heterotrimer (bottom). The domains in 
individual chains are marked. The N-terminal and L4 globular domains are shown in 
LN (al, ~l, yI chain) and L4 (al, yI chain) as circles which are interrupted by EGF 
repeats shown as rectangles (al, ~l, yI chain). The coiled-coil regions in al chain are 
joined together to form the heterotrimer with the C-terminus lie beyond the coiled-coil 
region and three independent short arms (bottom). Five LG domains (LG modules) are 
marked as circles in laminin trimer (al chain and bottom), in which LG 1-3 interact 
with integrin whereas LG 4-5 interact with a-DG. Integrins also interact with LN 
domain of a chain and Entactin/nidogen interacts with the EGF repeat in y chain 
(pointed in bottom). The self-assembly of laminin requires the N-terminal LN domains 
of a, ~, y-chain (pointed as pol ymer). 
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Figure 1-4 
m~r@~ 34 5 4 5 4 3 5 6 00 8 8 3 5 2 8 0005 2 3 2 2 8 1070 
equruor ---<ù------g§----~--~-----~-----;?~K 
row2 row4 row6 row8 trapezoid (adult) 
MF 
Figure 1-4: Photoreceptor patterning and rotation in the 3rd instar larvae dise. 
A wave of differentiation initiated by morphogenetie furrow (MF) moves from 
posterior to anterior and photoreceptor cells are sequentially reeruited as the dise 
matures. R8 photoreceptor eell is first to be speeified row 2 behind the MF followed by 
R2 and R5, then R3 and R4 are added to form a five-eell cluster. PRes around this 
stage begin to rotate cloekwisely dorsal to the equator, and eountercloekwisely ventral 
to the equator. As dise matures, RI, R6 and R7 are reeruited to form a trapezoid and 
adult PRes have rotated 90° to form a mirror-symmetrie pattern. AlI R7s in the 
trapezoid on both sides point to the equator whereas R3 and R4 face the pole of dise. 
This polarized pattern is referred as PRe planar polarity. R8 is below R7 and not shown 
in the adult trapezoid. Anterior is toward left. Posterior is right. Dorsal is up and ventral 
is down. 
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Chapter 2 
Evidence that dystroglycan is associated with dynamin 
and regulates endocytosis 
by 
Yougen Zhan, Mathieu R. Tremblay, Nadia Melian, Salvatore Carbonetto 
©2005 The Journal of Biological Chemistry, vol. 280, pages 18015-18024 
Reproduced by granted copyright permission of the American Society for 
Biochemistry and Molecular Biology, Inc., Bethesda, MD, 20814. 
66 
ABSTRACT 
Disruption of the dystroglycan gene in humans and mice leads to muscular 
dystrophies and nervous system defects including malformation of the brain and 
defective synaptic transmission. To identify proteins that interact with dystroglycan in 
the brain we have used immunoaffinity purification followed by mass spectrometry 
(Le/MS-MS) and found that the GTPase dynamin 1 is a novel dystroglycan-associated 
protein. The ~-dystroglycan-dynamin 1 complex also included a-dystroglycan and 
Grb2. Overlay assays indicated that dynamin interacts directly with dystroglycan and 
immunodepletion showed that only a pool of dynamin is associated with dystroglycan. 
Dystroglycan was associated and co-Iocalized immunohistochemically with dynamin 1 
in the central nervous system in the outer plexiform layer of retina where photoreceptor 
terminaIs are found. Endocytosis in neurons is both constitutive, as in non-neural cells, 
and regulated by neural activity. To assess the function of dystroglycan in former we 
have assayed transferrin uptake in fibroblastic cells differentiated from embryonic stem 
cells null for both dystroglycan alle1es. In wild-type cells dystroglycan formed a 
complex with dynamin and codistributed with cortactin at membrane ruffles which are 
organelles implicated in endocytosis. Dystroglycan-null cells had a significantly greater 
transferrin uptake, a process weIl known to require dynamin. Expression of 
dystroglycan in null cells by infection with an adenovirus containing dystroglycan 
reduced transferrin uptake to levels se en in wild type ES cells. These data suggest that 
dystroglycan regulates endocytosis possibly as a result of its interaction with dynamin. 
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INTRODUCTION 
Dystroglycan (DG) is encoded by a single gene (dagl), and is synthesized as a 
precursor protein that is cleaved into a and ~ subunits. a-DG is a peripheral membrane 
protein that binds, via its carbohydrate side chains (Ervasti and Campbell, 1993b; 
Michele et al., 2002), to globular motifs in the a chain of several laminins (Gee et al., 
1993; Ido et al., 2004; Talts et al., 2000), agrin (Bowe et al., 1994; Campanelli et al., 
1994; Gee et al., 1994; Sugiyama et al., 1994), perlecan (Jacobson et al., 2001; Peng et 
al., 1998) and a-neurexin (Sugita et al., 2001). ~-DG is a transmembrane protein bound 
non-covalently to a-DG that interacts intracellularly with dystrophin, utrophin, rapsyn, 
caveolin-3 and growth factor receptor-bound protein 2 (Grb2) (Winder, 2001). In 
skeletal muscle a- and ~-DG form the functional core of a larger complex that links the 
extracellular matrix to the cytoskeleton and serves to maintain the integrity of 
myofibers faced with the stress of repeated contractions (Durbeej and Campbell, 2002). 
Hence, mice with skeletal muscle deficient in DG develop a severe muscular dystrophy 
(Cohn et al., 2002; Cote et al., 1999). 
DG is expressed in the nervous system and in many tissues other than skeletal 
muscle (Durbeej et al., 1998) and mi ce null for dagl die at E6.5-7.0, long before 
muscle differentiation (Williamson et al., 1997). DG has been implicated in the 
formation of several (Jacobson et al., 2001; Michele et al., 2002; Moore et al., 2002), 
but not all basement membranes (Cohn et al., 2002; Cote et al., 1999; Holzfeind et al., 
2002; Li et al., 2002) and in Drosophila DG is necessary for epithelial polarization 
(Deng et al., 2003). In the nervous system DG is localized at glial endfeet in contact 
with basement membranes around blood vessels (Tian et al., 1996) and beneath the 
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meninges of the brain (Michele et al., 2002). DG is also concentrated at peripheral 
(Cohen et al., 1995; Gingras and Ferns, 2001; Leschziner et al., 2000) and central 
synapses (Brunig et al., 2002; Koulen et al., 1998; Levi et al., 2002; Moukhles and 
Carbonetto, 2001). Recent work has shown that myodystrophy (myd) mice, which have 
a mutation in LARGE, a gene that encodes an enzyme involved in O-glycosylation of 
a-DG (Grewal et al., 2001), have decreased affinity for laminin and disrupted 
meningeal basement membranes (Michele et al., 2002). As weIl, these mice have 
defects in neuronal migration in the cerebral cortex and cerebellum (Michele et al., 
2002). In humans similar defects, called lissencephalies, are associated with profound 
mental retardation and are manifested in Walker Warburg Syndrome, Muscle Eye Brain 
Disease and Fukuyama Muscular Dystrophy. AH of these are congenital muscular 
dystrophies that result from mutations in genes known or suspected to regulate 
glycosylation of a-DG (Montanaro and Carbonetto, 2003). Interestingly, mice with a 
targeted deletion of dagl in the brain have a similar phenotype (Moore et al., 2002) 
suggesting that many functions of DG are mediated by carbohydrate side chains which 
are responsible for most ligand binding (Ervasti and Campbell, 1993b; Michele et al., 
2002) (Kanagawa et al., 2004). In addition, mice lacking DG in the brain have defects 
in long-term potentiation in the hippocampus (Moore et al., 2002) and myd mice have 
an abnormal electroretinogram with no signs of disrupted neuronal migration in the 
retina (Holzfeind et al., 2002). DG is also necessary for stabilization of the postsynaptic 
density of acetylcholine receptors on skeletal myotubes in culture (Grady et al., 2000; 
Jacobson et al., 2001) and at nerve-muscle synapses in vivo (Cote et al., 1999; Jacobson 
et al., 2001). 
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Emerging evidence indicates that the proteins that interact with DG in non-
muscle tissues differ from those in muscle. For example, a-neurexin is complexed with 
a-DG in the central nervous system (CNS) (Sugita et al., 2001) while periaxin is 
associated with DG in Schwann cells (Sherman et al., 2001). To identify novel DG 
interactors we have used immunoaffinity chromatography to purify DG and its 
associated proteins from rat brains. We report that ~-DG forms a complex with 
dynamin 1, a GTPase essential for several modes of endocytosis including regulated 
endocytosis during synaptic vesicle release and constitutive endocytosis which occurs 
in neuronal and non-neuronal cells alike (D'Hondt et al., 2000; Jarousse and Kelly, 
2001; Praefcke and McMahon, 2004).The ~-DG-dynamin complex in the CNS also 
contains a-DG and the SH2 (src homology 2)/SH3 (src homology 3) adapter protein 
Grb2 and has the potential to anchor dynamin at discrete sites within the cell. In an 
overlay assay, ~-DG interacts directly with brain dynamin. In the retina DG is 
associated and immunohistochemically colocalized with dynamin at the outer 
plexiform layer where previous ultrastructural studies (Blank et al., 1999; Koulen et al., 
1998) have found DG to be distributed presynaptically in synapses formed by 
photoreceptors onto bipolar and horizontal cells. Finally, in fibroblasts differentiated 
from embryonic stem (ES) cells DG associates with dynamin and codistributes with 
cortactin at membrane ruffles, which are organelles implicated in endocytosis. Cells 
null for DG have an increased uptake of transferrin, and re-introduction of DG into 
these null cells reduces this increase to normallevels. 
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EXPERIMENTAL PROCEDURES 
Antibodies 
Antisera to ~-DG and monoclonal antibody (mAb 1B7) to a-DG were characterized 
previously (Jacobson et al., 2001; Moukhles et al., 2000). MAbs to the following 
proteins were used for western blotting: ~-DG (1:250) (Novocastra Laboratories Ltd.); 
a-DG (IIH6) (1:1000) (Upstate Biotechnology); Grb2 (1:500); GST (1:1000) (Santa 
Cruz Biotechnology). MAb Hudy-1 (Upstate Biotechnology) that recognizes dynamin 1 
found in the brain as weIl as the more ubiquitous dynamin 2 (Damke et al., 1994) was 
used at 1 :40,000 for western blotting and 1 :200 for immunocytochemistry. MAbs to 
cortactin (Upstate Biotechnology) were used at 1 :250. Antisera to amphiphysin (1874) 
were a gift from Peter McPherson (McGill). Horseradish peroxidase-conjugated goat 
anti-mouse (1:2000) and goat anti-rabbit antisera (1:4000) (Jackson ImmunoResearch 
Laboratories) were used as secondary antibodies in western blots. Rhodamine (TRITC) 
conjugated donkey anti-rabbit (1:200) and fluorescein (FITC) conjugated donkey anti-
mouse antisera (1:200) (Jackson ImmunoResearch Laboratories) were used for 
immunofluorescence staining. 
Tissue extraction 
Rat brains and hippocampi were dissected from adult rats euthanized according to the 
Guidelines of McGill University Health Center Animal Facility. Tissues were 
homogenized on ice four times (10 sec each) with a Polytron tissue homogenizer in 
phosphate-buffered saline (PBS; pH 9.0) containing 1 % sodium deoxycholate, 0.5mM 
CaCl2, and a protease inhibitor cocktail (Boehringer Mannheim). The homogenates 
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were incubated at 37° for 30 min followed by addition of Triton X-lOO (TX-lOO) to a 
final concentration of 0.5% in a total volume of 6 ml. After 2 hrs of incubation at 4° 
with occasional vortexing, the homogenates were centrifuged at 37,000x g for 30 min. 
The supernatants were collected and protein concentrations were determined (DC 
Protein Assay Kit; Bio-Rad). 
Synaptosomes were prepared from rat brains as described by Sugita et al. (2001) with 
minor modification. Briefly, rat brains were removed and homogenized with a Teflon 
glass homogenizer in a buffer containing 20mM Tris-HCL (pH7.2), 0.32M sucrose, 
1mM CaClz, and protease inhibitor cocktail. The homogenates were centrifuged for 10 
min at 700x g to remove nuclei. The post-nucIear supernatants were collected and 
centrifuged for 30 min at 9,800x g, and the resulting pellets were collected as crude 
synaptosomes. 
Immunoaffinity chromatography 
Antisera to ~-DG (11), bovine serum albumin (control) or rabbit immunoglobulin 
(control) were covalently coupled to Affigel 10 following the manufacturer's 
instructions (Bio-Rad). Five mgs of hippocampal extract (2-3ml) were incubated 
overnight with 1 ml of each Affigel-protein conjugate. The slurry was packed into a 
column, washed first with 10 ml of PBS (pH 9.0) containing 1 % sodium deoxycholate, 
0.5% TX-100 and 0.15M sodium chloride (buffer A), followed by a wash with 10 ml of 
0.5M NaCI in buffer A, and finally lOml of 5mM EDT A in buffer A. Proteins still 
bound to the column were eluted at low pH with O.lM glycine (pH2.5) and neutralized 
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with 0.3ml of lM Tris-HCl (pH8.0). The columns then were equilibrated each with 10 
ml of PBS and any remaining proteins were eluted with 3ml of O.lM triethylamine 
(pH11.5) and neutralized with 0.3ml of lM Tris-HCl (pH8.0). The glycine and 
triethylamine eluates were pooled, dialyzed against PBS overnight and then 
concentrated to equal volumes (Millipore Centricon filters), and equal aliquots of the 
eluates were subjected to SDS-PAGE. The SDS-PAGE and western blotting were 
carried out as described previously (Gee et al., 1993). 
Immunoprecipitation 
Crude synaptosomes or retinas were solubilized in PBS (pH 9.0) containing 1 % sodium 
deoxycholate, 0.5% TX-100, 1mM CaCl2 and protease inhibitor cocktail (buffer B) and 
centrifuged for 37,000x g for 30 min. 60-100 ~l of supernatant was pre-cleared with 20 
~l of protein G agarose (GibcoBRL) for 1 hr. After preclearing 20 ~l of protein G beads 
conjugated to relevant antibodies or pre-immune sera were added to the pre-cleared 
supernatants, and incubated overnight at 4° with constant shaking. The agarose beads 
were then pelleted by centrifugation at 4,000x g for 2 min. The supernatants were 
collected and the beads were washed twice with 1 ml of buffer C, followed by 0.5 ml of 
0.5M NaCI in buffer B, and finally with 0.5 ml of buffer B containing 5mM EOT A. 
The washed beads were then boiled in sample buffer for 5 min and subjected to SDS-
PAGE and western blotting. 
Overlay Assay 
The cytoplasmic tail of ~-DG was amplified by PCR from a plasmid containing the 
full-Iength DG cD NA sequence using sense 5'-GAAGATCTTCTATCGCAAGAA 
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GAGG-3', and anti-sense primers 5'-GCTCTAGATTAAGGGGGAACATACGG-3'. 
The amplified ~-DGcyto was digested with BgI II and gel purified. Plasmid pGEX-3x 
(Amersham Biosciences) was digested with EcoR l, blunt-ended, digested with Barn HI 
and gel-purified. The purified pGEX-3X vector and ~-DGcyto fragment were ligated to 
produce pGST -~DGcyto plasmid. The DH5a E. coli strain was transformed with 
plasmids pGST-3X and pGST-~DGcyto, and proteins induced with 1mM IPTG for 2-3 
hrs were purified according to the procedures described by Frangioni and Neel 
(Frangioni and Neel, 1993) using glutathione Sepharose (Amersham Biosicence). 
To assay the interaction of dynamin with ~-DG, dynamin was immunoprecipitated 
from 0.4 mg of synaptosomal ex tracts with 6""g of mAb Hudy-1 (Warnock et al., 1995). 
The immunoprecipitated dynamin was electrophoresed in a 4-15% acrylamide gel and 
electroblotted onto a PVDF membrane (Bio-Rad). The membrane was blocked for 1 
hour with 5% powdered skim in TBST (lOmM Tris-HCL, 150mM NaCL, 0.1 %Tween-
20) and incubated overnight with GST (20 ""g/ml) or GST -~DGcyto (20 ""g/ml) in TBST 
containing 5% skim milk. The membranes were washed three times with TBST (10 min 
each) and incubated with HRP-conjugated mou se anti-GST antibody (Bio-Rad) for 1 
hr. After three washes with TBST (15 min each), the signais were visualized by 
chemiluminescence (PerkinElmer Life Sciences). 
Cell culture, immunocytochemistry and transferrin uptake assay 
Wild type and DG null embryonic stem cells were engineered as previously described 
(Cote et al., 1999). Cells were differentiated into embryoid bodies that were grown on 
0.1 % gelatin-coated tissue culture dishes (Jacobson et al., 2001). After 3 d in culture, 
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cells from the embryoid bodies spread and fibroblast-like fIat cells appear at the 
periphery. At this point, cultures were treated with 200 jlg/ml transferrin (SIGMA) at 4° 
for 15 min, after which cells were washed extensively with PBS and incubated with 20 
!-tg/ml of rhodamine-conjugated transferrin in fresh growth medium at 37° for 15 or 120 
mins. After washing in PBS, cells were fixed in 4% paraformaldehyde in PBS, and 
permeablized in 0.5% TX-100 in PBS for 10 min. Nuclei were stained with DA PI 
(Sigma) for 10 min at room temperature. Immunocytochemistry followed previously 
described methods (Jacobson et al., 2001). Briefly, cells were washed with PBS, fixed 
in 4% paraformaldehyde, permeablized in 0.5% TX-100, incubated with primary 
antibodies for 1 hr, then washed with PBS 3 times and incubated with fluorescently-
labeled secondary antibodies for 1 hour. Cells were washed prior to mounting on slides 
in Immunofloure mounting medium (/CN Biomedicals, Ine.) and observed under a 63X 
objective using a Zeiss Axioskop fluorescent microscope. Images were captured with a 
Retiga 1300 Monochrome 10 bit digital camera (Qimaging Corp.) and analyzed with 
Northern Eclipse software (Empix). Quantifications were done on 8-bit images using 
threshold values of 86-255 pixels (Jacobson et al., 2001). The sum of the are as that 
were fluorescent were obtained for each field and normalized to the number of cells per 
field. Measurements were tabulated with Microsoft Excel and analyzed statistically 
using StatView (Abaeus Concepts, Ine.). 
To isolate and expand fibroblastic cells, wild type and DG null embryoid bodies were 
grown for 3 weeks. At this point embryoid bodies were surrounded by a halo of 
fibroblastic cells. The central cell mass was aspirated and the remaining adherent cells 
on the periphery were grown for 2d after which cells that did not appear fibroblastic 
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were carefully aspired. The fibroblastic cells were then harvested and grown on 175 
cmz dishes for 4d. Sorne cells were passaged onto dishes for transferrin uptake assays 
with same procedures as before except that cells are incubated with transferrin at 37° 
for 15 min. Others were harvested, solubilized in 1% TX-I00 containing 20mM Tris-
HCI, 150mM NaCI, ImM CaClz and protease inhibitor cocktail, centrifuged at 16,000x 
g for 20 min and supernatants were used for immunochemical studies. 
Adenoviral Constructs and Infection 
To express full-Iength DG in DG-null fibroblastic cells, we generated a replication-
defective adenovirus using the AdEasy system (Qbiogene) as described by the 
manufacturer. In brief, DG cDNA was subcloned into the multiple cloning site of 
pAdTrack-CMV(GFP) (GFP and DG are under separate CMV promoters producing 
two separate proteins), linearized using Pmel, and cotransfected with pAdEasy-1 into 
BJ5183, an electrocompetent E.coli strain. Recombinants (AdDG/GFP) were screened 
by colony size and confirmed by restriction digests. They were then linearized using 
PacI, purified, and transfected into HEK293 cells using Lipofectamine reagent 
(Invitrogen). Adenovirus production was observed by plaque formation and by GFP 
fluorescence. Viral particles were isolated from cellular lysates and amplified through 
several rounds of infections in HEK293 cells. Titers were determined by TCIDso 
infection test as described by the manufacturer (Qbiogene). For DG expression, ES 
cells were grown at low confluence, infected with 103 plaque forming units/mL (MOI 
5) of control AdGFP or of AdDG/GFP for 18 hrs in growth medium. Infection 
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efficiency was monitored by GFP reporter gene expression and was maximal 2 days 
post-infection. At this point, transferrin uptake was assayed. 
Immunohistochemistry 
Three-month-old male mice (strain C57BL/6) were anaesthetized using xylazine 
(2mg/ml, Bayer Inc.) and ketamine hydrochloride (15 mg/ml, Ayerst veterinary Lab.). 
After anesthesia mi ce were perfused intraventricularly with PBS followed by 4% 
paraformaldehyde. Whole eyes were dissected from the animaIs and post-fixed 
overnight in 4% paraformaldehyde followed by cryopreservation in 30% sucrose. Eyes 
were then frozen in Tissue-Tek a.CT. compound (Sakura Finetek U.S.A.) on cru shed 
dried ice and stored at -80°. Eight !--Lm horizontal sections were cut using a Leica 
CM3050S cryostat and stored at _20°. Sections were thawed to room temperature, 
washed with PBS and blocked with 10% horse serum and 0.3% TX-100 in PBS for 1 hr 
prior to immunostaining. The retinal sections were incubated 1.5 hrs in blocking buffer 
containing both Hudy-l and ~-DG antiserum. Incubation with secondary antibodies 
was done in blocking buffer containing both RITC-conjugated donkey anti-rabbit 
antiserum and FITC-conjugated donkey anti-mouse immunoglobulins. Sections were 
washed 3 times with PBS after both primary and secondary antibody incubations, 
mounted in immunofloure mounting medium (leN) and visualized using a Leica 
TCSNTSP confocal microscope. 
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RESULTS 
Identification of dynamin 1 as a tl-DG associated protein in brain 
Hippocampal homogenates were extracted directly with 1 % sodium deoxycholate 
(pH9.0) and 0.5% TX-100. This effectively solubilizes DG as weIl as most pre- and 
post-synaptic proteins (Huang et al., 2000). Immunoaffinity columns conjugated with 
antisera to ~-DG, non-immune rabbit IgGs (control), or BSA (control) were 
equilibrated with the extracts, washed extensively and eluted first at low and then at 
high pH (Methods). Following SDS-PAGE analysis of the eluates and Coomassie blue 
staining, several protein bands were evident at 43 kDa and", 100 kDa (Fig, 2-1A) that 
bound specifically to ~-DG antibody columns. The 43 kDa band was confirmed to 
contain ~-DG in western blots (Fig. 2-1B). The'" 100 kDa band was cut out, digested 
with trypsin and subjected to LC/MS-MS analysis (Montreal Proteomics Network). 
This yielded 21 tryptic peptides whose sequences matched that of rat dynamin 1 (gi: 
118966; 97 kDa) with the peptides covering 25% of the sequence of dynamin 1. The 55 
kDa band yielded peptides matching to the IgG heavy chain. Peptides from the ",66 
kDa band matched to Hsc70 (not shown). Consistent with the MS results, western 
blotting indicated that dynamin 1 was enriched along, with ~-DG, in brain extracts 
subjected to immunoaffinity chromatography (Fig. 2-1B). Since dynamin is a relatively 
abundant cytosolic protein and ~-DG is a transmembrane protein, we sought to 
determine the amount of dynamin 1 bound to ~-DG. ~-DG could be immunodepleted 
from brain extracts, although a significant am ou nt of dynamin 1 remained in the 
supernatant (Fig. 2-2A, B). No immunoprecipitation of either protein with control IgG 
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(Fig. 2-2B) was observed. These results suggest that there is a pool of dynamin 1 
tightly associated with ~-DG, and a pool of unbound dynamin 1. 
Detection of other DG-associated pro teins in brain 
To further characterize the ~-DG-dynamin complex in the CNS we used antibodies to 
several DG-associated proteins in muscle. Immunoaffinity-purified fractions of ~-DG 
from brain were western blotted with two monoclonal antibodies (mAb IIH6 and 1B7), 
that detect differentially glycosylated forms of a-DG (Leschziner et al., 2000; 
Moukhles et al., 2000). MAb IIH6, that recognizes larger and more heavily 
glycosylated forms, detected a band of a-DG enriched in the affinity-purified fraction 
(lane 2 of Fig. 2-3A), consistent with our previous data (Moukhles and Carbonetto, 
2001). MAb 1B7 that recognizes smaller and, hence, hypoglycosylated forms of a-DG 
(Moukhles and Carbonetto, 2001) also detected an enriched band with lower molecular 
weight (lane 3 of Fig. 2-3A). Thus the brain contains complexes of ~-DG and a-DG 
with different levels of glycosylation that may affect ligand binding of the a subunit 
(Leschziner et al., 2000; Michele et al., 2002). 
Grb2 is an SH2-SH3 containing adapter protein that is associated with dynamin in brain 
through its SH3 domains (Gout et al., 1993; McPherson et al., 1994). In muscle Grb2 
has also been shown to associate with ~-DG through its SH3 domain (Russo et al., 
2000; Yang et al., 1995). We therefore asked whether Grb2 could be part of a complex 
with DG and dynamin 1 in brain. AlI three proteins (DG, dynamin and Grb2) were 
immunoprecipitated from the synaptosomes using antibodies against ~-DG (Fig. 2-3B), 
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and in the immunoaffinity-purified fractions from brain (data not shown). Taken 
together these data indicate that the brain contains a complex of a-/~-DG with dynamin 
1 and Grb2. 
Although Grb2 has the potential to mediate binding to dynamin, other data indicate that 
SH2-SH3 domain-containing proteins such as amphiphysin (David et al., 1996; 
Ramjaun et al., 1997) and endophilin (de Heuvel et al., 1997; Ringstad et al., 1997) 
preferentially bind to proline-rich domains of dynamin (McPherson, 1999). This 
suggested that dynamin might bind directly to ~-DG. To test this, brain dynamin was 
immunoprecipitated with Mab Hudy-1, fractionated electrophoretically and transferred 
to PVDF membranes. The PVDF membranes were overlaid with a recombinant protein 
encompassing the entire cytoplasmic domain of ~-DG fused to GST (GST -~DGcyto). 
We found that GST -~DGcyto but not GST alone bound to bands containing dynamin 
(Fig. 2-4A). Thus there appears to be a direct interaction of dynamin with the 
intracellular region of DG. Interestingly, ~-DG immunoaffinity purification (Fig. 2-3, 
lanes 6, 7) revealed no detectable association of DG with amphiphysin suggesting that 
binding of Grb2 directly or via its SH3 domain occludes binding of amphiphysin in 
dynamin associated with DG. 
Association and colocalization of DG and dynamin in the outer plexiform layer of 
the retina 
DG has been localized to synaptic regions in the brain (Blake and Kroger, 2000; 
Moukhles et al., 2000; Zaccaria et al., 2001) as weIl as at GABAergic synapses in 
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culture by immunofluorescence microscopy (Brunig et al., 2002; Levi et al., 2002). It is 
challenging to localize antigens within most regions of the CNS so as to ascertain 
whether they are synaptically localized without resorting to EM. In the retina, however, 
rod and cone photoreceptors synapse on bipolar and horizontal cells and form so-called 
"ribbon" synapses where the presynaptic ribbon is readily detectable by light 
microscopy as plaques (cones) or large puncta (rods) running through the outer 
plexiform layer (Blake and Kroger, 2000). Both u- and f3-DG have been shown to be 
expressed in the outer plexiform layer of retina (Dalloz et al., 2001; Koulen et al., 1998; 
Montanaro et al., 1995), where they are thought to form a complex with dystrophin and 
f3-dystrobrevin (Blank et al., 2002). To extend these studies we determined whether 13-
DG is associated with dynamin in the retina. As in the brain, both dynamin and f3-DG 
were co-precipitated (Fig.2-5A) with antisera to f3-DG. Conversely 
immunoprecipitation with an antibody to dynamin (Fig. 2-5B) precipitated f3-DG and 
Grb2 together with dynamin. The amount of f3-DG precipitated was less th an that in 
Fig. 2-5A, consistent with previous data (Fig. 2-2A) that there is a pool of dynamin 
unbound to f3-DG. Immunohistochemically f3-DG immunoreactivity (Fig.2-5C, 
arrowheads) was found in puncta and bands in the outer plexiform layer of retina 
characteristic of rod and cone photoreceptor terminais (Blank et al., 1999; Koulen et al., 
1998). Dynamin immunoreactivity (Fig. 2-5C, arrowhead) was also restricted largely to 
the outer plexiform layer of the retina and, as expected, its distribution is more diffuse 
than that of f3-DG. Double labeling immunofluorescence showed, however, that 
essentially ail photoreceptor synapses labeled with antisera to f3-DG were also positive 
for dynamin (Fig. 2-5C, merge). Grb2 was expressed diffusely in virtually ail cells of 
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the retina, and, while it overlapped with the distribution of ~-DG and dynamin, it is not 
obvious that this is meaningful (data not shown). Taken together, these data suggest 
that in the retina ~-DG, dynamin and possibly Grb2 form a complex in the outer 
plexiform layer and this complex is presynaptically localized. 
DG in endocytosis 
Previously, we have studied DG function in differentiated ES cells wherein both dag 1 
alleles had been disrupted by homologous recombination (Cote et al., 1999; Jacobson et 
al., 2001; Li et al., 2002). Here we first generated mixed cultures of differentiated cells 
to monitor by immunofluorescence the effect of deletion of dagl on dynamin-mediated 
endocytosis. Differentiated ES cells yield a variety of cell types, including fibroblastic 
cells that quickly migrate out of the embryoid body and are easily visualized as well-
spread cells on the periphery of the cell mass. In addition, we have established lines of 
these fibroblastic cells that permit biochemical analysis. Unfortunately, we have not 
been able to isolate neural stem cells for similar studies nor do we have mice null for 
dagl in the CNS from which we could make primary neuronal cultures (Moore et al., 
2002). Nevertheless, constitutive endocytosis of transferrin is essentially the same in 
neuronal and non-neuronal cells and shares many features with regulated vesicular 
endocytosis in nerve terminaIs, including a requirement for dynamin (Jarousse and 
Kelly, 2001). 
Fibroblastic cells differentiated from wild-type ES cells express both a-DG (data not 
shown) and ~-DG (Fig. 2-6C and G) on the surface of the plasma membrane, 
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preferentially in regions called membrane ruffles (Fig. 2-6A). Ruffles also contain 
dynamin, ~-DG and cortactin (Fig. 2-6). Thus DG in these cells might be involved in 
endocytosis, which frequently occurs at membrane ruffles, and/or could regulate the 
actin cytoskeleton, a function also attributed to dynamin (McNiven et al., 2000). To 
assess this further, wild-type or DG-null cells were differentiated from embryoid 
bodies, and incubated with RITC-labeled transferrin. In mixed cultures both wild-type 
and DG-null fibroblastic cells take up transferrin, as demonstrated by the presence of 
many smalI, fluorescent puncta visible throughout the thickness of the cells (Fig. 2-7). 
Wild-type cells showed both submembranous and cytoplasmic localization of labeled 
transferrin, indicative of uptake into early and late endosomes (Fig. 2-7 A and C). Few 
cells had perinuclear staining. In contrast, in DG-null cells transferrin labeling was less 
frequently concentrated in the region of plasma membrane and most, if not aIl cells had 
intense labeling in the cytoplasm especially around the nucleus (Fig. 2-7D). We 
quantified the area occupied by transferrin labeling in wild-type and DG-null cells 
(methods). DG-null cells show a significant, 2.25-fold increase (P<0.05), in transferrin 
uptake (Fig. 2-7E) when compared with wild-type cells. To confirm that DG is 
associated with dynamin we isolated and expanded fibroblastic cells that appeared 
essentially identical to those which migrate from embryoid bodies (Fig. 2-6,7). 
Transferrin uptake by these celllines was the same as that of fibroblastic cells in mixed 
cultures (Fig. 2-8A and B). Furthermore, immunoprecipitation from wild type cells 
showed that a portion of dynamin is associated with ~-DG (Fig. 2-8C, lane wt of upper 
panel under IP). There was no DG detectable in DG-null cells (Fig. 2-8C, Pre-IP) and 
no dynamin was precipitated from these cells (Fig. 2-8C, IP). Taken together, the se 
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observations indicate that ~-DG interacts with dynamin at membrane ruffles, and 
suggests a role for DG in regulating endocytosis of transferrin. 
To confirm that the difference in endocytosis between wild-type and DG-null cells was 
due to DG, we re-introduced DG into the DG-null fibroblastic cells by infection with an 
adenovirus containing DG/GFP. In these experiments, GFP expression driven by a 
separate CMV promoter served as a reporter of successful infection. In DG-null cells 
infected with the DG/GFP virus DG is expressed in the plasma membrane and in ruffles 
(arrowhead, Fig. 2-9A, c') similar to the pattern in wild-type cells (Fig. 2-6). There was 
no DG expression seen in cells infected with the control adenovirus (GFP) (Fig. 2-9A, 
b'). To determine whether transferrin uptake was restored to wild-type levels in infected 
cells, we incubated wild-type and DG-null cells with rhodamine conjugated transferrin 
for 15 min 24 hrs after adenovirus infection (Fig. 2-9B). In uninfected cells transferrin 
uptake was significantly greater in DG null cells th an in wild-type ce Il s, as noted 
previously (Figs. 2-7 and 8). In DG null cells infected with DG/GFP there was a 
decrease in transferrin uptake when compared with DG null cells infected with GFP 
alone. The decrease was equivalent to that seen in wild-type cells uninfected or infected 
with GFP. DG-null cells infected with virus containing DG/GFP (DG-nulI:DG/GFP) 
had about a 2-fold reduction in transferrin uptake compared to DG-null cells or null 
cells infected with GFP (P<O.05), but no difference compared to wild-type cells or 
wild-type cells infected with GFP (P>O.05). Wild-type cells infected with GFP alone 
have the same transferrin uptake as non-infected wild-type cells (P>O.05). 
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DISCUSSION 
Our results reveal that a complex of ~-DG, a-DG, dynamin 1, and Grb2, is found in 
presynaptic terminaIs of CNS neurons. This complex is also present in non-neuronal 
cells where it appears to regulate endocytosis. Several lines of evidence support this 
claim. First, immunopurification of ~-DG-associated proteins followed by SDS-PAGE 
yielded a 97 kDa band, whose sequence by LC/MS-MS resulted in 21 peptides that 
covered 25% of the sequence of rat dynamin 1. Sixteen of these peptides were unique 
for dynamin 1 and five were shared with dynamin 2 but not dynamin 3, both of which 
are also expressed in the CNS (Urrutia et al., 1997). This suggests that dynamin 1 is the 
major dynamin isoform associated with DG. Second, the association of dynamin was 
confirmed by immunoprecipitation and extended to show interaction of ~-DG with a-
DG and Grb2. Other immunoprecipitation data indicate that only a subset of dynamin is 
associated with ~-DG in brain and retina. In an overlay assay, dynamin purified from 
brain bound directly to the intracellular portion of recombinant ~-DG. Third, ~-DG is 
associated and immunohistochemically colocalized with dynamin at ribbon synapses 
within the outer plexiform layer of the retina. Fourth, in fibroblast-like cells in culture 
DG is associated with dynamin at cortactin-rich membrane ruffles that are sites of 
endocytosis (Cao et al., 2003; Lynch et al., 2003). Finally, ES cells null for DG had a 
greater uptake of transferrin, a dynamin mediated process, than that of wild type cells. 
Expression of full length DG in DG-null ES cells restored transferrin endocytosis to 
levels seen in wild-type cells. 
Dystroglycan is found in nerve terminaIs in the CNS 
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DG is concentrated at sorne central (Levi et al., 2002; Moukhles and Carbonetto, 2001) 
and peripheral synapses (Gee et al., 1994; Gingras and Ferns, 2001; Leschziner et al., 
2000). At neuromuscular junctions DG binds to perlecan (Peng et al., 1998; Jacobson et 
al., 2001) and contributes to the assembly of acetylcholinesterase (Jacobson et al., 
2001) in the synaptic basement membrane. In addition, DG participates in the 
aggregation of acetylcholine receptors (Grady et al., 2000; Jacobson et al., 2001) into 
stable plaques within the myotube membrane. In the hippocampus DG is involved in 
LTP (Moore et al., 2002) where it has also been reported to function postsynaptically. 
In our studies immunoaffinity chromatography identified dynamin l, a neuron-specific 
form of dynamin (Grady et al., 2000), as the dominant dynamin isoform associated with 
DG. Dynamin 2 is also expressed in the CNS and is recognized by mAb Hudy-l 
(Damke et al., 1994). As a result immunoprecipitations with this mAb from brain 
homogenates may contain DG that is associated with dynamin 2. However, in 
synaptosomes DG is likely bound to dynamin l, the dominant isoform in neurons. 
Kroger and colleagues (Blank et al., 1999; Koulen et al., 1998) have localized DG in 
the vicinity of synaptic ribbons in the nerve terminaIs of photoreceptors in the outer 
plexiform layer of the retina (Blank et al., 1999; Koulen et al., 1998) and we have 
found that DG and dynamin colocalize in ribbon synapses in the outer plexiform layer 
of the retina (Fig. 2-5) that are readily detectable by light microscopy (Koulen et al., 
1998; Montanaro et al., 1995). We conc1ude that DG is localized presynaptically where 
it is associated with dynamin 1. 
Interactions of DG-dynamin in the CNS 
86 
Blank et al (2002) have suggested that ~-dystrobrevin and dystrophin are bound to ~­
DG based on their localization in the retina. Our biochemical and other data indicate 
that Grb2 and dynamin also interact with the cytoplasmic tail of ~-DG. Thus in the 
CNS a and ~-DG appear to be complexed with conventional components found in 
muscle, such as dystrobrevin, as well as a novel one, dynamin. Grb2 is an SH2-SH3 
domain protein that binds to ~-DG via either of its SH3 domains (Oak et al., 2001; 
Yang et al., 1995) but with different affinities (Russo et al., 2000). Grb2 also binds to 
dynamin 1 in brain, again via SH3 domain binding to proline-rich motifs (Gout et al., 
1993; McPherson et al., 1994). The N-terminal SH3 domain of Grb2 is essential for 
binding to dynamin (Vidal et al., 1999). So it is reasonable to think that Grb2 may bind 
to dynamin with its N-terminal SH3 domain and to DG with C-terminal SH3 domain, 
to form DG-Grb2-dynamin complex. Other studies indicated that amphiphysin and 
endophillin rather th an Grb2 are the major SH3-domain containing protein that 
interacts with dynamin at nerve terminaIs (David et al., 1996; Micheva et al., 1997). 
We have not, however, detected amphiphysin in immunoprecipifates of DG that contain 
dynamin (Fig. 2-3A). Moreover, our overlay data (Fig. 2-4) indicated that DG can 
interact directly with dynamin and may not require the intercession of Grb2 in-situ. 
Taken together it appears that DG, Grb2 and dynamin form a complex distinct from 
dynamin and amphiphysin. 
In addition to its intracellular interactions, j3-DG also binds to a-DG conferring 
on the complex the ability to interact with its ligands in the extracellular matrix 
(Montanaro and Carbonetto, 2003) as well as on other cells (Sugita et al., 2001). For 
many of its ligands of a-DG binds via its carbohydrate side chain(s) (Ervasti and 
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Campbell, 1993b) to laminin-like globular motifs (Gee et al., 1993; Michele and 
Campbell, 2003). Recent data show that aberrant glycosylation of DG in several 
muscular dystrophies and in the myd mou se leads to greatly reduced ligand binding and 
electroretinograms with altered b-waves indicative of defective synaptic transmission in 
the outer plexiform layer (Grewal et al., 2001; Holzfeind et al., 2002). Agrin, which 
contains several G domains and binds to DG (Bowe et al., 1994; Campanelli et al., 
1994; Gee et al., 1994; Sugiyama et al., 1994), is found within the synaptic cleft in the 
outer plexiform layer of the retina (Koulen et al., 1999). Moreover, the ability of a-DG 
to bind ligand appears necessary for normal synaptic function (Grewal et al., 2001; 
Michele et al., 2002). Thus linkage of dynamin to a transmembrane receptor complex 
and possibly to the matrix or cell adhesion molecules (Gee et al., 1993; Gee et al., 
1994; Peng et al., 1998; Smalheiser and Kim, 1995; Sugita et al., 2001) may be 
important in vesicle recycling during synaptic transmission where spatially regulated 
subdomains of endocytosis and exocytosis are thought to be critical for evoked release 
of neurotransmitter (Estes et al., 1996). 
Dystroglycan in endocytosis 
To assess the biochemical interactions of DG in cells we have resorted to cultured cells 
that are null for DG. Unfortunately, we do not have lines of neuronal precursors null for 
DG, but we do have fibroblastic and epitheliod cells. As a result, we have assayed in 
fibroblasts dynamin-mediated uptake of transferrin, a constitutive mode of endocytosis 
which employs many of the same molecules, including dynamin and clathrin, as the 
tightly regulated release during synaptic transmission (Jarousse and Kelly, 2001). We 
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have found that transferrin uptake is significantly greater in cell lines null for DG when 
compared with wild-type cells (Fig. 2-7-9). This holds for cells in mixed cultures 
differentiated from embryoid bodies as well as fibroblastic cell lines established from 
differentiated ES cells. In the latter instance, dynamin, most likely dynamin 2, is 
associated with DG (Fig. 2-8). This complex appears to be concentrated at membrane 
ruffles which have a high density of transferrin receptors (Bretscher and Aguado-
Velasco, 1998) and are also prominent sites of endocytosis (Cao et al., 2003; Lynch et 
al., 2003). Furthermore, Grb 2, that is associated with DG, has been implicated in 
endocytosis, most notably of the EGF receptor (Huang et al., 2004; Vieira et al., 1996; 
Wang and Moran, 1996; Yamazaki et al., 2002), but also in the internalization of 13-
adrenergic receptors in response to insulin (Karoor et al., 1998). 
In principle the inhibition of endocytosis by DG could be achieved by a number 
of mechanisms. Most obviously, DG may decrease the GTPase activity of dynamin, 
which is essential for its function in endocytosis. This seems unlikely to occur via Grb2 
bound to DG since SH3-domain containing proteins are reported to increase the 
enzymatic activity of dynamin and endocytosis (Shupliakov et al., 1997; Simpson et al., 
1999; Wigge et al., 1997). It is possible, however, that direct binding of DG to dynamin 
is inhibitory or that indirect binding via its SH3 domain displaces amphiphysin from a 
subset of dynamin (Fig. 2-3A) associated with DG at the cell surface. The SH3 domain 
protein amphiphysin 1 appears to function in the assembly of dynamin 1 into the ring-
like structures around coated pits (McPherson, 1999; Schmid et al., 1998; Takei et al., 
1999). Conceivably Grb2 localized to the cell surface through DG could compete with 
amphiphysin or other SH3 domain proteins to inhibit their function in endocytosis and 
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regulate the activity of membrane-associated dynamin (Simpson et al., 1999). Second, 
anchorage of a pool of dynamin at the membrane via DG may restrict it from 
movement into active sites of vesicles turnover. This may be the case in photoreceptors 
where DG is distant from the synaptic ribbon (Koulen et al., 1998). Third, in addition to 
its mechanochemical role in pinching off vesicles during endocytosis, dynamin can 
reorganize the cytoskeleton (McNiven et al., 2000; Orth and McNiven, 2003) by 
interacting with several actin-binding proteins including cortactin (McNiven et al., 
2000) at membrane ruffles (Orth and McNiven, 2003). DG itself may then contribute to 
actin organization. In fact ~-DG has been reported to bind directly to actin (Chen et al., 
2003) and to reorganize the actin cytoskeleton (Chen et al., 2003; Spence et al., 2004). 
This may be related to observations that the cortical actin cytoskeleton inhibits 
endocytosis (Qualmann et al., 2000). Thus, it is conceivable that the differences seen in 
endocytosis of wild-type and DG nuU ceUs are an indirect manifestation of altered 
cytoskeletal organization. We have not, however, detected any obvious abnormalities in 
cell attachment, actin or tubulin distribution in these cell types. Future experiments will 
be aimed at determining the mechanism of inhibition of endocytosis and whether DG 
directly inhibits dynamin function. At this point, however, our findings indicate that 
DG is associated with the GTPase dynamin, and provide evidence that this complex 
regulates endocytosis. In view of recent work implicating DG in synapse 
formation/function and in neural development, these observations may contribute to our 
understanding of the mental retardation associated with Duchenne and several other 
muscular dystrophies (Montanaro and Carbonetto, 2003). 
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Figure 2-1: Immunoaffinity purification of dystroglycan-associated proteins from brain. 
A: Equivalent volumes of eluate (Methods) from anti ~-DG antibody affinity column 
(~-DG), non-immune rabbit IgG column (NRIgG), BSA column (BSA), and 
hippocampal homogenates (H.H., 2f!g.) were loaded, and subjected to SDS-PAGE and 
stained with Coomassie blue. Two sets of molecular weight markers (36.6-175 kDa) are 
shown. The arrowhead points to an ~100 kDa band seen only in eluates from the ~-DG 
antibody affinity column. Band 1 is ~-DG (43 kDa). The band at 55 kDa is the IgG 
heavy chain and the band at ~ 70 kDa is Hsc70 (data not shown). The band at ~ 100 kDa 
was identified as dynamin 1 (97 kDa) by LC/MS-MS. B: Column eluates (5%) from 5 
mg of hippocampal homogenates were collected, electrophoresed and western blotted 
with antibodies to dynamin and ~-DG to confirm the data in A. Equivalent amounts of 
eluate from the NRIgG and BSA columns served as controls. The antibodies used as 
probes are noted on the left and molecular weight markers (kDa) are on the right. Image 
A or B is from a single gel. 
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Figure 2-2: Immunodepletion of ~-DG from rat brain extracts. 60 f..tg of rat brain 
homogenate was immunoprecipitated with 0.5 f..tg, 1.0 f..tg or 4.0 f..tg of anti ~-DG 
antiserum (pAb) coupled to agarose beads (A) or with non-immune rabbit IgG coupled 
to agarose beads (B). The beads were washed extensively (Methods) with solubilization 
buffer containing 5 mM EDTA and 0.5M NaCI, and the precipitated proteins (Pellet) as 
well as the supernatants (Supe) were analyzed by western blotting with antibodies to 
dynamin and ~-DG. With increasing amounts of ~-DG antiserum (A) there is an 
increase in the amount of both ~-DG and dynamin in the pellet and corresponding 
reduction in the Supe. At 4.0 I-lg of antiserum ~-DG is entirely depleted from the Supe 
but a prominent band of dynamin remains. (B) Immunoprecipitations with agarose 
beads coupled to non-immune rabbit IgG produced no precipitation of ~-DG or 
dynamin (Pellet) which remained in the Supe. The lanes in B contain 30% of the 
supernatants. Lanes in A or B are grouped from a single western blot that was scanned 
and computer reconstructed under the same conditions. 
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Figure 2-3: a-DG, Grb2 and ~-DG co-purification from brain. A: Five mgs of 
hippocampal homogenate were subjected to immunoaffinity purification and 10% of 
the e1uate volume was electrophoresed and blotted with a-DG antibodies IIH6 (lane 2) 
and 1B7 (lane 3). An equivalent volume of eluate from columns with normal rabbit IgG 
(lane 4) or BSA (lane 5) served as controls. 35 [!g of hippocampal homogenate (H.H.) 
(Iane 1) was Ioaded as positive control. Note that a-DG is recognized by both mAbs 
IIH6 and 1B7, moreover, the forms recognized by mAb 1B7 are smaller reflecting 
hypoglycosylation (Leschziner et al., 2000). Antiserum (1874) detected amphiphysin l 
and II (Ramjaun et al., 1997) in the homogenates (lane 6), but no amphiphysin in the ~­
DG column e1uates (lane 7). B: ~-DG, Grb2 and dynamin are associated in 
synaptosomes. SolubiIized synaptosomes (Method) were immunoprecipitated with an 
antibody to ~-DG, and the precipitated proteins (Pellet) and the supernatant (Supe) 
were subjected to SDS-PAGE and probed with antibodies to ~-DG, Grb2 and dynamin. 
Both Grb2 and dynamin are co-immunoprecipitated with ~-DG (lane ~-DG, Pellet). 
The non-immune rabbit IgG (NRIgG) and agarose beads alone were used as controls. 
Antibodies used for western blots are indicated (left) and the position of moiecular 
markers are shown (right). Lanes 1-5, lanes 6-7 and lanes in B are grouped from a 
single western blot that was scanned and computer reconstructed under the same 
conditions. 
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Figure 2-4 
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Figure 2-4: The intracellular portion of ~-DG interacts with dynamin. A: Dynamin 
was immunoprecipitated (I.P.) from 300 !-tg of brain synaptosomes with 6 !-tg of 
dynamin antibodies, subjected to SDS-PAGE in 4-20% acrylamide gradient gel 
(Bio-Rad) and transferred to a PVDF membrane. The membranes were incubated 
with 20 !-tg/ml of recombinant GST-~-DGcyto (right lane) or GST alone (left lane) 
overnight, washed and blotted with a HRP-conjugated anti-GST antibody. GST-~­
DG binds to two bands that react with antibodies to dynamin (right lane, B). The 
two bands either represent a dynamin doublet (Cook et al., 1994; Robinson et al., 
1993) or possibly a proteolytic product of dynamin. Neither of the se bands reacted 
with antibodies to GST (left lane, A). B: Membranes were subsequently stripped 
and re-probed with anti-dynamin antibodies (Hudy-l). Lanes in A or B are from 
one single gel and membrane. 
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C 
ONL 
OPL 
INL 
IPL 
ILM 
A 
ONL 
OPL 
-97 INL 
~-DG 
-42.7 
IPL 
ILM 
ONL 
B '3{\\i-O'l{\ ~~\Q,G ~e'3às OPL 
INL 
Dyn Jin -97 
~-DG ~ 
IPL 
-42.7 
ILM 
Grb2 •• 1 ' > t ~ -25 
Figure 2-5: ~-DG, dynamin 1 and Grb2 are associated in the retina. ~-DG was 
immunoprecipitated from rat retinal homogenates with antisera to ~-DG (anti-~-DG) 
(A), or antibody to dynamin (Hudy-l, anti-Dyn) (B). In A the controls included normal 
rabbit IgG (NRIgG), and agarose beads alone (Beads), and in B, normal mouse IgG 
(NMIgG) and agarose beads alone (Beads). The precipitated proteins were subjected to 
SDS-PAGE and probed with antibodies (panel A and B, left) to dynamin (Dyn), ~-DG 
(~-DG) or Grb2. The positions of molecular weight markers are shown on the right. C: 
Immunohistochemistry in the mouse retina shows that dynamin 1 (Top) is localized in 
the outer plexiform layer (OPL) and inner plexiform layer (IPL). ~-DG (C, middle) is 
localized in outer plexiform layer (OPL), inner limiting membrane (ILM) and blood 
vessels. In the outer plexiform layer (OPL) puncta of ~-DG and dynamin 1 are often 
colocalized as shown by the merged image (C, yellow). Arrowheads point to one 
example of puncta or ribbon synapse. ONL: Outer nuclear layer. OPL: Outer plexiform 
layer. INL: Inner nuclear layer. IPL: Inner plexiform layer. ILM: Inner limiting 
membrane. Lanes in A or B were grouped from single gel and under same exposure. 
Bar, 50 microns. 
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Figure 2-6 
Figure 2-6: DG, dynamin and cortactin are co-localized at membrane ruffles of 
fibroblastic cells. A and E: Phase images of fibroblastic cells derived from wild type ES 
cells. The arrow shows a typical membrane ruffle. B, C, F and G: Immunolocalization 
of dynamin (B, Hudy-l), ~-DG (C, G) and cortactin (F) show that all three proteins are 
concentrated in ruffles. D: The merged image of Band C shows DG and dynamin in 
ruffles. Bars, 50 microns. 
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Figure 2-7 
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Figure 2-7: DG regulates endocytosis in differentiated ES cells in culture. Uptake of 
rhodamine-labeled transferrin was studied in fibroblastic cells on the periphery of 
adherent embryoid bodies derived from wild-type (wt) (A and C) and DG-null (B and 
D) ES cells. Arrowheads point to typical labeled cells. Fluorescent puncta were 
observed in the cytoplasm and around the nuclei of DG-null cells (B, D), but this was 
substantially sparser and less intense than in the wild type cells (A, C). E shows 
quantification of the area occupied by transferrin labeling (Methods) in (A, C and B, 
D). Error bars show the S.E.M. Bar, 50 microns. 
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Figure 2-8 
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Figure 2-8: ~-DG is associated with dynamin in fibroblastic cells isolated from 
differentiated ES cells. A and B show a prominent increase in transferrin uptake (as in 
Fig.2-7) in DG-null fibroblasts (DG-null, B) compared with wild-type (wt) fibroblastic 
cells (wt, A) when cells are incubated with transferrin at 37° for 15 min before fixation. 
C: Immunoprecipitation (IP) of ~DG-dynamin complex from fibroblastic cells. 
Fibroblastic cell lysates from both wt and DG-null were electrophoresed, and blotted 
with antibody to dynamin (upper panel, Pre-IP) and ~-DG (lower panel, Pre-IP). 
Antiserum to ~-DG was used for immunoprecipitation from both fibroblastic cell 
lysates. The immunoprecipitated proteins were subjected to SDS-PAGE and probed 
with antibodies to dynamin (upper panel, IP) and ~-DG (lower panel, IP). Note 
dynamin was co-immunoprecipitated from wt celllysates (lane wt, upper panel, IP) but 
not DG-null ceUlysates (lane DG-null, upper panel, IP). AU images in C were grouped 
from a single gel and composed into a figure under uniform conditions of exposure. 
Bar, 50 microns. 
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Figure 2-9: Expression of DG in DG-null cells restores normal levels of transferrin 
uptake. A: Fibroblasts derived from both wild-type (wt) (a'-a"') and DG-null (b'-b'" and 
c'-c"') ES cells were infected with an adenovirus containing GFP (a'-a"', b'_b"') or 
DG/GFP (c'-c"'), and stained with antiserum to DG followed by RlTC-Iabeled 
secondary antibody(a', b', Cl). DG was observed at the cell surface and ruffles in DG-
null cells infected with DG/GFP (arrowhead, Cl), similar to labeling in wt cells (Fig. 2-
6) or wt cells infected with GFP (a'). B: Rhodamine-conjugated transferrin (Tfn) was 
incubated with fibroblastic cells for 15 min 24hr after infection with an adenovirus 
containing GFP or DG/GFP. DG-null cells infected with virus containing DG/GFP 
(DG-null:DG/GFP) had decreased Tfn uptake compared with non-infected (DG-null) 
cells or cells infected with GFP alone (DG-null:GFP). The level of uptake was 
essentially the same as in wt cells infected with GFP (wt:GFP) or wt cells without viral 
infection (wt). Fluorescence was quantified (Methods) in cells 25-35 um in diameter to 
control for variation in cell size. Transferrin fluorescence is often concentrated in a 
portion of the cell so the full size of the cell was determined from GFP fluorescence in 
infected cells (A) or by phase imaging of uninfected cells. More than 20 cells were 
quantified for each treatment and fluorescence intensity was normalized to that in wild-
type cells. Bar in A is 50 um. 
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Chapter 3 
Dystroglycan expression in photoreceptors is essential for Drosophila eye 
development 
By 
Y ougen Zhan, Charles Bourque, Y ong Rao, Hannele Ruohola-Baker 
and Salvatore Carbonetto 
Unpublished manuscript, Montreal General Hospital Research Institute, Central for 
Research in Neuroscience, McGill University 
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Abstract 
Mutations in genes affecting dystrophin glycoprotein complex (DGC) result in 
Duchenne/Becker and other forms of muscular dystrophy. Dystroglycan (DG) is the 
core member of the DGC linking the cell cytoskeleton to the extracellular matrix. 
Targeted deletion of DG gene leads to muscular dystrophy and impaired brain 
development, which resembles several human congenital muscular dystrophies that are 
defective in glycosylation of a-DG. DMDIBMD and congenital muscular dystrophy 
not only affect muscle and brain but it also causes retinal defects. Here we use the 
Drosophila eye as a model to demonstrate that DG is required cell-autonomously for 
photoreceptor differentiation. Homozygous eyes containing severe hypomorphic DG 
alleles show severe disruption of retinal structure, aberrant lens formation and 
abolishment of electroretinogram in the adult fly eye. These adult defects appear 
derived from autonomous photoreceptor cell (PRC) defects in the early pupa that 
include size arrest, loss of polarity and progressive degeneration. In the 3rd instar larvae 
DG is present in the apical tips and the basal membranes of photoreceptor cells, two 
polarized locations opposing the extracellular matrix. At the pupal stage it continues to 
mainly distribute at the apical rhabdomere and basal membrane of PRCs. Expression of 
wild-type DG in DG-deficeint PRCs that would ortherwise be disrupted reverses the 
defects in the entire eye including the lens, suggesting DG function cell-autonomously 
for PRCs and non-autonomously for the lens. Over-expression of DG leads to larger 
ommatidia but the PRC number remains unchanged, suggesting that DG is both 
necessary and sufficient for PRC expansion. In rescue experiments, we found that 
extracellular DG alone can not rescue DG-deficient eye defects, whereas the 
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intracellular DG can substantially ameliorate PRe degeneration and structural defects 
while sorne PRes remain disoriented, a sign of disrupted PRe pl anar polarity. 
Therefore, our data suggest that the degeneration and planar polarity disruption in DG-
deficient PRes are two independent processes that appear to attribute to respective 
function of the intracellular and the extracellular DG. Our data provide a great model to 
study DG-related congenital muscular dystrophies and DG biology. 
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INTRODUCTION 
Muscular dystrophies are a group of diseases often caused by loss-of-function 
mutations affecting the dystrophin glycoprotein complex (DGC). The DGC-related 
muscular dystrophies involve not only muscle degeneration, but sorne of them also 
display mental retardation, brain defects and retina disruptions. 
Dystroglycan (DG) is a core member of the DGC that spans the muscle 
sarcolemma and links the cytoskeleton to the extracellular matrix. DG is encoded by a 
single gene and post-translationally cleaved into tightly connected Œ and ~-subunits 
(Holt et al., 2000). ~-DG directly binds to multiple proteins including dystrophin, Grb2 
and caveolin3 (Winder, 2001), whereas carbohydrate chains in mucin-like region of Œ-
DG confer the ability to bind to the extracellular ligands laminin, agrin and perlecan in 
the matrix (Bowe et al., 1994; Campanelli et al., 1994; Gee et al., 1993; Gee et al., 
1994; Ido et al., 2004; Jacobson et al., 2001; Peng et al., 1998; Sugiyama et al., 1994; 
Talts et al., 2000). Mutations in the gene encoding dystrophin cause Duchenne and 
Becker muscular dystrophies (Hoffman and Kunkel, 1989; Koenig et al., 1988; Monaco 
et al., 1986) that are often associated with defects in synaptic transmission in the retina, 
(PilIers et al., 1990; PilIers et al., 1993; Cibis et al., 1993; PilIers et al., 1995) and 
mental retardation (Campbell, 1995). Targeted deletion of the DG gene in mice results 
in embryonic lethality at day 6.5 or 7 (Williamson et al., 1997), and chimaeric mice 
deficient in DG and mice with specific deletion of DG in skeletal muscle develop a 
progressive muscular dystrophy and loss of dystrophin and sarcoglycans from 
sarcolemma (Cohn et al., 2002; Cote et al., 1999). Interestingly, expression of DG 
constructs in DG-null skeletal muscle that lack the mucin-like region is not sufficient to 
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prevent the muscle dystrophies, although the intracellular DG targets dystrophin, 
sarcoglycans and sarcospan to the muscle sarcolemma to form the complex (Barresi et 
al., 2004; Kanagawa et al., 2004). DG is also required to stabilize acetylcholine 
receptors in the postsynaptic muscle membrane and loss of DG causes the disruption of 
synaptic but not extrasynaptic basement membrane (Cohn et al., 2002; Grady et al., 
2000; Cote et al., 1999; Jacobson et al., 2001; Li et al., 2002). 
Recent data show mutations in several glycosyltransferases that cause a group 
of congenital muscular dystrophies named as Fukuyama congenital muscular dystrophy 
(FCMD), Muscle eye brain disease (MEB) and Walker-Warburg syndrome (WWS), aIl 
have defective glycosylations of a-DG, and, loss of its ability to bind to ligands 
(Hayashi et al., 2001; Michele et al., 2002; Moore et al., 2002; Muntoni et al., 2002). 
Similar defective glycosylation of a-DG are also found in dystrophic mice (myd mice) 
and human congenital muscular type ID that carry a mutant LARGE gene normally 
encoding a protein necessary for glycosylation of a-DG DG (Barresi et al., 2004; 
Longman et al., 2003; Grewal et al., 2001; Kanagawa et al., 2004). Patients with 
congenital muscular dystrophies and the myd mice aIl have severely disrupted brain 
morphogenesis resembling the phenotype in the brain-specifie DG-null mice, including 
fusion of cerebral hemisphere, disrupted layering of cortex and aberrant neuronal 
migration (Grewal et al., 2001; Holzfeind et al., 2002; Michele et al., 2002; Moore et 
al., 2002). As weil, patients with FCMD, MEB and WWS display retinal defects 
including corneal opacities, retinal detachment, mis-folding and fusion and 
degeneration that can result in blindness at a very young age (Fahnehjelm et al., 2001; 
Hino et al., 2001; Takeda et al., 2003; Vervoort et al., 2004; Zervos et al., 2002). 
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However, the myd mice only display disrupted b-waves in electroretinogram (ERG) but 
no sign of abnormal neuronal migration, detachment or misfolding in the retina 
(Grewal et al., 2001; Holzfeind et al., 2002). Thus, despite the similar defects in brain, 
eyes have a wide spectrum of defects among these different types of muscular 
dystrophies, raising the questions about the biological roles of DG in the eye and the 
specificity of glycosylation of a-DG in pathogenesis of congenital muscular dystrophy. 
Taking advantage of the powerful Drosophila genetics, we have used the 
Drosophila eye as a model to study the roles of DG. Because of the convenient 
FLP/FRT system to generate mutant clones, the UAS-GaI4 system to drive expression 
of gene of interest and the molecular and genetic markers available in the eye 
development, we can more precisely analyze the function of DG. In addition to 
advantage in genetics, Drosophila DG is conserved in the functional domains. 
Comparing with human DG, Drosophila DG is 31 % identical in the intracellular 
domain and 51 % identical in the last 15 ami no acids that interact with dystrophin. The 
extracellular mucin-like region in the Drosophila DG is poorly conserved in core amino 
acids, but it contains man y serine and theronine residues, among them fifteen consensus 
sites exist for putative O-glycosylation similar to the mucin-like region in vertebrate 
DG (Fig. 1-2). Recent data have demonstrated that DG is required for a polarity 
formation in both follicle epithelial cells and oocytes (Deng et al., 2003), but the role of 
DG in the eye development remains unknown. 
The Drosophila compound eye contains ",800 regularly repeated units called 
ommatidia. Each ommatidium is comprised of eight photoreceptor cells (RI-R8), four 
non-neuronal cone ce Il s, three classes of surrounding pigment cells and a bristle 
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complex (Longley and Ready, 1995; Ready et al., 1976; Tomlinson and Ready, 1987). 
Photoreceptor cells differentiate from the monolayer of epithelial cells in the 3rd instar 
imaginaI dise (Baker and Rubin, 1989; Freeman, 1996; Reinke and Zipursky, 1988), 
followed by cone cell and pigment cell differentiation (Cagan and Ready, 1989; 
Tomlinson and Ready, 1987). While cell specification is complete in the 3rd instar 
larvae, the patterning and differentiation of the ommatidia continue until mid-pupal life 
(Cagan and Ready, 1989; Longley and Ready, 1995; Tomlinson, 1988). This later 
differentiation involves PRC rotation, apical rhabdomere formation, PRC elongation, 
differentiation and assembly of cone and pigment cells in the ommatidia. Many genes 
have been shown to be essential for the pupal development, such as the polarity 
determinant crumbs, stardust and bazooka (Hong et al., 2003; Izaddoost et al., 2002; 
Pellikka et al., 2002), the actin cytoskeleton organizer moesin and Rac1 (Chang and 
Ready, 2000; Karagiosis and Ready, 2004), rhodopsin (Kumar and Ready, 1995) and 
neuronal membrane specifie glycoprotein chaoptin as weIl (Van Vactor et al., 1988). 
Here, we show that DG is essential for cell-autonomous PRC differentiation in pupal 
development. 
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Materials and Methods 
Fly strains and induction of DG-deficient clones 
The generation of DG248 allele, a DG-hypomorphic allele, was described 
previously (Deng et al., 2003). Homozygous DG248 clones in the eyes were generated by 
mitotic recombination using ey-FLP/FRT system (Newsome et al., 2000), which 
efficiently generates large clones (>85% total eye tissue). The genotypes of flies that 
have DG-deficient clones in the eyes were y w ey-FLP; FRT42D, LW+/FRT42D, DG248• 
W l1l8, ey-FLP; FRT42D, GMR-myr-GFP flies (Bloomington stock center) were crossed 
with FRT42D, DG248/Bc flies to generate small GFP-negative DG-deficient clones, 
whereas wild-type cells in the eye disc express GFP in the plasma membranes. The 
genotypes of flies which have GFP-negative DG-null clones in the eyes are W Il / 8, ey-
FLP; FRT42D, GMR-myr-GFP/FRT42D, DG248• 
Electroretinograrns 
Flies were immobilized by gently taping them onto slides with one eye facing 
up. Glass microelectrodes were filled with a solution containing 130 mM NaCl and 50 
mM KCl and inserted inside the eye. The ground electrodes were placed on the back of 
the head in contact with the solution. The ERGs were tested first on the depth of 
insertion in the eye and final ERGs were recorded after 5-10 min dark adaptation 
followed by a 2 sec bright-light purse. 
Rescue analysis and generation of UAS-DGextra-rnRFP transgenic Oies 
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To carry out rescue experiments, three DG transgenic fly lines containing UAS-
DG, UAS-DGcyto and UAS-DGextra-mRFP driven by ELAV-GAL4 (Luo et al., 1994) 
were used in combination with ey-FLP/FRT system to rescue DG-deficient phenotypes 
in the eye. The genotypes of the flies in rescue experiments are ey-FLP; FRT42D, 
LW+/FRT42D, DG248; ELAV-GAL4, UAS-DG/+ for rescue with the full-length DG; ey-
FLP; FRT42D, LW/FRT42D, DG248 ; ELAV-GAL4, UAS-DGextra-mRFP/+ for rescue 
with the extracellular and transmembrane DG and ey-FLP; FRT42D, 
LW+ /FR T42D, DG248 , UAS-DGcyto ; ELAV-GAL4/+ for rescue with the intracellular and 
transmembrane DG. UAS-DG and UAS-DGcyto fly tines were generated and 
characterized previously (Deng et al., 2003) and over-expression of proteins in PRCs 
was confirmed by staining with 1: 1000 diluted anti-Drosophila DG antiserum (Fig. 3-7 
and Fig. 3-9a' respectively). cDNA of DGextra encoding extracellular and 
transmembrane domains of Drosophila DG was PCR-amplified using sense S'-GAG 
TAA GCT TAT GAG ATT CCA GTG GTT CTT ATC GGC-3' and antisense primer 
S'-GAG TAG ATC TAG CCA GTG CAG GCA ACA GGC AAT G-3' from genomic 
DNAs of UAS-DG flies, and inserted in frame into HindIII and BglII sites 5' upstream 
of mRFP in pcDNA3 vector (provided by Keith Murai). DGextra-mRFP was digested 
with HindIII, blunt-ended, followed by digestion with Xbal, and then inserted into 
blunt-ended BglII and Xba 1 sites of pUA ST vector. The sequence was confirmed by 
The McGill University and Genome Québec Innovation Centre. The UAS-DGextra-
mRFP transgene were micro-injected into fly embryos by Genetic Services, Inc. 
(Cambridge, MA) and transgenic lines were generated using standard procedures. The 
over-expression of DGextro-mRFP driven by Elav-gal4 was confirmed by live imaging 
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of mRFP without fixation and permeabilization in the nervous system and pupal eye 
dises. 
Immunostaining and histology 
Eye dises of 3rd instar larvae and pupa were dissected in PBS, fixed in 4% 
paraformaldehyde, permeabilized in 0.5% Triton X-100 and stained with following 
primary antisera: rabbit polyclonal anti Drosophila DG (1 :250 or 1: 1000), mouse and 
rabbit anti-GFP (1:500, Molecular Probes), anti-chaoptin (24BlO, 1:100, DSHB), anti-
Boss (1:2000, DSHB), anti-armadillo (1:400, DSHB), anti-elav (1:200, DSHB) and 
mouse anti-a-DG (IIH6, 1: 1000, Upstate Biotechnology). Secondary antibodies 
conjugated with rhodamine or fluorescein (Jackson ImmunoResearch) were used at a 
dilution of 1:200. Rhabdomeres were labeled with rhodamine-conjugated phalloidin 
(Sigma, 1:500). DNA was stained with 4'-6-Diamidino-2-phenylindole (DAPI) (1:5000, 
Sigma). Fluorescent images were captured using a confocal imaging system (LE/CA 
DM LFSA) or a high-resolution fluorescence imaging system (Canberra Packard) and 
analyzed by 2D deconvolution using MetaMorph imaging software (Universal Imaging, 
Brandywine, PA). 
For plastic sections of adult or pupal fly eyes, adult eyes or pupal dises were 
dissected, fixed in 4% paraformaldehyde overnight, sequentially dehydrated in 50%-
100% ethanol and embedded in plastic for sectioning as described (Van Vactor et al., 
1991). The sampi es in epon were trimmed and eut for 80 sections per eye, l!-tm per 
section in thickness, mounted on glass slides and stained by toluidine blue dye. 
111 
DNA transfection and Immunocytochemistry 
To determine whether fly DG could be functionally glycosylated, DG-null 3C12 
embryonic stem cells engineered previously (Cote et al., 1999; Jacobson et al., 2001) 
were differentiated in cultures as described (Zhan et al., 2005) and transfected with 
DGextra-mRFP and mRFP under control of CMV promoter in pcDNA3 vector by 
Fugene transfection reagent (Roche) according to manufacturer's recommendations. A 
mou se antibody IIH6, which recognizes the functional carbohydrates of a-DG in 
vertebrates, was used to visualize the glycosylation of the transfected Drosophila DG 
containing the extracellular and transmembrane sequences fused to mRFP (DGextra-
mRFP). Procedures for immunocytochemistry were similar to the described previously 
(Zhan et al., 2005). Briefly transfected cells were fixed in 4% paraformaldehyde, 
washed and incubated with IIH6 without permeablization and then incubated with 
fluorescein-Iabeled secondary antibody. Cells were observed by a Zeiss Axioskop 
epifluorescent microscope and images were captured with a Retiga 1300 monochrome 
10 bit digital camera (Qimaging Corp.) and analyzed with Northern Eclipse software 
(Empix). 
Scanning electron microscopy and DG over-expression analysis 
Adult flies were immersed in 2% glutaraldehyde for 2 days, and sequentially 
dehydrated 10 minutes in 50%, 75%, 80%, 90%, 95%, three times in 100% ethanol, 
and further substituted with amyl acetate by placing flies 15 minutes into amyl 
acetate/ethanol (25/75), (50/50), 75/25 and 100% amyl acetate sequentially. The flies 
then went through critical point drying and the eyes were coated with gold palladium, 
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and observed with scanmng electron mIcroscope (McGill Facility for Electron 
Microscopy Research). 
To observe the DG over-expression phenotypes, Elav-gal4 flies were crossed 
with UAS-DG flies. Wild-type flies and flies containing Elav-gal/+ and Uas-DG/+ 
were used as the controls. The genotype of DG over-expression flies is Elav-gaI4/UAS-
DG. The plastic sections were made as described above and at least 10 eyes have been 
prepared for each DG over-expression and control sample. To minimize the error in 
measurement resulting from samples at different location in the eye, sections were 
chosen from similar depths within the retina as judged by the size of the section. The 
perimeter and are a of each ommatidium were measured from ommatidia localized in 
the center of each section. Measurements were done with Northern Eclipse software 
(Empix) and tabulated with Microsoft Excel and analyzed statistically using StatView 
(Abacus Concepts, Inc.). 
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Results 
Loss of DG causes severe disruption of adult eye 
Severe hypomorphic allele of DG in Drosophila melanogaster was previously 
generated in the laboratory of Dr. Hannele Ruohola-Baker (Deng et al., 2003). Using 
Ey FLP/FRT-induced mitotic recombination (Newsome et al., 2000), we induced DG-
deficient (DG248) cell clones in developing eyes. The DG-null clones do not contain 
pigment granules and thus could be identified as the white-colored patches that often 
have more th an 85% of the eye surface (Fig, 3-la'). Eyes with DG-deficient cells 
appear glossy because the eye surface is flattened and the lens facets and bristles of 
each ommotidium are missing (Fig. 3-la' -c'). Irregular shapes ofthe entire external eye 
morphology are also observed (Fig. 3-la' -c'). Analysis of the internaI retinal structures 
in the adult revealed that DG-deficient clones, marked by absence of pigment granules 
around each ommatidia because of the loss of white gene in DG-deficient clones, have 
no rhabdomere in the longitudinal sections (Fig. 3-ld') that would otherwise extend 
from the distal to the proximal in the wild type (Fig. 3-ld). The thickness of the retina 
is also reduced 40-50% in the mutants compared with wild type retina (Fig. 3-ld and 
d'). The lenticular shape of the lens is also disrupted and is flattened on the external 
face (Fig. 3-ld' and e'). Cross sections of adult eyes revealed that areas containing DG-
null ommatidia, marked by absence of pigment granules, lack PRCs and non-neuronal 
accessory cells (arrow, Fig. 3-lf') and sorne cell debris are present in the area (red 
arrowhead in Fig. 3-lf'). Sorne DG-deficient ommatidia (white arrowhead, Fig. 3-lf') 
have smaIl, disorganized PRCs and appear degenerating. Within a separate 
ommatidium (red arrow, Fig. 3-lf'), one wild-type PRC with pigment granules appears 
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normally present (red arrow pointed) but other PRCs that do not contain pigment 
granules are missing, indicating a cell-autonomous role. To analyze the function of DG-
null celIs, electroretinograms (ERGs) were recorded from the DG-nu Il areas upon light 
stimulation after dark adaptation. The DG-null clones demonstrated a nearly abolished 
receptor potential and a complete disappearance of on/off transients (Fig. 3-8a and 3-
8b). The receptor potential is the depolarization of PRCs in response to light and on-
and off-transients are synaptic components of ERG. The ERG results confirm that there 
are almost no phototransduction in the DG-null retina. Small residue response is likely 
due to current spread from neighboring normal tissues. ERGs from non-DG-deficient 
eye patches remain normal (data not shown). We conclude that DG is essential for the 
adult development and deficiency of DG leads to loss of normal ommatidial structural, 
loss of PRCs and diminished ERG in the adult eye. 
DG is required for PRe growth and organization 
Analysis of homologous recombination-induced DG-deficiency in vertebrate 
adults has revealed that DG is required for muscle survival and has complex roles in the 
central nervous system. To determine the roles of DG in Drosophila eye development, 
we analyzed the DG-deficient celIs at various developmental stages. As mentioned, 
DG-deficient clones are efficiently induced by the EyFlp/FRT system and are usually 
accounted for >85% (Fig. 3-10h) of the eye disc are a (Cafferty et al., 2004; Newsome 
et al., 2000). In the 3rd instar larvae larval, DG-deficient eye discs do not show 
abnormalities (Fig. 3-2) in 24BIO and Elav stainings, which specifically mark PRC 
plasma membrane protein chaoptin and nuclei protein Elav, indicating that the neuronal 
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specification and patterning are normal. Moreover, bride of sevenless (Boss), a ligand 
of sevenless on R8 membrane that is required for R7 specification is also normal (a-f, 
Fig. 3-2) (Reinke and Zipursky, 1988; Van Vactor et al., 1991). These data suggest that 
DG deficiency does not disrupt cell specification of PRes and PRes are normally 
present in the 3rd instar larvae. 
A requirement for DG in PRe development was first observed in early pupa. 
Staining of DG-deficient mosaic dises in ",20% pupa with neuronal specifie mAb 
24BlO, that specifically lebel the PRe membrane, revealed aberrant PRe morphology. 
Sorne ommatidia contain no or few PRes. Arrows in Fig. 3-3a point to four cell 
clusters that are significantly smaller than adjacent, normal PRes. Normally, the 
average length of lateral membrane of normal PRe at this stage is about 4.59±0.52 !lm 
and the length of the basal membrane of the PRe is about 4.79±0.49 !lm, however, the 
average lengths of small PRes are reduced to about 1.22±0.45 !lm for both lateral and 
basal membranes (Fig. 3-3b). This suggests that cells in the small ommatidia are 
retarded in their differentiation while normal cells are undergoing expansion in cell 
volume during the early pupa. 
In a separate experiment, DG-deficient mosaic eye dises are generated by Ey 
FLP/FRT system that favors production of small clones where DG-deficient cells are 
GFP-negative but DG-expressing cells are positive for membrane-targeted GFP 
(methods). In these flies, DG-deficient cells in the 3rd instar larvae form normal zonula 
adherens (ZA) as revealed by antibodies to the apical ZA marker armadillo (g-i, Fig. 3-
2). This indicates that, in addition to the normal specification, ommatidial cells in the 
3rd instar larvae are properly polarized. Proceed to ",20% pupa, however, DG-deficient 
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PRes, revealed by a negative GFP labeling, show a profound irregular spatial 
organization and lose their polarity within an ommatidium (white arrowhead, Fig. 3-3c-
e). In this DG-deficient ommatidium, there are still seven PRes labeled with 24BlO but 
they occupy only half space of the ommatidium and are shrunken and disorganized. 
Next to this ommatidium, we can see a devoid of six out of seven PRes (stars in Fig. 3-
3c-e) and the only remaining PRe is a non-DG-deficient cell (arrow, Fig. 3-3c-e). As 
loss of DG does not cause concordant loss of chaoptin protein as shown in larvae and in 
Fig. 3-3c-e, the absent PRes have likely degenerated. Strikingly, as pointed out by 
arrows (Fig. 3-3c-e) this single non DG-deficient PRe within a mosaic ommatidium 
with its accessory cells develops fairly weIl while the rest of PRes have degenerated or 
disrupted. The morphology of the cell appears normal and the apical membrane begins 
to form microvilli that will later become a mature rhabdomere (arrows, Fig. 3-3c-d) 
(n=25 in 25 ommatidia). This result indicates that cell-cell contacts may not be 
essential for PRe differentiation or maintenance of polarity in the early pupal 
development once it has been initiated and loss of DG in one PRe does not affect 
neighboring PRes at this early stage. In view of this data and the severe disruption of 
the retina in the adult flies (Fig. 3-1), it appears that PRes are degenerating first and 
this affects the surrounding accessory cells in the ommatidium and even the lens. 
Indeed, we can see wild type accessory cells that have migrated out of position in 
ommatidia lacking PRes (top to the star in Fig. 3-3d-e) similar to that seen following 
induced-death of PRes (Ryoo et al., 2004). To precisely determine if PRe defects 
disrupt the accessory cells or contrarily DG-deficient accessory cells are sufficient to 
lead to PRe defects, we did DG expression and rescue experiments (described below). 
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Progressive degeneration of PRes 
The cellular phenotypes observed in the small DG-defieient clones at ",20% and 
",40% pupal development were quantified in Table 2. Briefly, at "'20% pupa 45% of 
PRes in 120 DG-deficient clones (one clone usually covers more than one PRe) are 
not detectable as revealed by no stainings on antisera 24B10 and fluorescence-Iabeled 
phalloidin that binds to actin (Fig. 3-4b, c), whereas 55% of PRes in DG-defieient 
clones (n=120) are still present, which includes 31% null cells showing irregular 
organization and small cell size, and 21 % null cells without any observed phenotypes 
(Fig. 3-4c,d,e) (Table 2). By ",40% pupal life, 74% PRes in DG-deficient clones 
(n=I03) are undetectable, whereas 26% DG-deficient PRes are still present, within 
which 15% display phenotypes and Il % appear normal (Fig. 3-4a, b, e) (Table 2). 
Because increased numbers in 24BlO negative staining cells and eorresponding high 
percentage in phalloidin-negative staining cells, these data suggest a progressive 
degeneration of PRes following cell disorganization and growth arrest. 
To achieve evidence of cell death, at 40% papa DAPI was used ta visualize 
nuclear DNA in the DG-defieient mosaie eye dises. Normal ommatidia have nuclei 
with clusters of sharply stained DNA that is localized in the center of 24B lO-stained 
PRes (arrowhead in Fig. 3-4e-f). However, in the are a where PRes have cellular 
defects revealed by aberrant 24B 10 staining (delineated region in Fig. 3-4d-f), DNA 
labeHng is often diffuse (arrows, Fig. 3-4d-f) that probably represents cleaved DNA. 
Therefore, these data suggest that nuclear breakdown and cell death oecur in DG-
defieient dise. Cross sections of eye dises with large DG-deficient clones in ",70% pupa 
show few reeognizable ommatidia (asterisk, Fig.3-4h) while one ommatidium is present 
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and appear normal (arrow, Fig. 3-4h) that looks like a non-DG-deficient ommatidium 
because of surrounding granules. AIso, in contra st to earlier pupal stages in which most 
accessory cells surrounding the DG-deficient PRes appear normal (open arrowhead, 
Fig. 3-3d-e), the ommatidial accessory eells at this stage are grossly disorganized and 
PRes virtually absent. The dise appears filled with cell debris and tissue (asterisk, Fig. 
3-4h). Interestingly, sorne ommatidia have accumulations of maerophage-like cells 
(arrowheads, Fig.3-4h). Hemocytes or macrophages in Drosophila are known to 
aecumulate and engulf apoptotie eells (Stramer et al., 2005; Tepass et al., 1994), which 
is consistent with event of cell death happening in DG-defieient eells. Together, our 
data suggest that, while normal PRes undergo dramatic expansion and morphogenesis 
during pupal development, loss of DG leads to arrest of PRe growth and 
disorganization of PRes, which may eontribute to cell degeneration. 
Distribution of DG in the eye dises 
To better understand the roles of DG, the distributions of DG in the 3rd instar 
and early pupa were mapped with antisera to Drosophila DG (Deng et al., 2003). In 
the late 3rd instar larvae imaginaI dise, DG is found as "dots" at the very apical eye disc 
(Fig. 3-5b) that eo-Ioealizes with 24B10 staining (Fig. 3-5a-e, s). Beeause 24B10 
staining is neuron-specifie, this suggests that DG is expressed at PRe tips. Benzer and 
eolleagues (1987) showed that these apical tips are deeroted with mierovilli that projeet 
into the extracellular matrix, which lies between the dise surface and the peripodial 
membrane (Banerjee et al., 1987), a membrane formed by epithelial cells that lies 
outside of ommatidial cells. On the basal side of PRes in the 3rd instar larvae where 
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axons project to the brai n, DG is expressed as a "ring" (Fig. 3-5h) that surrounds and 
overlaps with 24B 10 immunoreactivity in the periphery (Fig. 3-5g-i, s). In the DG-
deficient dises in which cells are DG-deficient, anti-DG immunoreactivity is absent 
from the apical and basal domains of eye dises (Fig. 3-5e, k). Therefore, in the 3'd instar 
larvae, DG is expressed at the apical microvilli and basal subdomains of PRes, two 
locations that are known next to the extracellular matrix (Banerjee et al., 1987; Longley 
and Ready, 1995). 
Beginning with pupation, following PRe 90° rotation the apical surfaces of 
PRe become toward the center of ommatidia and the apical-basal axis is perpendicular 
to and the distal-proximal axis is parallel to the light entering the lens. In the distal part 
of 40% pupal eye dises, as in the 3rd instar DG is expressed in the apical membrane of 
PRes (arrowheads in Fig. 3-5n-o and left panel of t), where the rhabdomere faces the 
inter-rhabdomere space and is recognizable by enriched 24BlO immunoreaetivity (Fig. 
3-5m and 0). DG is also expressed in the basal membrane of PRe (arrows in Fig. 3-5n-
o and left panel of t) that makes contact with the accessory cells. In addition, DG also 
appears in non-PRe cells that are adjacent to PRes (red arrows Fig. 3-50 and left panel 
in t) which are probably interommatidial cells. In the proximal part of 40% pupa eye 
dises, where axonal bundles penetrate the eye dises (arrowheads, Fig. 3-5p-r), DG is 
again found as a "ring" in the retinal floor (arrowhead in q, Fig. 3-5) that surrounds and 
partially overlaps with the 24BlO-staining (arrowhead in Fig. 3-5q, rand right panel in 
t). In addition DG is also found in the glial sheath along the axon bundles (arrows in 
Fig. 3-5q, rand right panel in t), in which its expression is increased in response to DG-
deficiency (unpublished observation). This "ring" could either be the basal domain of 
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PRCs or pigment cells that are anchored to the "grommet", an extracellular matrix 
membrane formed at the retinal floor around ",37% pupa (Cagan and Ready, 1989; 
Longley and Ready, 1995), or it could be the enrichment site of glial cells similar to 
vertebrate DG localization at the microvilli of Schwann cells at the nodes of ranvier 
(Occhi et al., 2005; Saito et al., 2003). Nevertheless, our data demonstrate that DG is 
localized at both apical and basal membranes of PRCs as early as the 3rd instar larvae 
and continues to express so during pupal development, where DG could make contact 
with the extracellular matrix or other cells, and DG deficiency leads to loss of the 
contact which causes cell growth arrest, loss of polarity and ultimate cell death. 
Over-expression of DG increases PRe size 
We further investigate the roles of DG by over-expressing it in fly eyes. In sorne 
instances, over-expression of DG has been reported to act as a dominant inhibitor 
(Heathcote et al., 2000; Deng et al., 2003). However, when full-Iength DG is over-
expressed in aIl the posterior cells of eye discs by crossing the GMR-gaI4 flies with 
VAS-DG flies, we do not observe a phenotype comparable to the "glossy" DG-
deficient adult eye (Fig. 3-1). Instead, eyes of GMR-GaI4/+, VAS-DG/+ flies are 
slightly larger th an eyes of wild type and GMR-GaI4/+, +/+ flies (data not shown). 
Next, we determine to examine the internaI ommatidia in the DG over-expression eyes. 
Full-iength DG was specifically over-expressed in PRCs by a neuron-specific driver 
Elav-gal4 (Homyk et al., 1985; Campos et a;l., 1985; Koushika et al., 1996; Luo et al., 
1994) and the individual ommatidia are examined in plastic sections. The over-
expressed DG is confirmed in Fig. 3-7 a-b. Similar to the larger external eye, trans-
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heterozygous flies containing Elav-gaI4/+, UAS-DG/+ have larger ommatidia with 
expanded membranes and celI bodies (Fig. 3-6d). The individual ommatidia in DG 
over-expressed eyes have significantly larger areas (226.3±4.8 f-lm2, n=146) and longer 
perimeters (55.2±0.6 f-lm, n=146) compared with those in wild type eyes (area: 
196.3±5.7 f-lm2, n=138; perimeter: 50.1±0.5 f-lm, n=138) and with two controls that 
contain Elav-gal4 alone or UAS-DG al one (Fig.3-6e, f), but the PRe numbers remain 
unchanged. Thus, DG appears directly involved in regulating PRe growth and does not 
simply sustain celIs that would otherwise degenerate. 
Full-Iength DG rescues the defects in DG deficient eyes 
To ascertain if the observed phenotypes reflect a role of DG in PRes or 
accessory celIs, fulI-length DG transgene was re-introduced into DG-deficient PRes 
under control of a neuronal driver Elav-gaI4. The expression of DG transgene in PRes 
was evident. For example, when antisera to Drosophila DG protein (Deng et al., 2003) 
was diluted 1 to 1000 it is unable to detect DG in the wild type disc (Fig. 3-7a) but 
easily detected the over-expressed DG at the apical tips of PRes (Fig. 3-7b). When DG 
is expressed in the PRes, 247/248 eyes examined appeared indistinguishable from wild 
type eyes (Fig. 3-7c). Histological analysis showed that PRes are normalIy organized 
and the retina structure appears as in the wild type flies (Fig. 3-7e-f). Furthermore 
ERGs are fully restored to the levels comparable to the wild type eyes (Fig. 3-8c). The 
external eye morphology is also normal with normaliens and organization (Fig. 3-7 d), 
indicating that non-neuronal lens defects observed in the DG-deficient adult are 
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secondary to loss of DG in PRCs. These data indicates that DG is required in PRCs for 
eye morphogenesis. 
Gene replacement and functional domain requirements for DG 
Conceivable with required cleavage on the polypeptide for normal DG function 
(Jayasinha et al., 2003; Esapa et al., 2003), recent studies in the vertebrate muscles have 
suggested independent functions for a- and ~-DG. a-DG by virtue of its interaction 
with ligands via its carbohydrates is required for muscle integrity and survival (Grewal 
et al., 2001; Holzfeind et al., 2002; Kanagawa et al., 2004) and modulate AChR 
aggregates independently of ~-DG at the NMJs (Trembly and Carbonetto, 2006), 
whereas ~-DG is required and sufficient to target dystrophin and the sarcoglycan 
complex to the muscle sarcolemma (Cote et al., 1999; Cohn et al., 2002; Kanagawa et 
al., 2004). In this study, we have shown that DG is required for PRC expansion, 
organization and survival. To test the roles of DG domains in PRCs in view of these 
functions, we performed the rescue experiments with the intracellular and extracellular 
DG using Gal4/UAS system. The intracellular DG (DGcyto) containing the intracellular 
and transmembrane sequence was first used to rescue the DG-deficient eye phenotypes. 
Genetic crosses were performed to express DGcyto transgene in DG-deficient PRCs in 
mosaic eyes, which contains one copy of Elav-gal4 and UAS-DGcyto in Ey; FLP/FRT 
induced DG-deficient mosaic eyes. Crosses also generated another group of flies that 
contains one copy of UAS-DGcyto alone in the DG-deficient mosaic eyes to serve as a 
control. The expression of DGcyto was confirmed on the membrane of PRCs, using the 
anti-Drosophila DG antisera diluted at 1: 1000, in the mosaic eyes containing one copy 
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of Elav-gaI4-and UAS-DGcyto (Fig. 3-9a') but not in UAS-DGcy1o control eyes (Fig. 3-
9a). We examined the glossy eye phenotypes of DGcy1o-containing (Fig. 3-9c) and 
control (Fig. 3-9b) flies, based on the scope of glossy patch on the eye surface area, and 
over 300 eyes have been examined. We found that DG-deficiency causes much smaller 
and less frequent glossy patches in eyes containing DGcyto transgene th an control eyes 
(Fig. 3-9d). Statistically, the big glossy patches in DG-deficient mosaic eyes containing 
DGcyto transgene appear much less frequently comparing with the control (Fig. 3-9d). 
For example, we could not see any 100% normal eyes in the control (Fig. 3-9b, a 
representative), but near one third of mosaic eyes looks almost entirely normal in the 
flies containing DGcyto transgene (Fig. 3-9c, a representative). Thus, it appears that the 
intracellular DG substantially ameliorates the DG-deficient phenotype in the external 
eye. Next, we examined the histology of DGcyto-containing eyes that do not show glossy 
patches and the histology of control eyes with small patches (",5%). Not surprisingly, 
DG-deficient eyes containing DGcyto transgene have largely preserved retinal structures 
and most PRes and accessory cells are present (Fig. 3-9g) comparing with DG-
deficient eyes (Fig. 3-lf' and Fig. 3-10f) and with DG-deficient control eyes containing 
UAS-DGcyto al one (Fig. 3-9h). However, retinae of these expected rescued eyes still 
show disorganization of PRes but the size and number of PRe appear normal (star, 
Fig. 3-9g), and occasionally ommatidia have only six visible PRes (arrows, Fig. 3-9g). 
This disorganization of PRes appears as disrupted PRe pl anar polarity. In the wild type 
eyes, PRes are recruited and oriented beginning in the 3rd instar larvae so that at one 
part of disc PRe clusters are uniformly oriented PRes (Fig. 3-ge'), whereas in DG-
deficient eyes that containing DGcyto transgene sorne ommatidia show dis-oriented 
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PRCs with R3 and R4 have chaotic directions (red, Fig. 3-9g') comparing with the 
neighboring ommatidia (blue, Fig. 3-9g'). In the control eyes containing UAS-DGcyto 
al one (Fig. 3-9h), DG-deficient eyes show strong phenotypes similar to the DG-
deficient eyes containing no UAS-DGcyto (Fig. 3-lf' and Fig. 3-1Of), which have a 
degenerated retina and disrupted ommatidia (arrow, Fig. 3-9h) and an autonomous 
degeneration of single PRCs (arrowhead, Fig. 3-9h). Furthermore, over-expression of 
DGcyto in heterozygous PRCs does not cause visible defects in the histology (Fig. 3-9f), 
planar polarity (Fig. 3-9f') and the external morphology (data not shown). Therefore, 
these data suggest that the intracellular DG partially rescues PRC degeneration, but not 
the organization of PRCs. A disrupted pl anar polarity of PRCs remains in these eyes, 
suggesting an independent function for the extracellular domain of DG. 
In vertebrates carbohydrates of a-DG in the mucin-region are the ligand binding 
domains which is required for muscle survival, brain development and synaptic 
transmission. The amino acids of Drosophila extracellular DG are poorly conserved but 
contain 15 consensus O-linked glycosylation sites (Fig. 1-2). To find out if the 
functional carbohydrates are conserved in Drosophila DG, the extracellular Drosophila 
DG (DGextra-mRFP), containing the extracellular and transmembrane regions of DG that 
are fused with mRFP in the C-terminus, was expressed in differentiated DG-null 
embryonic stem cells and mAb IIH6 was used to identify the functional carbohydrates. 
The DG-null mouse embryonic stem cells were engineered (Cote et al., 1999) and 
differentiated as described previously (Zhan et al., 2005). In the transfected DG-nu II 
cells, DGextra-mRFP protein is clustered at the cell membrane and can be recognized by 
antibody IIH6 without permeabilizing the membrane (Fig. 3-lOb-b"). IIH6 is known to 
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recognize the functional O-linked carbohydrate chains of a-DG, thus, Drosophila DG 
can be glycosylated to contain the same functional carbohydrate epitope as the 
vertebrates, which suggests that ligand binding appears to be a conserved function of 
DG and glycosylation and transport of extracellular DG do not need the participation of 
intracellular DG same as in the vertebrates (Trembley and Carbonetto, 2006). 
Additional experiments also show that IIH6 recognizes the endogenous DG in the 
western blots of Drosophila homogenates (Shah and Carbonetto, unpublished result). 
To test the necessity of the extracellular domain of DG in the development, 
genetic crosses were performed to express the extracellular DG (DGextra-mRFP) in the 
DG-deficient PRCs using GaI4-UAS system. The crosses resulted in one group of flies 
containing one copy of Elav-gal4 and UAS-DGextra-mRFP in DG-deficient mosaic eyes 
and another group containing neither Elav-gal4 nor Uas-DGextra-mRFP in the DG-
deficient mosaic eyes to serve as a control. The red fluorescence generated by DGextra-
mRFP was found in aIl the nervous system in living animaIs (data not shown) and in 
plasma membranes and rhabdomeres of DG-deficient PRCs in pupal eye discs 
containing one copy of Elav-gal4 and UAS-DGextra-mRFP (Fig. 3-lOa), without fixation 
and permeabilization. This confirmed that DGextra-mRFP transgene is indeed expressed 
in the PRCs. We next examined the scope of glossy patches on DG-deficient eyes 
containing DGextra-mRFP transgene and those containing no transgene in a same way as 
in the DGcyto rescue experiment. About three hundred eyes were examined on both 
groups. DG-deficient eyes containing the transgene (Fig. 3-10d) showed no difference 
in the size and frequency of glossy patches comparing with eyes containing no DGextra 
transgene (Fig. 3-10c) and Figures 3-10c and 3-lOd are the representatives. 
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Statistically, the size and frequency of glossy patches in eyes containing DGextra-mRFP 
show a same trait comparing with the fly eyes containing no DGextra transgene (Fig. 3-
lOh). For example, about half of eyes examined on both types of flies show greater than 
70% are as with glossy patches (Fig. 3-lOh). Histology of retina was examined from 
flies with small patches on both types, which demonstrates the same retinal 
degeneration and disruption (Fig. 3-lOf, g). As control, over-expression of DGextra-
mRFP on PRes does not cause disruption in the retina of wild type flies (Fig. 3-1 Oe) 
and in the external morphology (data not shown). Therefore, different from intracellular 
DG, the extracellular DG is unable to rescue the loss of PRe phenotype. These results 
suggest that role of DG in cell survival is independent from its action in cell polarity. 
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Discussion 
Muscular dystrophy is a group of diseases that are often caused by loss-of-
function mutations affecting dystroglycan-dystrophin complex. The major feature of 
the disease is muscle degeneration, but this can be associated with mental retardation 
and various retinal defects ranging from defective retinal b-wave (Holzfeind et al., 
2002; Pillers et al., 1993), abolished ERG, retinal degeneration and blindness 
(Fahnehjelm et al., 2001; Hino et al., 2001; Takeda et al., 2003; Vervoort et al., 2004; 
Zervos et al., 2002). However, mechanisms of the disease remain to be understood, 
especially for those in the CNS. Using Drosophila eye as the model, 1 demonstrated an 
essential role of DG in autonomous PRC development and non-autonomous 
requirement for the entire retina, and gene replacement experiments revealed distinct 
functions for DG domains in eye development. 
DG-deficient eyes don't have retinae. Adult eyes without DG show disrupted 
ommatidia, loss of photoreceptors and accessory cells with replacement by connective 
tissue as weIl as abolishment of ERG. These severe phenotypes begin with 
disorganization of PRC or loss of polarity and simultaneous retardation in PRC growth 
in the early pupa when ommatidial ceIls undergo early pupal differentiation. With pupal 
development in DG-deficient eyes progressive PRC degeneration occurs, DNA 
disorganization and dispersion and macrophage-like ceIl infiltration are also observed. 
Similar events occur in DG-nuIl dystrophic muscle (Cote et al., 1999; Cohn et al., 
2002). 
DG controls PRC growth and spatial organization. DG-deficient PRCs in 20% 
pupal development show a growth arrest with smaIler ceIl size in addition to the 
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abnormal spatial organization. This disrupted organization demonstrated that PRCs lose 
their polarity, including the planar polarity that was initiated earlier in the larval stage 
(Klein and Mlodzik, 2005). Therefore, DG appears to play a role for PRC pl anar 
polarity, in addition for the apical-basal polarity in epithelial cells of Drosophila 
embryos (Deng et al., 2003). Does loss of cell organization cause the growth arrest and 
final degeneration of PRCs? Loss of polarity is not necessarily associated with arrest of 
cell growth and degeneration since mutations in many polarity genes such as scribble, 
discs-large, and lethal giant larvae disrupt cell polarity but cause simultaneous cell 
proliferation and tissue overgrowth (Bilder, 2004). Moreover, mutant Frizzled causes 
disruptions in planar cell polarity within a tissue but those cells do not show growth 
arrest and degeneration (Vinson and Adler, 1987; Zheng et al., 1995; Adler and Lee, 
2001); also mutant Crumbs in pupal PRCs disrupts the adherens junctions but PRCs 
show no sign of degeneration (Izaddoost et al., 2002; Pellikka et al., 2002). In our data, 
over-expression of one copy of DG driven by GMR-GaI4 or Elav-Gal4 in the wild-type 
flies significantly increases the size of eye and individual PRCs, suggesting that DG is 
not only necessary but also sufficient to promote postmitotic PRC growth. More 
importantly, our data demonstrate that intracellular DG can largely rescue the PRC 
degeneration and cell size but PRCs remain disorganized. Therefore, DG is required for 
two different cellular processes: growth of PRC and organization of PRe. As DG has 
been shown to associate with signaling adaptor Grb2 (Yang et al., 1995; Zhan et al., 
2005), MAPK pathway (Jones et al., 2005), PIK3/Akt pathway (Langenbach and 
Rando, 2002) and other intracellular signaling (Li et al., 2005), involvement of DG in 
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ceIl size growth that is largely dependent upon protein synthesis (Stocker and Hafen, 
2000; Kozma and Thomas, 2002) deserves further investigation. 
Our data demonstrate an autonomous effect for DG in PRCs, but non-
autonomous effect for other cells including accessory ceIls and lens. First, when DG-
deficient PRCs show defects in organization and cell size in ",20% pupal development 
the surrounding cells appear normal (open arrows, Fig. 3-3d, e). Interestingly, 
degeneration of PRCs at 20% pupa is not accompanied by degeneration of accessory 
ceIls, instead, there is an invasive behavior for wild-type accessory cells that protrude 
into the "empty" ommatidial space (Fig. 3-3d, e). It appears that PRC defects arise 
independent of and begins prior to ommatidial accessory cell defects. Second, DG is 
expressed in PRCs with an apical localization at tips of PRCs in the 3rd instar where 
PRCs form the apical microvilli that project into the extracellular matrix and at 
rhabdomere microvilli in the pupa which face the inter-rhabdomere space. As weIl, DG 
is localized at the basal membrane of PRCs as a "ring' at the late 3rd instar (Fig. 3-5h, 
i), which is formed by PRCs because it overlaps with PRC-specific 24B 10 staining at 
the periphery (Fig. 3-5i, s). One thing should be noted that this "ring" in the 3rd instar 
larvae appears like the axon-surrounding grommet that is formed by pigment cells and 
the cone cell plates at the pupal retina floor (Longley and Ready, 1995), but it actually 
can not be the grommet because grommet is not formed until 37% pupal development 
(Cagan and Ready, 1989; Longley and Ready, 1995). Although the basal co ne cell 
processes are adjacent to the basal domain of PRC and surrounds the axons (Longley 
and Ready, 1995), this basal DG immunoreactivity belong most likely to PRCs because 
it overlaps with 24B 10 staining in the periphery (Fig. 3-5i). Therefore, this "ring" at the 
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basal disc of 3rd instar larvae could be the site where PRCs make contact with the 
extracellular matrix or with the accessory cells (Fig. 3-5s). When PRCs rotate 90°, 
expand and become surrounded by accessory cells at the pupal stage (Cagan and 
Ready, 1989; Longley and Ready, 1995; Tomlinson and Ready, 1987), our pupal 
staining has indeed shown that DG continues to be expressed at the basal membrane of 
the PRCs (Fig. 3-5n, 0, t). Therefore, similar to vertebrate DG that connects cells to the 
extracellular matrix or to other cells, Drosophila DG containing the sa me functional 
carbohydrate chains (Fig. 3-lOb-b") could make contact of a photoreceptor with the 
extracellular matrix at both apical and basal membranes. Thus, loss of DG could cause 
loss of PRC contact with the extracellular matrix or with other cells, which could be the 
reason why PRCs are disrupted. Zonula adherens among the ommatidial celIs are the 
best known cell-celI contact involved in maintaining PRC polarity. Our data show that 
individual DG-positive PRC shows no sign of defects when neighboring photoreceptors 
are degenerated or disorganized (Fig. 3-3d, e). This is very interesting and suggests that 
DG is sufficient to maintain PRC organization and DG-negative PRCs do not maintain 
the neighboring PRCs within one ommatidium. Third, re-introduction of DG 
specifically in the PRCs can rescue the phenotypes of the whole eye (Fig.3-7) including 
those in PRCs, in accessory cells and lens and the ERG is also restored to the normal 
(Fig. 3-8c). This confirms that the structural and functional phenotypes are mainly 
resulted from loss of DG in PRCs, and the entire retinal defects including those of 
accessory cells observed in ",70% pupa (Fig. 3-4h) and adult (Fig. 3-lf') are secondary 
to failure of PRC development. Also, it demonstrated that non-PRC expression of DG 
in pupal development is not functionally important. And, lens defects observed in 
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adults are secondary to PRC defects and are most likely caused by lens-secreting co ne 
cell defects prior to ",45% pupal development (Cagan and Ready, 1989). 
Our results demonstrate that intracellular DG is sufficient to largely rescue the 
eye phenotypes, especiaIly PRC degeneration, but not the organization of PRC or 
pl anar polarity of PRCs (Fig. 3-9g). Therefore, it is the function of extraceIlular domain 
of DG to organize PRCs and disorganization or disrupted PRC planar polarity is not 
sufficient to induce PRC degeneration. Indeed, seven PRCs exist in these rescued 
ommatidia while their polarity is disrupted (stars, Fig. 3-9g), suggesting ceIl survival 
and pl anar polarity are two uncoupled processes and intraceIlular DG is largely 
required for ceIl survival and extracellular DG is required for pl anar polarity. This 
rescue data also suggests that an intracellular signaling(s) is coupled to DG and 
sufficient to keep PRC alive, which is consistent with the over-expression data that DG 
is involved in regulating PRC expansion (Fig. 3-3a and Fig. 3-6). On the other hand, by 
sequence comparison, extraceIlular Drosophila DG contains a mucin-like region with 
15 putative O-linked glycosylation sites and our data show that extraceIlular DG can be 
glycosylated to contain same carbohydrate epitope that is recognized by IIH6 (Fig. 3-
lOb-b"), suggesting that Drosophila DG has the functional ligand-binding ability. 
However, when extracellular DG is used to rescue the DG-deficient phenotypes, the 
retina shows same phenotypes as eyes containing no transgene. Therefore, keeping ceIl 
in contact and organization with extracellular DG does not sustain the challenge of loss 
of intracellular DG, and PRC degeneration caused by absence of intracellular DG is 
sufficient to cause the eye phenotypes similar to loss of entire DG protein. These data 
are consistent with the previous evidence that DG polypeptide must be cleaved to 
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function properly (Jayasinha et al., 2003; Esapa et al., 2003) and a- and ~-DG subunits 
play coordinate but also distinct roles in vertebrate muscles (Kahl and Campanelli, 
2003; Kanagawa et al., 2004; Trembley and Carbonetto, 2006). Moreover, extending 
the previous evidence, our data suggests that a-DG is required for but appear not 
sufficient to rescue DG-deficient phenotype in PRCs. 
In summary, our data demonstrated for the first time an autonomous 
requirement of DG in postmitotic PRC differentiation and showed that cell growth 
arrest, disrupted PRC polarity and progressive PRC degeneration could be the reasons 
leading to the severe disruption in adult DG-deficient eye. Extending previous evidence 
that a and ~-DG could play distinct roles in muscle, using rescue experiments we 
demonstrated PRC pl anar polarity disruption and cell degeneration are independent 
processes which are attributed to respective function of extracellular and intracellular 
DG. 
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Table 2. Progressive degeneration of PRCs in DG-deficient clones. 
24BIO negative phalloidin negative 24BlO positive cells 
cell s cell s -------------------------------------------------------------------
misorganized/small normal morphology 
20% pupa 45% N.D. 34% 21% 
(n=120 null clones*) 
40% pupa 74% 74% 15% 11% 
(n= 1 02 null clones) 
*a clone usually contains multiple PRCs. N.D. not done. 
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Figure 3-1 
Figure 3-1: Deletion of DG in the eye disrupts the structure of the adult eye 
Light and scanning EM micrographs of the wild type fly eye (a-c) show the 
classical ommatidial facets and bristles of the external eye. al_cf show equivalent 
micrographs of flies expressing DG248 generated by the FLP/FRT system which induces 
typically 80-90% DG-deficient (DG248) tissue. The DG-deficient tissue in a' is white 
while tissue with heterozygous expression of the wild type DG gene is red. The DG-
deficient (white) regions appear flattened and glossy (a'). Electron micrographs reveal 
regions where the external eye has collapsed (b') and the facets have been obliterated 
(c'). Histology of the wild-type eye stained with toluidine blue show regularly arranged 
rhabdomeres (d, arrowhead) and surrounding pigment cells that span the thickness of 
the eye and rest on a retinal floor (d, arrow). In DG-deficient eyes the internai structure 
is disorganized and the eye thinner (d'). Interestingly in e' the lenses which normally 
(e) form a biconvex disc are flattened on their external, but not internaI, faces though 
cuticle that forms the external boundary is visible within an flattened and partially 
"empty" lens (e', arrow). Cross sections of the internaI eye reveal that the normal (f) 
array of PRe with central rhabdomeres is disrupted (f', arrow) and there appears to be 
macrophage-like cells (f', top of the arrow) in these regions. Open arrow points to an 
ommatidium that has only two pigment-containing PRCs visible while other non-
pigment-containing PRCs appear disrupted. Therefore, DG appears function 
autonomously. Heterozygous ommatidia contain normal rhabdomeres and 
photoreceptor cells (f', asterisk). Triangle marks the pseudocone on the edge of the eye. 
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Figure 3-2. DG deficient photoreceptor celis develop normaliy through the 3rd instar 
larvae. 
Immunohistochemistry with antibodies to chaoptin (a, d), Elav (b, e) and Boss 
(Bride of Sevenless) (c, f) were used to identify R celis in wild type (a-c) and DG-
deficient regions of the eye imaginai disc (d-f) of late 3rd instar larvae. Chaoptin 
(Fig.1) and Elav, a neuron specific nuclear protein, is localized normaliy (a, b) in DG 
deficient eye discs (d, e). Similarly Boss, which is expressed on the apical surface of 
R8 and necessary for formation of R7, is localized normally (c) in DG deficient eye 
discs (f). In smali, DG-deficient clones generated by the ELP/FRT system wild-type 
cells can be identified by membrane-targeted GFP (g-i). In this instance both wild type 
ommatidia (h, i; arrow) and DG-deficient ommatidia appear normal and have welI-
organized zonula adherens (h, i; arrowhead) between neighboring R cells marked by 
armadillo (Arm). Bar, 10 microns. 
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Figure 3-3. DG is required for photoreceptor size increase and organization during 
early pupal development. 
Antibody 24BlO was used to identify PRC in pupal eye discs (20% of pupation) 
mosaic for wild type and DG deficient cells generated by the FLP/FRT system. Aline 
in (a) separates a disrupted region of the eye from a normal region. In 20 such 
preparations there were many small PRC (arrows) adjacent to patches with normal 
ommatidia. b, Quantification of the lengths of R cell lateral (apical to basal axis) 
membranes and (circumferential) basal membranes showed that those in disrupted 
regions were significantly shorter in lengths (**, P<O.Ol). c-e, In pupal eye discs with 
small clones of DG-deficient cells (Fig.3-2) individual PRCs, identified with antibody 
24BlO to chaoptin, are absent from sorne ommatidia (asterisk). These cells are 
invariably deficient for DG as reflected in the lack of GFP labeling (d). The arrowhead 
points to an ommatidium (c) with DG-deficient PRCs (d) that have pulled away from 
the supporting cells of the ommatidium and are misoriented and shrunken. Conversely, 
adjacent to this ommatidium, one sees a single wild type PRC (arrow) within an 
otherwise empty ommatidium (c, e). This DG positive cell appears normal, is attached 
to adjacent supporting cells and has elaborated a rhabdomere (d, e). In the same 
ommatidium (top to the asterisk, d,e) supporting cells appear to be moving into a 
vacated ommatidial cavity (d, e). Open arrowheads point to normal appearing 
accessory cells that surround the misoriented DG-deficient PRCs. 
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Figure 3-4 
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Figure 3-4. Progressive degeneration of photoreceptor cells. 
a, Stainings of 24BlO(red) and GFP (green) in clones at 40% pupa show same 
phenotypes as in the 20% pupa. Sorne PRC in DG-deficient clones are lost (asterisk), 
sorne are smaller and disorganized (arrow), while sorne are still normal (arrowhead). b-
e, Phalloidin staining in 40% pupa is mostly lost in DG-deficient ommatidia (arrow, 
b,e) but strongly present in the normal ommatidia, which is concentrated at 
rhabdomeres (arrowhead, b). This phalloidin staining is merged with GFP stainings (e). 
Statistics of these stainings in 20% and 40% pupa were summaried in (Table 2). d-f, 
Affected DNA in 40% pupal DG-deficient mosaic disc. 24B 10 was used to mark PRCs 
in the disc (d). DAPI was used to recognize nuclear DNA (e). Normal ommatidia 
contain sharply-stained DNA clusters while each dot is localized in the center of PRC 
(arrowhead, e and f). Delineated are a shows cellular defects by 24BlO staining and also 
has diffused DNA (arrows, e, f), suggesting a cell death is happening. g-h, Cross 
sections of wild type (g) and DG-deficient mosaic (h) discs in 70% pupa. Most areas of 
retina (asterisk, h) are disrupted and show tissue deposit and cell debris. Macrophage-
like cells are accumulated in sorne ommatidia (arrowheads, h). The arrow points to one 
ommatidium, surrounded by normal pigment granules, thus, probably a non-DG-
deficient ommatidium, has relatively normal rhabdomeres and PRCs. 
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Figure 3-5. Distribution of DG in the developing fly eye 
The eye imaginaI disc of the 3rd instar larvae is immunolabeled with mab 
24B 10, that recognizes chaoptin, a membrane protein that is concentrated in the apical 
tips of PRCs in these apical, optical sections (a-t). Antiserum to Drosophila DG (Deng 
et al., 2003) labels the apical tips of wild-type (b) but not DG-deficient R cells (e). In 
basal regions of the imaginaI disc (g-l), chaoptin-positive axons can be se en exiting the 
retina surrounded by an area that also expresses DG. An amplified image shows the 
peripheral co-staining of 24B 10 and DG (i). In DG-deficient imaginai discs the 
bundling of axons in the basal region appears normal as revealed by chaoptin labeling 
(j) despite the absence of DG (k). In the 40% pupa DG is found along with chaoptin in 
the rhabodomere at the centre of each ommatidium (m-o, arrowhead) and at the basal 
aspect of each PRC (n-o, arrow), as weil within axons (p-r, arrow) and surrounding glia 
that exit the retina in the proximal side of the disc (p-r, arrowhead). s, Carton shows the 
distribution of DG in the 3rd instar PRCs. DG is distributed in the apical and basal parts 
of PRCs where it is co-stained with chaoptin, while chaoptin is uniformly distributed on 
PRC surface and axon. t, Top of the left panel is two amplified PRCs in o. Bottom is a 
cartoon showing the distribution of DG in PRCs; Top of the right panel is an amplified 
sites where axons exit the pupal eye disc (arrowhead, r). Bottom is a cartoon showing 
the distribution of DG at this site. 
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Figure 3-6. Over-expression of DG in photoreceptor cells increases ommatidial size. 
Cross sections of ommatidium (encircled) in wild type flies (a) and flies 
containing Uas-DG/+ alone (b), Elav-GaI4/+ alone (c) and Elav-ga14/Uas-DG (Elav-
DG, d) showed that over-expression of DG in PCRs induces larger ommatidia with 
expansion of PRCs (d) as compared with the controls (a-c), but the number of PRCs 
remains unchanged (d). e, Ommatidia perimeters are significantly increased when DG 
is over-expressed in PRCs driven by Elav-Ga14. f, Ommatidial areas are significantly 
increased when DG is over-expressed. Over-expression of the DG transgene was 
confirmed immunohistochemically in Fig. 3-7b. **, P<O.Ol. Bar, 10 microns. 
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Figure 3-7 
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Figure 3-7. DG expression in photoreceptors is sufficient to restore the normal eye 
structure 
a-b, Diluted antisera Cl: 1000) to Drosophila DG were used to visualize the 
expression of DG in wild type (a) and DG-over-expressed (Elav-DG) flies (b) driven 
by Elav-gaI4. Although the antisera at 1:250 dilutions recognize the wild type DG (Fig. 
3-5b,h), the antisera at 1: 1000 dilutions barely detect the wild type DG (a), however, it 
easily detected DG at the apical tips of 3rd instar PRCs containing Elav-gal4 and Uas-
DG (Elav-DG) (b). As the DG transgene driven by Elav was induced in PRCs of the 
DG mosaic eyes generated by FLP/FRT system (Fig.3-l) (DG-/-; Elav-DG), the 
external eye, visualized by scanning electron microscopy, looks completely normal (d) 
as does the internaI structure in histological section (1). 
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Figure 3-8. DG expression in photoreceptor cells is sufficient for development of a 
functional eye. 
Electroretinograms (ERGs) were recorded from wild-type flies, DG-deficient 
mosaics and mosaics expressing a DG transgene in their PRCs (Fig. 3-7b). (a) ERGs 
were recorded after a 5 min dark adaptation followed by a 2 sec bright-light pulses (a, 
Top trace). The bottom trace shows representative ERGs of wild type (left) and DG-
null regions (white) of mosaic eyes (right). In DG-deficient regions the 9-14mV PRC 
depolarization (left) was greatly di mini shed and the early and late synaptic transients 
(left) completely aboli shed. (b) Quantification of ERG parameters in wild type and DG 
null patches showed significant differences (P<O.Ol) between wild-type and DG null 
eyes. (c) ERGs from wild type eyes (N=8) DG-deficient mosaic eyes (N=15) or those 
expressing the DG transgene in PRes (N=9) again shown significant differences in the 
receptor potential and synaptic transients between wild type and DG-deficient eyes. 
Mosaic deficient eyes expressing the DG transgene also had significantly greater ERG 
responses that were indistinguishable from wild-type eyes. * *, p<O.O 1. 
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Figure 3-9. Expression of cytoplasmic domain of DG in DG-deficient PRCs partially 
rescues PRC defects and show disrupted PRC planar polarity. 
a, PRCs in DG-deficient mosaic eye discs (Fig.3-5) are unlabeled by antisera to 
DG. al, In DG-deficient mosaic discs containing Elav-gaI4/+; Uas-DGcyto/+ (DG-/-; 
Elav-DGcyto) that drives expression of a construct consisting of the transmembrane 
and cytoplasmic domain of DG (DGcyto), the DG labeling is evident on the cell surface 
and in the rhabdomere when the antiserum was used at 1:1000 dilutions. b) The 
external structure of a DG-deficient mosaic eye (genotype: EyFlp; FRT42D, LW+ / 
FRT42D, DG248, Uas-DGcyto ; +/Sb) has an obvious glossy patch of disrupted ommatidia. 
c) In contrast, in mosaic eyes expressing the membrane anchored cytoplasmic domain 
of DG (genotype: EyFlp; FRT42D, LW+ / FRT42D, DG248 , Uas-DGcyto ; Elav-gaI4/+) 
the size of the glossy patch in the mosaic eyes is greatly reduced. d) Fly eyes were 
categorized by the percent of the surface that was glossy for these two genotypes. More 
than 120 of the DG deficient mosaic eyes (b) have glossy patches that coyer greater 
than 70% of the eye and none have completely normal eyes. In contrast in DG-deficient 
mosaic eyes expressing DGcyto (c) more than 120 eyes are completely normal and none 
have large glossy patches. e-e', Cross section of wild type adult fly eyes (e) showing 
normal structure and normal PRC planar polarity with R3 pointing to a uniform 
direction in this part of eye (e'). f, Cross section of heterozygous (DG+/-) eyes 
containing DGcyto transgene (genotype: FRT42D, DG248, Uas-DGcyto/+; Elav-gaI4/+) 
show normal PRCs (f) and pl anar polarity (f') similar as the wild type (e, e'). g, DG-
deficient eyes containing DGcyto transgene (genotype: EyFlp; FRT42D, LW+ / FRT42D, 
DG248, Uas-DGcyto ; Elav-gaI4/+) show that the retina is largely preserved and most 
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ommatidia have seven PRCs (g) comparing with the DG-deficient eyes without DGcyto 
transgene (h) (genotype: EyPlp; FRT42D, LW+ / FRT42D, DG248, Uas-DGcyto ; +/Sb). In 
two ommatidia (g), there are only six PRCs (arrows), and some ommatidia have 
disoriented PRCs, a sign of disrupted pl anar polarity (asterisks, g). g', A drawing shows 
that PRCs with disrupted pl anar polarity (red, g') have different direction comparing 
with the neighboring normal ommatidia (blue, g'). The number in e', f'and g' 
represents individual RI-R6 and their orientation in one ommatidium. h, Control eye 
that contains Uas-DGcyto but no driver show severe disruption of retina and PRC defects 
(arrow) similar to observed in DG-deficient retina (Fig. 3-lf'). Arrowhead in h points 
to disrupted PRCs in a mosaic ommatidium indicating an autonomous effect of DG in 
PRCs. Triangle in h points to pseudocones on the edge of retina. Ten eyes were 
sectioned from each genotype and shown here are the representatives. 
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Figure 3-10. Expression of extracellular domain of DG in DG-deficient PRCs does not 
rescues PRC defects. 
a, DG-deficient mosaic discs containing Elav-gaI4/+; Uas-DGextra-mRFP (DG-/-
Elav-DGextra-mRFP) that drives expression of a construct consisting of the 
transmembrane and extracellular domain of DG fused with mono red fluorescence 
protein (mRFP) in its C-terminus. The expression of the fusion protein (DGextra-mRFP) 
was found in the plasma membrane and rhabdomeres of PRCs (a) when discs were 
dissected and directly visualized by fluorescence microscope. b-b", DGextra-mRFP was 
transfected in DG-null differentiated ES cells and stained with IIH6, an antisera 
recognizing the functional carbohydrates of vertebrate DG. mRFP (b) was found to co-
cluster with IIH6 staining (b') in the non-permeabilized cells on the plasma membrane 
(b"). c-d, Glossy patches were similarly estimated as percentage of eye are a in two 
kinds of flies. One contains no DGextra-mRFP transgene (c) and the other contains the 
transgene (d). In ~300 eyes examined there was no difference in size of glossy patches 
in flies expressing the extracellular portion of DG compared with DG-deficient mosaic 
eyes (h). Cross sections of eyes from flies containing over-expressed DGextra-mRFP in 
wild-type (e) show normal retina and PRes; Expression of DGextra-mRFP in DG-
deficient mosaic flies (f) show similar retina disruption as those in DG-deficient eyes 
(f). Genotypes: e, Elav-gaI4, Uas-DGextra-mRFP/+; c and f, EyFlp; FRT42D, LW+/ 
FRT42D, DG248 ; +/Sb; g and d, EyFlp; FRT42D, LW+/ FRT42D, DG248 ; Elav-gaI4, Uas-
DGextra-rnRFP/+. Ten eyes were sectioned on each genotype and shown here are the 
representatives. 
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Chapter 4 
General Discussion 
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DG is the core member of the DGC linking the cytoskeleton to the extracellular 
matrix. DG contains the transmembrane f3-DG and the tightly attached extracellular a-
DG, both of which are derived from a single polypeptide but post-translationally 
cleaved and modified by glycosylation. Direct mutations in DG genes have not been 
found in human most likely due to essential roles of DG in embryonic development 
(Williamson et al., 1997). Targeted deletion of DG gene in mice, however, leads to 
muscle degeneration and cell death (Cote et al., 1999; Cohn et al., 2002) resembling 
those human muscular dystrophies caused by mutations in dystrophin, sarcoglycans and 
laminin. Mutations in genes encoding several glycosyltransferases that lead to hypo-
glycosylation of a-DG, and, thus, loss of binding to extracellular laminin, cause several 
congenital muscular dystrophies (Barresi and Campbell, 2006; Muntoni et al., 2004). 
The main cause of the muscle degeneration is due to the disruption of the linkage 
between the cell and extracellular matrix. However, the detailed mechanisms are 
unclear. 
Using the Drosophila visual system as the focus of my work 1 have found that 
loss of DG in retina leads to a failure in retinal development that results from cell 
autonomous defects in PRC growth, organization and a progressive PRC degeneration 
beginning when photoreceptor cells initiate the early pupal development. Moreover, 
gene replacement experiments show that the intracellular DG is sufficient to partially 
rescue the PRC survival and retinal structural defect (Chapter 3) but not the 
organization of PRCs in an ommatidium. 
ln contrast to the functional and anatomical defects in DG-deficient retina of 
Drosophila melanogaster, loss of dystrophin isoform Dp260 in human and mouse retina 
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causes synaptic transmission defects, the disrupted b-wave in the ERG, but the retinal 
structure is well maintained (PilIers et aL, 1990; Pillers et aL, 1993, Cibis et aL, 1993; 
Pillers et al., 1995). The DGC, including Dp260 and DG, in retina is localized to the 
presynaptic terminal of photoreceptor cells in the outer plexiform layer (Koulen et al., 
1998; Schmitz and Drenckhahn, 1997b; Ueda et aL, 1997; Ueda et al., 1995) and the b-
wave defects in DMD patients and mou se models are most likely the consequence of 
loss of DGC members in the presynaptic terminal (Blake and Kroger, 2000). Although 
specific deletion of DG in the eye causes aberrant structure and function in Drosophila 
(Chapter 3), recent data showed that mutations of LARGE gene in mice that lead to the 
disruption of a-DG glycosylation cause reduced and delayed b-waves but no gross 
abnormalities in the eyeball or in the retinal structure (Grewal et al., 2001; Holzfeind et 
al., 2002). Therefore, DG and its complex members appear to be required 
presynaptically for normal photoreceptor synaptic function; however, the mechanism 
for this requirement is unknown. In chapter 2, using proteomics methods a novel DG-
associated protein, the GTPase dynamin 1, was found to directly associate with ~-DG 
in the brain and the retina where they are colocalized in the outer plexiform layer 
(Chapter 2). Dynamin is the well-known protein required for vesicle endocytosis and 
we showed that loss of DG affects dynamin-mediated transferrin uptake in 
heterologous cells (Chapter 2). These data indicate that DG may regulate synaptic 
vesicle endocytosis at the photoreceptor terminaIs and the disrupted b-wave in the 
DMD/BMD patients may be caused by failure in this regulation as the consequence of 
DG disruption in photoreceptor terminal of muscular dystrophy patients. 
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DG Distribution 
DG has a very broad and complicated distribution dependant on the tissue and 
cell type. DG is concentrated at postsynaptic sites of peripheral (Gingras and Ferns, 
2001; Leschziner et al., 2000; Ohlendieck et al., 1991b) (Cohen et al., 1995) and 
inhibitory central synapses (Brunig et al., 2002; Levi et al., 2002), and is uniformly 
localized at the extra-synaptic sarcolemma (Ohlendieck et al., 1991b), neuronal cell 
bodies and glial endfeet around the blood vessels (Tian et al., 1996). In the vertebrate 
retina, DG is expressed at the outer plexiform layer, the inner limiting membrane, 
around the blood vesicles (Fig 2-5B, chapter 2), and at the retinal pigment epithelium 
during development (Lunardi et al., 2006; Ueda et al., 2000). As presented previously, 
DG is colocalized with dynamin 1 in the outer plexiform layer and biochemically DG 
and dynamin 1 can be co-immunoprecipitated from retina extracts. Dynamin is widely 
distributed in aIl kinds of synapses and dynamin 1 is localized presynaptically (De 
Camilli et al., 1995; Praefcke and McMahon, 2004; Warnock et al., 1997). In retina 
dynamin is expressed in the outer and inner plexiform layers (Fig. 2-5B), both of which 
are synaptic layers containing glutamatergic synapses (Sterling and Matthews, 2005). 
But, only in the outer plexiform layer is DG colocalized with dynamin 1, which is 
consistent with the biochemical results in brain that association of DG and dynamin 1 is 
not in 1: 1 stoichiometry (Fig. 2-2), implying that DG is only expressed and colocalized 
with dynamin 1 at subpopulations of synapses in the CNS including the ribbon synapse 
of the retina. 
DG has been shown to express in the actin-enriched microvilli in many cell 
types. In several vertebrate cell lines DG is distributed at the microviIli, the actin-
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enriched membrane tips (Spence et al., 2004) as well as in the microvilli of Schwann 
cells at nodes of Ranvier (Occhi et al., 2005; Saito et al., 2003). In the cultured ES 
cells, DG is codistributed with dynamin 1 and cortactin in the membrane ruffles (Fig.2-
6), an actin-riched membrane protrusion (Faix and Rottner, 2005). In Drosophila PRes, 
DG is expressed at the apical tips, the microvilli, of PRes at the 3rd instar larvae (Fig. 3-
5a-c). The microvilli at the apical larval discs are the membrane-enriched structure of 
cells that project into the extracellular matrix (Banerjee et al., 1987), and, thus, DG 
could connect PRes to this matrix. In the pupal development DG continues to be 
expressed at the apical membrane, in rhabdomeres, facing the extracellular molecules 
in the inter-rhabdomere space (Figure 6, chapter 3). 
DG is also localized at the basal side of epithelial cells opposing to the BM in 
both vertebrate and Drosophila embryos (Deng et al., 2003; Durbeej et al., 1995). In 
the 3rd instar larvae eye disc, DG is also distributed at the basal subdomain of 
Drosophila PRes in a "ring" (Fig. 3-5) and continues the pattern in the basal surface of 
PRes in pupal development opposing the surrounding ommatidial accessory cells (Fig. 
3-5). Because this "ring" surrounds and partially overlaps with neuron and axon 
specific 24B 10 staining (Fig. 3-5f) in the peripheral but not in the central axonal (Fg. 3-
5f), we conclude that DG is expressed at the basal domain of PRe. This basal 
localization is the site that PRe makes contact with the extracellular matrix or possibly 
with the accessory cells (Longley and Ready, 1995). Ultrastructurally, whether DG 
connects the basal membrane of PRe to the base ment membrane or to the accessory 
cells remains to be answered. Nevertheless, DG displays a polarized distribution at the 
both apical and basal sides of PRes, where PRes are in contact with the extracellular 
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matrix or to other cells. In addition, we suggested in Chapter 3 that Drosophila DG 
contains the same functional carbohydrates as the vertebrate DG that are required to 
bind to the G domain-containing molecules in the extracellular matrix or in other cells, 
therefore, these carbohydrates could be the units linking PRCs to extracellular matrix or 
to other cells. 
DG regulate endocytosis 
As mentioned previously, ~-DG forms an intracellular complex with Dp260, ~­
dystrobrevin, syntrophin in the periactive zone of photoreceptor terminal (Blank et a., 
1999; Claudepierre et al., 1999; Dalloz etaI., 2001; Jastrow et al., 2006), where it 
connected to a-DG that could in turn bind to synaptic agrin in the cleft (Koulen et al., 
1999). As shown in chapter 2, ~-DG is also associated and colocalized with dynamin in 
the presynaptic terminaIs (Fig. 2-5). Thus, dynamin could be anchored through DG 
complex to the extracellular matrix in this ribbon synapse although direct evidence is 
lacking. 
Dynamin is required for endocytosis and a temperature-sensitive dynamin 
mutant called shibire in Drosophila leads to a severe impairment in pre-synaptic 
transmission in the restrictive temperature due to failure in synaptic vesicle "pinching 
off" and depletion of vesicles (Koenig and Ikeda, 1989; Poodry and Edgar, 1979; 
Poodry et al., 1973; van der Bliek and Meyerowitz, 1991). The function of dynamin in 
endocytosis results from its ability to self-assemble into rings and spirals on the "neck" 
of vesicle and its ability to hydrolyze guanosine triphosphate (GTP) (De Camilli et al., 
1995). The latter is dependant on the self-assembly (Warnock et al., 1996), the amino 
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terminal GTPase domain and the GTP effector domain (GED) of the dynamin molecule 
(Muhlberg et al., 1997; Sever et al., 1999). In our transferrin-uptake assay, we showed 
that DG-deficient cells have a two-fold increase in the transferrin-uptake compared to 
that in wild-type cells (Fig. 2-7, 8, 9), which could be reversed by re-introduction of 
DG (Fig. 2-9). Thus, DG appears to negatively control transferrin-uptake in normal 
conditions. In DG-deficient cells, we could not observe change in dynamin distribution 
under immunofluorescence microscopy (Zhan and Carbonetto, unpublished 
observation) due to the abundant presence of dynamin in the cytoplasm. Nevertheless, 
DG could more likely affect dynamin functionally in addition to serving as an anchor 
site. For example, the direct interaction of DG with dynamin (Fig. 2-4) could limit the 
ability of dynamin to self-assemble or hydrolyze GTP. Therefore, future experiments 
would investigate the domain requirement for interaction of DG and dynamin and test 
its impact in the assembly and GTP hydrolysis. 
Transferrin-uptake utilizes many of the same molecules, including dynamin and 
clathrin, and shares many basic endocytic mechanisms as the synaptic vesicle 
endocytosis although it is not tightly regulated by synaptic transmission (Jarousse and 
Kelly, 2001). DG, by coupling dynamin to the DGC scaffold and the extracellular 
matrix at the peri-active zone where vesicle endocytosis often occurs (Jarousse and 
Kelly, 2001), could regulate synaptic vesicle endocytosis at the ribbon synapse of outer 
plexiform layer. This hypothesis can be tested in animal models. As suggested from 
chapter 3, DG is essential for development of the whole eye, so it is very difficult to 
utilize DG-deficient animais to analyze the synaptic function. However, myd mice have 
a defective glycosylation of a-DG and the synaptic transmission defect is seen in 
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disrupted b-waves whereas the reported retinal structure is conserved (Grewal et al., 
2001; Holzfeind et al., 2002), therefore, it would be interesting to determine if the 
defective glycosylation of a-DG affects the interaction of DG and dynamin, and, thus, 
a changed endocytosis. On the other hand, DMDIBMD patients and md~cv mice that 
have normal retinal structures show disrupted b-waves and reduced DG distributions in 
the outer plexiform layer (D'Souza et al., 1995; Kameya et al., 1997; PilIers, 1999; 
Pillers et al., 1999), thus, future experiments could determine whether increased 
endocytosis occurs in the photoreceptor terminaIs of md~cv mice. 
Possible mechanisms of DG function in the eye 
Using Drosophila eye as a model loss-of-function, gain-of-function studies as 
weIl as rescue experiment suggested a possible mechanism of DG function. Loss of DG 
leads to defective PRC contact with its ligands in the extracellular matrix or in other 
cells and results in simultaneous disruptions of cell polarity and intracell ular DG-
mediated signaling that appears essential for the cell growth and survival. Below, 1 first 
discuss the possible intracellular mechanisms that could be involved in the cell growth 
and death, and then 1 discuss if dynamin-mediated endocytosis could contribute to 
defects in DG-deficient eye. 
Cell growth is a distinct process from proliferation especially in postmitotic 
ceIls, and size control in cell mass and dimensions is linked to protein synthesis 
(Kozma and Thomas, 2002; Neufeld et al., 1998; Stocker and Hafen, 2000). DG is 
known to associate directly with an adaptor protein Grb2 in both muscle and neuron 
(Yang et al., 1995; Chapter 2), thus, loss of DG may affect Grb2-mediated, Sos (son of 
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sevenless)-induced activation of the small GTPase Ras in the growth factor receptor-
Ras-MAPK-Myc pathway, a known pathway leading to protein synthesis and cell 
growth (Kozma and Thomas, 2002; Neufeld et al., 1998; Stocker and Hafen, 2000). 
Loss-of-function mutations in Ras cause poor cell growth with small cell size and over-
expression leads to increased cell size with normal cell cycle rate (Prober and Edgar, 
2000). Moreover, Ras also participates in the PI3K (phosphatidylinositol 3-kinase)-
AktlPKB (protein kinase B)-mTOR (mammalian target of rapamycin) pathway, a key 
regulator of cell size in many species and a suppressor of apoptosis (Cantley, 2002; 
Franke et al., 2003; Schmelzle and Hall, 2000; Stocker and Hafen, 2000). Therefore, in 
future experiments it would be interesting to determine how DG could affect the Ras 
and the downstream molecules in the two signaling pathways. On the other hand, 
independently from my Drosophila studies, Sgambato et al. (2006) recently showed 
that suppression of DG in cultured dividing epithelial cells leads to a growth arrest that 
is caused by accumulation of cells in S-phase of the cell cycle. Moreover, they showed 
that down-regulation of DG is accompanied by down-regulation of PTEN, upregulation 
of AKT, and increased apoptosis (Sgambato et al., 2006). Therefore, it would be very 
interesting to further investigate whether intracellular DG is coupled to cell cycle or 
cell growth in vivo using Drosophila as a model. 
Could dynamin play a role in DG-deficiency induced defects in the eye? In 
addition to the requirement for endocytosis in synapses, flies carrying the temperature-
sensitive allele of dynamin, shibire, when heated to inactivate shirbire during early 
embryo stage, die (Poodry et al., 1973). Heating for 3-6 ho urs during the period from 
48 hrs before to 3 hrs after pupariation results in a scar in the eye while the remaining 
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areas are normal, which was said to reflect a disruption of the morphogenic furrow 
(Deitcher, 2002; Poodry et al., 1973). Longer heating (12 hrs) in this period gives a 
roughened small eye resembling eyeless (Poodry et al., 1973), a master gene controlling 
eye development (Hal der et al., 1995). It was found that Notch acts upstream of eyeless 
(Kumar and Moses, 2001a) and notch and delta signaling requires endocytosis (Parks et 
al., 2000), which could explain why shibire resembles eyeless. These data demonstrate 
that dynamin is critical for eye development in the 3rd instar larvae stage. 
Unfortunately, it is not documented what are the phenotypes if the shibire flies are 
heated after pupation starts, during which DG plays a critical function. In other 
instances, when endocytosis is blocked by over-expression of a dominant-negative 
dynamin that is defective in GTP hydrolysis, heterozygous eyes show a rough eye 
phenotype with disorganized morphology, but the external ommatidia or lens exist 
(Chang et al., 2002). Moreover, when endocytosis is blocked in homozygous mutant for 
Hsc70, a protein required for clathrin uncoating, the photoreceptors and ommatidia are 
essentially normal (Chang et al., 2002). Thus, defective endocytosis appears to lead to 
less severe phenotypes th an DG homozygous. But, since intracellular portion of DG has 
multiple interacting proteins, defects in dynamin-mediated endocytosis could still 
contribute to the phenotypes we observed in DG-deficient retina. For example, 
dynamin is required for Grb2-mediated EGF receptor internalization (Huang et al., 
2004; Vieira et al., 1996; Wang and Moran, 1996; Yamazaki et al., 2002), loss of DG 
could lead to higher rate of EGF receptor internalization, thus, affecting the PRC 
growth and survi val. 
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From Drosophila to human muscular dystrophy 
Congenital muscular dystrophy type ID is caused by mutations III LARGE 
gene, and its animal model is myd mice. LARGE directly participates in synthesis of 
carbohydrates of a-DG and transfer of LARGE into ceUs isolated from FCMD, MEB 
and WWS patients can functionally restore the defective glycosylation of a-DG 
(Kanagawa et al., 2004; Barresi et al., 2004). myd mice have similar phenotypes in 
brain as the DG-null mice, which also resemble the brain defects in FCMD, MEB and 
WWS patients (Moore et al., 2002; Michele et al., 2002). These brain data suggest that 
a-DG or its carbohydrate chains is functionally essential for the DG molecule. 
However, in the retina the situation appears more complex. In FCMD, MEB and WWS 
patients, retina show severe defects including disorganized retinal structure, retinal 
degeneration and blindness (Fahnehjelm et al., 2001; Hino et al., 2001; Vervoort et al., 
2004; Zervos et al., 2002). In fukutin-null mosaic mice, there are complete loss of 
ERG, retinal misfold and lens defects (Takeda et al., 2003). However, in the well-
characterized myd mice, retinae show mainly b-wave defects without defective neuron 
migration or misfolding (Grewal et al., 2001; Holzfiend et al., 2002), and only mi Id 
structural defects have been recently reported in the outer plexiform layer and the inner 
limiting membrane (Lee et al., 2005). In our DG-deficient Drosophila eye, the retinal 
phenotypes are quite severe and more resemble those in fukutin-null mice eyes or those 
in MEB patients with retina degeneration and early blindness (Fahnehjelm et al., 2001; 
Vervoort et al., 2004), but not the myd mice. Since LARGE protein is known to directly 
bind to a-DG and participate in synthesis of the functional carbohydrates, phenotypes 
in myd mice more likely demonstrate the function of a-DG. Therefore, if the severe 
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phenotypes in Drosophila DG-deficient eyes are compared to the mil der phenotypes in 
myd mice eye, one would conclude that, in retina, a-DG only represents part of the DG 
functions, which appears different from the brain. Indeed, in our rescue experiments, 
our data show that extracellular and intracellular DG play distinct functions, while the 
extracellular DG appears responsible for PRC organization or pl anar polarity, the 
intracellular DG largely rescues the DG-deficient eye phenotype but extracellular DG 
could not. However, we should consider the retina data very carefully because the DG-
deficient phenotypes in Drosophila eye are in sorne degree similar to those in fukutin-
null mosaic mice and in the FCMD, MEB and WWS patients. More experiments 
aiming to understand how the individual mutant glycosyltransferase in these congenital 
muscular dystrophies affects glycosylation of a-DG or other proteines) should be 
address. And, due to the huge difference in retina structures between Drosophila and 
mammals, a mouse model with eye-specific DG deletion could be more decisive to 
answer sorne of these questions. 
In skeletal muscle, loss of DG cause muscle degeneration, without defects in the 
extrasynaptic basement membrane (Cote et al., 1999), and apoptotic cell death appear 
obvious in DG-null cells (Montanaro et al., 1999; Li et al., 2002). This resembles the 
phenotypes in DG-deficent retina of Drosophila. Therefore, it is possible that DG 
deficiency causes muscle disorientation and growth defect. Kanagawa et al., (2004) 
showed that DG mutant constructs containing no mucin-like region are not sufficient to 
rescue the DG-null skeletal muscle phenotypes, my data imply that, unlike in retina, 
loss of ligand binding to the extracellular matrix could lead to autonomous 
disorientation of muscle cells, which under the constant contraction challenge is 
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sufficient to cause muscle fiber damage even if the intracellular functions of DG is 
conserved. In addition to that, my data aiso suggest an important function for f3-DG and 
its associated complex in contribution to the DG-null dystrophy. 1 propose that 
although f3-DG in muscle is not sufficient to rescue the phenotype, loss of dystrophin, 
sarcoglycans/sarcospan or other signais from the sarcolemma in response to DG 
deficiency contribute to DG-nu Il muscular dystrophy. 
Conclusion 
My experiments demonstrate two novel DG functions in the nervous system. 
First, they show DG interacts directly with the GTPase dynamin 1 in brain and retina 
and regulates dynamin-mediated endocytosis. Thus, it suggests one of the mechanisms 
in DG and dystrophin-related muscular dystrophies could be the disruption of synaptic 
transmission in the nervous system, especially in the retina where defective 
transmission has been known for decades. Second, using Drosophila as the model, 
show that DG is autonomously required for PRe development, which in turn causes 
severe disruption of whole eye, and provide more detail analysis of DG functions, thus, 
it can serve as a great model to further investigate the molecular mechanisms of 
muscular dystrophies and DG biology in general. 
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